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α alpha 
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LASEK Laser Assisted Sub-Epithelium Keratomileusis 
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Definitions 
* Definition 
  
 
 
Additive model When combined effects of disease alleles at 
different loci are equal to the sum of their 
individual effects 
Agonist A false ligind that binds to a cell receptor to mimic 
the action of the natural ligind 
Aneuploidy Miss-segregation of chromosomes resulting in extra 
or missing chromosomal numbers 
Antagonist A false ligand that binds to a cell receptor to inhibit 
normal ligand-binding actions and responses 
Apoptosis A programmed form of cell death with minimal 
debris release due to absence of cell lysis and 
lysozomal enzyme release 
Autocrine Intra-cellular  
Autologous Derived from the self same individual 
Blastocyst Inner cell mass that subsequently forms the embryo 
Cell fate Self-renewal and expansion versus differentiation 
properties 
Cerebral cortex Sheet of outermost neural tissue to the cerebrum of 
the mammalian brain 
Chemokine Cytokine molecules with immune trafficking roles 
Chemotaxis Cell movement in response to a chemical substance 
Chimeric graft Donor cells/tissue are grafted into a host of a 
different species 
Cytokine Small secreted  cell-signaling protein molecules  
Dendritic processes Cell body branching-out-like structures 
Dry-eye syndrome Tear film disorder resulting in chronically dry eyes 
Ganglia  Encapsulated neural cell bodies  
Gap junction Cell-cell structures that allow inter-cytoplasm 
connections 
Genomic imprinting A subset of alleles expressed according to either 
inheritance fom the mother or from the father 
Glial cells Nonc-neuronal cells that serve as support cells in 
the nervous system 
Heritability Mesure of the variation of a phenotype due to 
genetic factors 
HMG-box Sex-determining region on the Y chromosome 
Homeobox Transcription factors that switch on other gene 
networks, typically in embryonic development 
Immunologic privilege The toleration of  the introduction of a foreign 
antigen without eliciting an inflammatory immune 
response 
Indian American Indian race (Amerindians, Amerinds, 
or Red Indians) 
Inuit Culturally similar indigenous people inhabiting 
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the Arctic regions of Canada 
IQ Score derived from a standardised test designed to 
assess intelligence 
Keratectasia Abnormal bulging/protrusion of the cornea of the 
eye 
Keratoconus Abnormal cone-shaped protrusion of the cornea of 
the eye 
Keratoplasty A cornea transplant to replace damaged or defected 
corneas, also referred to as a corneal transplant, 
penetrating keratoplasty or corneal graft 
Lymphangioblast Lymph vessels that arise from mesenchymal stem 
cells 
Microkeratome A precise surgical instrument with an oscillating 
blade designed for creating a corneal incision flap 
Monomorphic SNPs SNP for which a single allele (homozygous) can be 
identified in a population of interest  
Neural tube Compartment of the developing brain and spinal 
cord comprising neural precursor cells 
Overt An observable disease phenotype  
Pannus Fibrotic vascular membrane that covers the corneal 
surface 
Paracrine Inter-cellular 
Penetrance The proportion of individuals carrying the particular 
real risk allele that also express the associated 
phenotype 
Phototherapeutic 
keratectomy 
Laser ablation procedure to remove stromal 
opacities or irregularities 
Pterygium A  wing-shaped, fibrovascular conjunctival 
outgrowth that centripetally invades the clear 
cornea 
Retina proper Photoreceptor layer 
Retinoic acid receptors Nuclear receptors that function as ligand-dependent 
transcription factors 
Sherpa Ethnic group from the high mountainous Himalaya 
region of Nepal  
Slit lamp A high-intensity light source that can be focused to 
shine a thin sheet of light into the eye. It is used in 
conjunction with a microscope. 
Support cell Play a role in the maintenance of hair cell function 
and structure 
Vimentin Intermediate filament important for eukaryote 
cytoskeleton structure 
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General Introduction 
 
This PhD thesis is composed of two projects. The first project is a genetic study on 
high myopia, the second project is a cell biology study on the corneal stroma. 
High myopia can lead to severe impairment of vision, and in extreme cases to 
blindness, making it a serious public health concern. The first project is a genetic study 
designed to better define the genes underlying the high myopia phenotype in the French 
Caucasian population. It is based on a new genome-wide scan method designed to capture 
all underlying genetic variants of the high myopic phenotype within this population. The 
identification of genes involved in high myopia development is not only crucial for the 
understanding of the physiopathology of the disease, but also for the development of 
alternative treatments that today rely on the correction of refractive error by wearing glasses 
or contact lenses. 
Myopia can be corrected by refractive error surgery. This requires the removal of 
corneal stromal tissue to reshape the cornea. In the majority of cases, this corneal wound heals 
and does not leave a scar. However, in an average of 1.75% of operated patients the wound 
healing response is impaired, leading to corneal stromal scarring, known as “opacities”. These 
reduce corneal transparency and impede clear vision. It is important to analyse the cellular 
mechanisms that cause this abnormal wound response in order to improve the current surgical 
treatments of myopia.  
The second part of this PhD thesis is a cell biology project. It is a phenotypic study of 
corneal stromal cells throughout in vivo adult murine corneal wound healing. Our results 
demonstrate for the first time in vivo that following corneal injury, corneal stromal cells can 
express a range of stem cell markers during wound repair. These new in vivo findings may 
provide targets for the prevention or treatment of corneal opacities.  
The projects can be read independently. The most important chapters and all 
conclusions are translated into French (indicated by (#) following the titles in the index).  
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Introduction générale 
 
 
Ce manuscrit de thèse est composé de deux projets. Le premier projet est une étude 
génétique sur la myopie forte, et le second une étude de biologie cellulaire sur la cornée 
stromale. 
La myopie forte peut gravement altérer la vision. Dans des cas extrêmes, elle peut 
causer une cécité, posant un problème de santé publique sérieux. Le premier projet est une 
étude génétique visant à mieux identifier les gènes impliqués dans la myopie forte chez 
une population française caucasienne. Cette étude est basée sur une nouvelle méthode de 
criblage de l’ensemble du génome pour capturer toutes les variations génétiques causantes. 
L’identification des gènes impliqués dans le développement de la myopie forte est non 
seulement essentielle pour la compréhension de la physiopathologie de la maladie, mais 
également pour le développement de nouveaux traitements, qui aujourd’hui, reposent sur une 
correction de la réfraction à l’aide de lunettes ou de lentilles. 
La myopie peut être corrigée par la chirurgie réfractive. Cette chirurgie consiste à 
l’ablation du tissu cornéen stromal pour remodeler la cornée. Dans la plupart des cas, la 
blessure ne laisse pas de cicatrice. Cependant, en moyenne 1,75 %  des patients opérés ont 
une réponse cicatricielle stromale anormale qui mène à la formation d’ « opacités » dans le 
stroma de la cornée qui réduisent la transparence cornéenne et nuisent à la vision. Il est  
important d’analyser les mécanismes cellulaires causant cette cicatrisation anormale en vue 
d’améliorer les traitements actuels de la myopie.  
Le second projet de cette thèse porte sur la biologie cellulaire. C’est une étude 
phénotypique des cellules cornéennes stromales lors de la cicatrisation cornéenne chez la 
souris adulte. Pour la première fois, nous mettons en évidence la localisation in vivo, de 
cellules cornéennes stromales exprimant des marqueurs de cellules souches lors de la 
réparation stromale. Ces nouvelles données in vivo pourraient fournir des cibles pour la 
prévention et le traitement des opacités cornéennes.  
Les deux projets peuvent être lus séparément. Les chapitres les plus importants sont 
traduits en français ainsi que les conclusions (indiqué dans l’index derrière le titre par (#)). 
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I Introduction 
    The Eye: A Visual System  
Humans are highly visual species. Most of our information about the world comes to 
us through our eyes, from which most of our cultural and intellectual heritage is stored and 
transmitted as words and images to which our vision gives access and meaning [1]. 
 
1 The Eye: Structure, Function and Development 
1.1  Global Structure and Function of the Eye 
Light enters the eye through the pupil and is focused on the retina. The cornea and the 
lens focus images from different distances onto the retina. The colored ring of the eye, 
the iris, controls the amount of light entering the eye by controlling pupil size upon 
contraction and expansion. It closes when light is bright, and opens when light is dim. The 
tough white sclera covers the outside of the eye. Towards the most anterior part of the eye the 
sclera gives rise to a transparent structure in order to allow the light to enter; the cornea. 
Ciliary muscles automatically control the focusing action of the lens. Images formed on the 
retina are transmitted to the brain by the optic nerve. The choroid forms the vascular layer of 
the eye supplying nutrition to the eye structures. A “jelly-like” substance called the 
vitreous humor fills the space between the lens and the retina. The lens, iris and cornea are 
nourished by a clear fluid, the aqueous humor, formed by the ciliary body that fills the space 
between the lens and the cornea. This space is known as the anterior chamber. The fluid flows 
from the ciliary body to the pupil and is absorbed through the channels in the anterior 
chamber. The delicate balance of aqueous production and absorption controls the pressure 
within the eye (Fig.1) [1]. 
 
Fig.1. The Anatomical Structure of the Eye. The anterior and posterior chambers relate to two 
spaces divided-up by the lens and iris (adapted from Index A).  
15 
 
1.2 Embryonic Eye Development  
Human eye development is throughout the early development stage. Within a month a 
miniature adult eye is almost formed and development is complete by the end of embryonic 
week 8. The eyes of all vertebrates develop in a pattern which produces an "inverted" retina in 
an invaginated cup-like structure. The eye is derived from three types of embryonic tissue: 1. 
Essentially the neural tube* (neuroectoderm), from which arises the retina proper* and its 
associated pigment cell layer. 2. The mesectoderm (neural plate) of the head region, which 
produces the choroid, ciliary body, iris and corneosclera. The mesectoderm is of neural crest 
cell origin; cells that are actually of neural plaque origin but detach and migrate into the 
mesoderm during neurulation. This is an epithelial-to-mesenchymal transition (EMT). 3. The 
surface ectoderm, from which derives the lens [1]. 
The earliest stage of eye development is the formation of the paired optic vesicles on 
either side of the forebrain. These growing diverticula expand laterally into the mesectoderm 
of the head and develop a stalk-like connection to the main portion of the rudimentary central 
nervous system. In humans, this process begins at about embryonic day 22 (E22). The 
vesicles continue to grow; their connection to the brain becomes progressively narrower and 
more stalk-like. The forming stalks will eventually become the rudiments of the optic nerves 
(Fig.2.A) [1]. 
Simultaneously to formation of the optic vesicles, the surface ectoderm thickens to 
form a lens placode. This is a region visible on the surface of the embryo. This transformation 
is triggered by the proximity of the optic vesicles. Once the formation of the lens placode has 
begun, the expanding optic vesicles begin to invaginate to form a cup-shaped structure, and 
also to fold along their centerline, enclosing a small amount of angiogenic mesenchymal 
tissue as they do so (Fig.2.B). The mesenchyme forms the hyaloid artery and vein, which 
supply the forming lens. Later, in the fully formed stage this will derive the central artery and 
vein of the retina [1]. 
The optic cup then invaginates and folds, forming two distinct layers. The inner layer 
forms the neurosensory retina. The outer layer forms the pigment epithelium layer, which lies 
outside the sensitive portion. The space between these two layers (intraretinal space) is 
obliterated when the two layers fuse. The uveal and corneoscleral tunics differentiate from the 
surrounding mesectoderm. Meanwhile, the surface ectoderm of the lens placode thickens and 
begins to differentiate into the lens vesicle. As the lens rudiment detaches and drops into 
position, a space forms external to it that becomes the anterior chamber of the mature eye. 
16 
 
The surface ectoderm and the mesectoderm above it differentiate into the eyelids and the 
cornea respectively [1].  
By approximately E40, the retina begins to develop as the intraretinal space is 
eventually obliterated. Neuro-sensory photoreceptor retinal cells (rods and cones) are 
developed (Fig.2.C). The remaining template ectoderm serves as a template for the 
organisation of corneal keratocytes (a detailed description of corneal development is in 
Project 2 section 1.5 page 83). Tissue maturation continues from here until birth. At birth the 
only remaining requirement is the concentration of cone cells in the retina macula. The 
postnatal human eye structure then continues to grow until around the age of 3 years old [1]. 
17 
 
 
 
Fig.2. Schematic Representation of Vertebrate Embryonic Eye Development. A: Formation of the 
paired optic vesicles on either side of the forebrain. B: The surface ectoderm thickens to form a lens 
placode, a region visible on the surface of the embryo. The expanding optic vesicles begin to 
invaginate to form cup-shaped structures. C: The retina begins to develop as the intraretinal space is 
obliterated. The lens detaches from the surface and the cornea begins to form from the thickened 
ectoderm. Photos of human embryos in A and B were kindly donated by Dr Heather Etchevers 
(INSERM UMR910, La Timone, Marseille). Left panel images [2]. Bottom right image [3].  
 
Index B 
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2 Myopia: Changes in Visual Refraction 
2.1 The Normal Eye and Refraction 
  In the normal eye, entering light rays are focused and intersect on the retina by a 
succession of transparent components; the cornea, lens, aqueous and vitreous humors. This 
creates a sharp image that is transmitted to the brain by the optic nerve. This is normal 
emmetropic refraction. The ciliary muscles adjust lens shape to properly focus images on the 
retina depending on the distances of the images; this is known as accomodation (Fig.3.A).  
Emmetropisation is acquired by coordinated growth of eye structures and it is 
considered for an emmetrope that there are no further refractive changes after the age of 16 
years old [4, 5]. Refraction depends on the refractive index of the cornea, lens, vitreous and 
aqueous humor, as well as the anterior chamber depth and the axial length of the eye 
(refractive components) [6]. Anomalies in these components result in refractive error defects 
and a failure of the eye to focus images sharply on the retina, causing blurred vision. 
 
2.2        Myopia, High myopia and Hyperopia 
2.2.1      Myopia 
Myopic eyes relate to blurred far vision due to image formation in front of the retina 
(Fig.3.B). However, close objects appear clear without the eye’s accommodation effect, thus 
myopia is also called shortsightedness. The extent of myopia is clinically measured by the 
correction necessary to reestablish clear vision in dioptries (D). Different types of myopia can 
be distinguished by their origins [7, 8]: 
 
• Pseudo-myopia: This is a false myopia due to consecutive spasms in accommodation. 
• Excessive corneal curvature: This is frequent in patients suffering from Keratoconus 
(a degenerative disorder involving structural changes within the cornea. It becomes 
thinner and adopts a more conical shape than its normal gradual curve).  
• Increased lens refractive indice: Due to cataract, the size and shape of the lens. 
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Fig.3. Emmetropic and Myopic refraction. A: A normal emmetropic eye; a clear image focused 
directly on the retina. B: A myopic eye; image focused in front of the retina and note the inceased axial 
length of the eye. C: The combination of anterior chamber depth (ACD), lens thickness (LT) and 
posterior chamber depth (VCD) = axial length (AL) [9]. D: Representation of the visual defect of a high 
myopic patient suffering from retinal detachment. Photo effect kindly designed by Remy Pillot 
(ActenGo, Toulouse). 
 
• Increased axial length: Axial length is a combination of anterior chamber depth, lens 
thickness and posterior chamber depth (Fig.3.C). Axial length myopia is the most 
common form of myopia [6]. The normal eye measures approximately 24 mm. Axial 
length myopia can be separated into three forms by artificial clinical definition of 
corresponding refractive error values [6, 10]: 
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1. Weak myopia: Corresponding to an error of refraction between -0.5 D and -3 D. 
2. Moderate myopia: Corresponding to between -3 D and -6 D. 
3. High myopia: Corresponding to an error of refraction ≤-6 D [6, 10, 11]. Some genetic 
definitions of high myopia are not in agreement with this clinical definition. Geneticists 
sometimes study only phenotypes with higher errors of refraction (-8 to -12 D) in order to 
be certain of exclusion of milder forms of myopia [12, 13]. High myopia usually develops 
by a rapid refractive error decrease between the ages of 10 and 12 years during education 
[6, 14]. High myopia is accompanied in almost all cases by an increase in axial length due 
to accelerated post natal eye growth [15]. Clinically, high myopia corresponds to an axial 
length increase to at least 26mm [11]. A 1 mm axial length elongation corresponds to a 2-
2.5 D refractive error shift [16]. Some high myopes with extensively increased axial 
lengths have refractive errors beyond -20 D. It is well confirmed that there is a negative 
relationship between axial length and myopia, the more severe (negative) the myopia, the 
longer the axial length [17, 18]. High myopia can lead to blinding secondary 
complications, such as retinal detachment (Fig.3.D), retinal hemorrhage and glaucoma, 
making high myopia one of the principal causes of adult visual defects and blindness in 
the world [19-26]. 
4. As well as appearing as an isolated pathology, high myopia can also appear as part of 
a rare disease syndrome. The majority of these syndromes are associated with collagen 
defaults, such as Type I Stickler (type 2 alpha (α) 1 collagen) and Type II Stickler (type II 
collagen mutations).  
 
2.2.2     Hyperopia  
This can be considered as the opposite to myopia, or farsightedness. The point of focus 
is behind the retina because the cornea is too flatly curved, the axial length is too short, or 
both. In adults, both near and distant objects are blurred. Children and young adults with mild 
hyperopia may be able to see clearly due to their ability to accommodate. 
 
2.2.3     Distribution of Refractive Errors in the General Population 
Upon removal of highly myopic and hyperopic subjects from the general population, 
refractive errors demonstrate a normal distribution. The same observation is made for each of 
the refractive components in the general population (Fig.4) [27]. This led to the hypothesis 
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that there is a relationship between all the refractive components that contribute to the overall 
refractive status. Conversely, analysis of the refractive components including the highly 
myopic and hyperopic subjects in the general adult population results in loss of a normal 
distribution, and a deviation towards an accumulation of myopes (Fig.4). This has been 
regarded as a compensatory correlation between refractive components; one component is 
out of line, so the others adjust to compensate [28]. In other words, the refractive components 
excessively try to emmetropise.  
 
Fig.4. Distribution of Axial Lengths in the General Population. Black line: Normal distribution of 
axial length in a population of 114 twins 20-45 years old (excluding severely high myopic and 
hyperopic subjects). Red line: Estimation of graph curve deviation towards an accumulation of myopes 
when all axial length data in the general population is accounted for (adapted from [29]).   
 
3 Epidemiology 
Human myopia and high myopia prevalence varies depending on the age group 
concerned and the country and region under study. Due to variable inter-study criteria it is 
also difficult to make accurate conclusions from the different population studies that have 
been carried out. In general, myopia is the most common refractive disorder world-wide and 
is thought to affect approximately 20% of the western (industrialised) population aged 
between 40 and 80 years old (16% in Australia, 18% in Holland, 25% in America) [30]. 
However, in Asian countries myopia prevalence is higher; approximately 80% in some urban 
populations in Honk Kong, Taiwan and Singapore [31-34]. In 2004, average high myopia 
prevalence in the western population of adults aged over 40 years old was estimated to be 
4.5% [30]. The rate in Asian populations is higher, manifesting 8 to 9% of high myopes [30, 
35, 36]. Multiple studies, as well as national and international government statistics have 
found an increase in the prevalence of myopia over the last few decades [37, 38].  
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 4.  The Use of Animal Models to Determine the Mechanisms Underlying 
Myopia Development 
The majority of animal models used to investigate the physiopathological mechanisms 
at play in myopia development are induced myopic forms in rodents that are simple to 
manipulate in laboratory conditions. Species used include primates (Marmoset and Rhesus 
monkeys), cats, tree-shrews, especially small rodents (mouse and guinea pig), and in most 
cases chicks. Myopia development is achieved by both eye lens defocalisation and complete 
eye light deprivation (form deprivation). Animal models have been developed on young 
animals before completion of adult eye development. 
 
 4.1 Animal Visual Defocalisation Models 
Lenses can be fixed to the exterior of animal eyes (Fig.5.A). A negative lens provokes 
an artificial myopia so the image is focused behind the retina, thus the animal eye reacts by 
increasing the axial length [39-42]. Conversely, a positive lens provokes eye globe length to 
decrease as the image is focused in front of the retina [39]. As soon as the eye retains clear 
vision, growth or retraction ceases. Also, if the lenses are removed soon enough (before the 
adult eye is formed), the eye can restore emmetropia and a normal axial length is restored 
[42].  
4.2 Animal Visual Deprivation Models 
Complete monocular light deprivation can be achieved by suturing the eyelids, using 
an opaque cover or translucid diffuser, allowing no, or a small amount of light to pass 
(Fig.5.B). Results obtained show that under these conditions the axial length continues to 
grow, and only slows down growing when the eye is reexposed to normal light. This is 
explained by a lack of image focus on the retina, leading to the complete lack of a signal to 
stop ocular growth [40, 43-49]. Once the cover is removed the eye returns to emmetropy and 
a normal axial length is restored, but again, only if the developing eye does not reach full 
adult size [40, 50, 51]. If so, the myopia can persist.  
 
Fig.5. Animal Models of Myopia. A: A defocalisation lens fixed to a chick [51]. B: Guinea pig monocular form 
deprivation using a facemask [52].   
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On the whole, animal studies use environmental factors to provoke ocular growth, 
influencing axial length growth to mimick the human myopic phenotype. From here, 
comparisons between normal and myopic animal eye tissue structures and molecular gene 
expression levels have allowed the identification of mechanisms that could underly the human 
myopic disease phenotype. Animal models are generally moderate myopic forms; results 
being equally considered as potential players in the development of high myopia. Below are 
the some most important examples.  
 
4.3   Scleral Thinning 
The sclera is an external rigid connective tissue of collagen fibrils and proteoglycans 
that are responsible for the highly organised scleral structure. Human high myopia is often 
associated with posterior staphyloma. This is scleral thinning and weakening, often leading to 
a scleral tissue protrusion [53-55]. The proteoglycans decorin and biglycan regulate collagen 
fibril assembly and spacing in the sclera. Aggrecan is composed of elastic laminin and 
fibrilin, responsible for the hydration of the sclera. The sclera is constantly remodelling 
throughout eye growth, but in the case of high myopic eyes, the sclera is excessively 
remodeled. Animal defocalisation and deprivation models confirm this, showing increased 
scleral remodelling and thinning with increased axial length [43, 56]. Two different 
hypothesises have been put forward; 1. The sclera undergoes remodelling caused by axial 
length increase and/or 2. Scleral properties are pre-modified (more elastic) and well adapted 
for axial length increase, thus being a cause of scleral remodelling. In both cases, collagen 
fibril diameters decrease and proteoglycan quantity is reduced [15, 57-59], contributing to the 
weakened biomechanical properties of the sclera. 
Hypotheses have looked into a role of the factors involved in scleral remodelling in the 
development of myopia. Notably matrix metalloprotease (MMP) family members 1, 2, 3, 9 
and 14 regulated by tissue inhibitor matrix metalloproteases (TIMP) are present, but not 
active in the normal human sclera [60-64].  It was discovered in myopic scleral tissue that 
MMP2 activity is increased [62], in parallel to reduced TIMP3 or unchanged TIMP1 and 2 
activities [59, 65]. MMP2 is involved in collagen fibril degradation, implying a reduced 
scleral structural organisation in myopic eyes [65, 66].  
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 4.4 Local Emmetropisation Defects 
We know that the process of emmetropisation is regulated by image formation on the 
retina. This induces sclera remodelling and a compensatory axial length elongation in order 
for retinal positioning to be altered to focalise images [59]. However, deprivation of a specific 
and small retinal area in animal models resulted in only this specific area elongating axially 
[67]. Similarly, blocking transmission of image signals via the optic nerve to the brain did not 
prevent myopia [68]. Finally, the retina exerts Go/Grow and Stop signals for eye growth 
depending on the permanence of visual messages received. Go/Grow signals correspond to 
those elicited during childhood hypermetropy, and Stop signals are elicited when emmetropy 
is gained. Chick models have shown that changing negative lenses for positive lenses for even 
just a few minutes each day prevents myopia development, indicating the existence of 
counteracting Go/Grow and Stop retinal signals [69]. These studies favor the idea that myopia 
development is deregulation of the eye’s own local emmetropisation mechanisms.  
 
4.5 Identification of Molecules in Retinal Signaling with Implications in Myoia 
Development (Molecular Candidates) 
It is generally believed that the pathways involved in the control of eye growth involve 
signal cascades initiated in the retina which send signals through the retinal pigment 
epithelium (RPE) and choroid to control the growth of the sclera. However, the identities of 
the retinal molecules and pathways involved are still unclear. Recent work has investigated 
global changes in retinal gene expression during the development of animal myopia, giving 
some insights into molecules involved in the regulation of ocular growth. Below are some 
major examples.  
 
 4.5.1 Retinal Neurotransmitters 
A Gamma Aminobutyric Acid (GABA) 
GABA is a human neurotransmitter that mediates neurotransmitter inhibition 
throughout the retina and central nervous system (CNS). Three main classes of GABA 
receptors exist; GABAA, GABAB, and GABAC receptors [70, 71]. GABAA retinal 
neurotransmission has no effect on pre-induced myopia in animal models, yet GABAA 
antagonists* limit form-deprivation myopia development [72]. The same effect is observed by 
GABAC [73]. Both GABAB agonists* and antagonists decrease eye growth [72]. This implies 
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both Go/Grow and Stop roles for these molecules in retinal signaling and myopia 
development.  
 
B Glucagon  
Glucagon is a 29-amino-acid long peptide produced by the proteolytic cleavage of the 
precursor molecule preproglucagon (PPG) [74]. Glucagon is part of a superfamily of secretin-
glucagon peptides that act through G-protein coupled receptors, and has increasingly been 
identified as a possible neurotransmitter in the CNS [75, 76]. At the RNA transcript level, it 
has been reported that PPG levels were initially upregulated following 2 h of negative-lens 
treatment, before showing significant down-regulation after 24 h of lens wear [77]. It has also 
been demonstrated that glucagon agonists can prevent experimentally induced myopia, while 
glucagon antagonists can prevent compensation for positive lens wear [78]. This suggests a 
Stop signal role for glucagon in the modulation of eye growth through direct and rapid action 
on retinal circuits to enhance sensitivity early-on in the signaling process [79].  
 
 4.5.2 Growth Factors 
A Transforming Growth Factor-β (TGF-β) 
TGF-β is a protein involved in the stimulation and inhibition of diverse cellular 
signaling events depending on the ‘cellular context’, from proliferation and cellular 
differentiation to programmed cell death. The TGF-β signalling system is highly conserved 
throughout the animal kingdom [80]. Of primary importance to myopia development, TGF-β 
regulates extracellular matrix (ECM) turnover, and the three mammalian isoforms of TGF-β 
(TGF-β1, TGF-β2 and TGF-β3) have been shown to regulate collagen production by scleral 
cells. Furthermore, decreased TGF-β expression, which occurs within 24 h of the initiation of 
myopia development, has been linked to the altered regulation of ECM production found in 
the sclera of eyes developing myopia [81]. Recent in vivo mammalian work suggests the 
presence of a constant myofibroblast cell population in the sclera [82]. These cells exhibited a 
contractile phenotype which could be modulated by all TGF-β isoforms. The increase in TGF-
β pathway mediated changes in myofibroblast numbers in the sclera was found to increase 
myopia development, and vice versa; reduced TGF-β pathway mediated changes in 
myofibroblast numbers resulted in myopia recovery. On the other hand, when scleral cells 
were exposed to both reduced TGF-β levels and increased static stress, a larger population of 
scleral myofibroblast cells were found to be present. Thus, although TGF-β is a major 
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contributor to the remodelling of the sclera during changes in eye growth, it is matrix stress 
that is the major determinant of the scleral cell phenotype. 
 
B Fibroblast Growth Factor-2 (FGF-2) 
FGFs with their receptors (FGFRs) and signaling cascades are involved in a diverse 
range of cellular processes including proliferation, apoptosis*, cell survival, chemotaxis*, cell 
adhesion, motility and differentiation. FGF-2 is a potent mitogen for fibroblasts and 
myofibroblasts [83], and has also been shown to be involved in the control of ECM turnover, 
specifically regulating collagen and proteoglycan production, and mediating tissue 
degradation through controlling synthesis of MMPs and their regulators [84]. Importantly, 
FGF-2-mediated signaling is regulated through its capacity to bind proteoglycans [85]. 
Studies have shown that exogenous delivery of FGF-2 can prevent the development of 
myopia in the chick [86], reducing the excessive axial elongation and retinal neuronal 
apoptosis in chronic form-deprivation myopia [87]. Both FGF-2 and FGFR-1, are expressed 
ubiquitously in the retina and sclera of chicks [88], so evidence as a whole indicates that FGF-
2 is a potential regulator of retinoscleral signaling, controlling sclera remodelling and ocular 
growth in myopia development.  
 
4.6 Contribution to the Understanding of the Mechnanisms Underlying 
Human Myopia Development 
Animal models show that myopia can be reversed by a local active emmetropisation 
effect and suggest that human myopia is the result of default in the emmetropisation response. 
Unfortunately today we cannot precise whether an accommodation default is the cause or the 
consequence of myopia. Similarly, in some human subjects an defect in emmetropisation has 
been observed before [89, 90] and others after [91] myopia development. Thus, human 
myopia development is due to a genetic defect resulting in a default in the emmetropisation 
program, and an environmental emmetropisation defect that results in eye growth in search 
of visual input. Both of these cases result in axial length elongation. Moreover, multiple 
molecular changes in myopic animal tissues imply that human myopic and high myopic 
disease phenotypes are polygenic. From here, genetic studies are required to confirm an 
underlying genetic defect, and consequently which of these molecular candidates could 
underly the genetic defects causing this defect in human emmetropisation.   
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5  The Human Myope: Genetics versus the Environment 
A disease phenotype can vary depending on the variation in response to environmental 
factors as a function of the underlying genetic makeup, a phenomenon known as gene-
environment interaction [92]. Myopia is a complex trait affected by both genetic and 
environmental factors, and their interactions [93]. The increase in myopia rates over the last 
few decades shows that genetics cannot account fully for the myopic phenotype. Many active 
studies involving large human cohorts have been carried out to try and quantify such 
environmental-gene interactions. Note that such studies are limited for high myopia due to 
greater difficultly in human cohort collection compared to the more prevalent moderate 
myopia phenotype.  
 
5.1 Environmental Effects  
A number of studies have shown that the incidence of myopia increases with level of 
education [94, 95]. Many studies have shown a correlation between myopia and IQ* [96], 
likely due to the confounding factor of formal education. Other personal characteristics, such 
as school achievement, time spent reading for pleasure, language abilities and time spent in 
sport activities correlates to the increasing occurrence of myopia [97, 98].  
 
5.1.1 Education and Near-work 
Former studies investigating education levels and refractive error prevalences 
discovered that upon introduction of an education system among young Alaskan Eskimos, the 
rate of myopia increased compared to older Eskimos that did not have a high level of 
education [99]. Similar studies carried out on Indian*, Inuit* and Sherpa* ethnic populations 
with former low education levels gave similar results [100-102]. Note that high myopia rates 
were very rare in these studies. Higher levels of myopia are mentioned in studies carried out 
on highly educated western populations [37, 95, 103]. In Singapore young adults with 3-5 
years of university study show a 40% rate of high myopia [104].   
Level of education is often used as a surrogate measure for near work with more 
myopia among the more educated [95, 105, 106]. Several clinical studies have documented an 
association between myopia and higher levels of children’s near work [107-110]. Support for 
an important role for near work also comes from animal studies that have demonstrated the 
plasticity of refractive error in response to environmental stimuli. Neonatal chicks, tree-
shrews and monkeys experience increased ocular growth and become myopic or less 
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hyperopic after wearing minus lenses, presumably to compensate for the hyperopic defocus 
produced by these lenses [111-114]. The current environmental model derived from these 
studies is that exposure to hyperopic defocus from accommodative lag during prolonged near 
work leads to excessive growth of the eye and a myopic refractive error. 
 
 5.1.2 Urban versus Rural Lifestyles 
A handful of studies have shown that myopia prevalence is higher in urban compared 
to rural populations. For example, the myopia rate in school children aged 6-7 years old in 
Singapore city was found to be higher than in Xiamen city (a countryside Chinese city); the 
lowest rates were found in Xiamen countryside [115]. As these Chinese populations were of 
similar genetic backgroubd (predominantly from Southern China), it was postulated that the 
differences in myopia rates in these three localities may be related to environmental factors. 
Children closer to or living in the countryside may spend more time doing outdoor activities, 
thus increased greater distance accommodation, and less near-work accommodation. The 
same correlation is observed with myopia rates and the amount of time children spend doing 
outdoor sport activities, notably in more rural country regions [98, 116]. Modern food habits 
in industrialised countries have also shown a favorable link between increased sugar levels, 
hyper-insulination and interaction with retinoic acid receptors* in the retina of developing 
children, resulting in increased axial elongation [117]. This suggests hormonal interaction and 
regulation of vitreous chamber growth.  
 
5.2 Human Myopia Genetics 
Myopia and high myopia appear as complex traits. Complex traits do not show typical 
Mendelian inheritance patterns [118]. The majority of high myopia is caused by increased 
axial elongation [119], caused by multiple gene effects (polygeneity). Myopia and high 
myopia can be compared to the continuous and complex height trait, which is also controlled 
by both different genetic and environmental factors [118]. The simultaneous involvement of 
several different genes makes the study of complex disease phenotypes difficult as individuals 
suffering from myopia or high myopia can have the same or different underlying gene 
mutations or even different mutations in the same gene(s). This is known as genetic 
heterogeneity. In addition, individuals with a causative genetic variation may not express the 
phenotype, while others do. Despite this complexity, myopia and high myopia have shown 
genetic inheritance in the following genetic studies.  
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Myopia and high myopia phenotypes coexist in the same families as myopia is a 
continuous trait that is difficult to separate into two separate diseases. Thus, note that 
many references to studies on the myopia phenotype (including molecular candidates 
indentified in animal myopia models) are extrapolated to the high myopia phenotype.  
 
5.2.1   Heredity 
A Twin Studies  
Twin studies have presented the strongest evidence for genetic inheritance in the 
control of eye size and refractive errors. Monozygotic twins have much higher (83-97%) 
concordance of myopia and related ocular components, such as axial length, anterior chamber 
depth and corneal curvature, compared to dizygotic twins (47-50%) [29, 120-124]. 
Considering that monozygotic twins share the totality of their genetic patrimony and dizygotic 
twins share only half, these differences in concordance can only be genetic. This is assuming 
that more often twins are brought up together, implying that differences in concordance are 
genetic more than environmental [125].      
 
B Family Studies  
Family studies indicate that if at least one of two parents is myopic, then the children 
are more likely to develop myopia and have longer anterior and vitreous chambers, even 
before the onset of myopia development [126-130]. It was also shown that having 2 myopic 
parents instead of no myopic parents significantly increases the risk of developing myopia 
[131].  
 
C  Segregation Analysis 
Despite the heterogeneity of myopia, a handful of studies have tempted to test the 
segregation of myopia in family studies. It was found that high myopia in the majority of 
cases favours an autosomal dominantly transmitted disease model [132-134]. Only one case 
of autosomal recessive transmission of high myopia in a consanguineous Chinese family has 
been suggested [135].  
 
5.3  High Myopia Genetic Mapping  
Despite the complexities in the myopia and high myopia phenotype and different 
environmental effects, many researchers have made attempts to localise candidate genes with 
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genetic susceptibility to myopia and high myopia. Many different genetic mapping techniques 
and analyses have been tested to try and trace myopia and high myopia susceptibility genes in 
family-based and population-based studies using different ethnic-originated cohorts. It is 
important to understand genetic mapping techniques in order to evaluate the importance of the 
different candidate chromosomal and candidiate genes put forward for high myopia 
susceptibility.  
 
5.3.1  Microsatellites versus Single Nucleotide Polymorphisms  
A Microsatellites 
Microsatellites, also called short tandem repeats or sequence length polymorphisms, 
are assays of short repeated sequences. They are usually di-, tri- and tetra-nucleotide repeats 
that display different length variations with different alleles carrying different numbers of 
repeat units. They are multi-allelic and there are 5-10 for each allele at each locus (Fig.6.A) 
[118]. Differences in DNA length can be detected using automated DNA sequencers via 
capillary gel electrophoresis. This separates microsatellite containing fragments that are 
amplified by polymerase chain reaction (PCR). Microsatellite genetic maps show known 
positions of microsatellites, thus indicate the location of a DNA variation in relation to the 
genes in the chromosomal region. This information is also readily available in NCBI 
(National Centre for Biotechnology Information) databases. Concerning myopia, 
microsatellites have been successfully used for linkage analysis, linking myopia genes of 
interest to large chromosomal regions [136-152]. These regions can extend into a few 
thousand kilobases (Kb) segments.  
 
B Single Nucleotide Polymorphisms (SNP) 
An SNP is a DNA variation of a single base. Approximately 99.9% of the human 
genomes between unrelated individuals are identical. The remaining 0.1% is accounted for by 
80% by SNP variation. SNPs are bi-allelic and thus simple to detect (Fig.6.B). There are 
different classes of SNP variations: 
 
• Coding SNPs: Single base variations in the exon sequence, thus present at protein 
level.  
• Non-synonymous SNPs: Variations that result in coding of a different amino acid. 
• Synonymous SNPs: Variations that do not encode a different amino acid.   
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• Non-coding SNPs: Variations found only in DNA introns, thus not present at protein 
level. These can have functional consequences if the variation occurs in a gene 
promoter region or 5’/3’ untranslated region (UTR). These variations can effect gene 
transcription, mRNA splicing or mRNA stability.  
 
 
Fig.6. Microsatellite and SNP Markers. A: A multi-allelic microsatellite with each allele carrying at 
least 11 GT di-nucleotide repeats (placed within brackets for the sake of clarity). B: A di-allelic SNP 
with a G allele and A allele (underlined) [118]. 
 
C Linkage Disequilibrium (LD) 
LD is a theory that describes a non-random association of SNPs markers at two or 
more loci, not necessarily on the same chromosome. Two SNPs that are in strong LD may 
serve as proxies for one another. That is, if the correlation between the two SNPs, measured 
by an r2 value, is high (Fig.7). If this is the case, genotyping one of the SNPs gives nearly 
complete information regarding the genotype of the other SNP. Therefore, a SNP array that 
genotypes 1 million SNPs effectively assays a larger proportion of human genetic variation 
than represented on the array. Taking advantage of this principle, genotyping array 
manufacturers have been specifically designing arrays to query SNPs that correlate with, or 
‘tag’, a large number of other SNPs in the human genome [153]. The requisite knowledge of 
the LD structure in the genome was largely facilitated by the International HapMap Project 
[154]. HapMap data is an online database with free access to SNP allele frequencies and LD 
data of human control populations including Nigeria, America (CEU; Northern and Western 
European ancestry), Japan and China.  
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Fig.7. IL10 Gene Common SNPs in a Visual LD Block (CEU population). r2 between SNPs is shown 
(VG2 program; http://pga.gs.washington.edu/VG2.html). The important point is that even in a 7-kb 
non-recombinant region (sometimes referred to as a ‘haplotype block’), if we genotyped SNPs 1498 
and 6570 (indicated by arrows), we would observe strong LD between several markers (r2 = 1; shown 
in red). But there are clearly a number of SNPs (for example, 2767, 2911, 3582 and 4467) that are 
weakly associated with either of these two marker, therefore not all variation would be detected 
(adapted from [155]). 
 
Microsatellites allow zoom in analyses into chromosomal regions containing 
susceptibility genes. Large-scale studies require between 400 and 800 microsatellites evenly 
spaced throughout the genome, meaning strong systematic searching. This is expensive and 
time consuming [118]. SNPs give a vague genetic marker “hot spot” requiring further 
genotyping studies on huge chromosomal regions. However, SNPs can undergo modern high-
throughput genotyping analyses meaning genetic mapping is a faster process. SNPs are also 
more stable, especially synonymous SNPs as they are considered to be protected from natural 
selection processes. This means SNPs are easier to trace across different population 
generations [118].   
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5.3.2  Copy Number Variation (CNV) 
CNVs are segments of DNA ranging from 1 kb to several megabases (Mb), for which 
copy-number differences have been revealed by comparison of two or more genomes [156]. 
Inter-human variation in CNV is approximately 0.7% [157]. These quantitative structural 
variants often encompass one or more genes [158]. They can be CNV gains (duplications or 
insertional transpositions), losses (deletions), gains or losses of the same locus, or multi allelic 
or complex rearrangements [158]. CNVs can affect gene function in several ways. Deletion or 
disruption of one or more genes can cause functional loss, with CNVs functioning as 
dominant or recessive alleles according to the cellular function of the affected gene 
product(s). Alternatively, CNVs may disrupt a regulatory element, generate novel fusion 
products, or act by causing genomic imprinting* and differential allelic expression [156, 159]. 
Conversely, some large CNVs involving dozens of genes have shown no overt* phenotype 
[156, 158, 160, 161]. To date variations in CNV have not yet been reported to underly the 
myopia or high myopia phenotypes.   
 
5.3.3  Qualitative versus Quantitative Analysis 
A qualitative trait is a discontinuous trait with two or more distinct categories where 
each category can be separated from the other categories and qualitative disease traits are 
shown by phenotypic deviations from the norm. For example, the ABO blood group system.  
 A quantitative trait is a continuous trait and exhibits a wide range of possible 
phenotypes in a constant spectrum. It does not follow Mendelian inheritance and quantitative 
trait diseases are usually complex. In genetic studies myopia and high myopia phenotypes of 
refractive error and axial length phenotypes have been converted into qualitative traits upon 
fixation of a specific phenotype threshold. High myopia has often been classed as an error of 
refraction of at least -6 D [6, 10, 11]. Different threshold have however been set depending on 
different studies, leading to difficulties in comparison of results [118]. 
 
5.3.4 Linkage Analysis; Parametric versus Non-parametric  
Genetic mapping uses both qualitative and quantitative traits in linkage studies. 
Briefly, linkage analysis is a method used for detecting if there is significant evidence for co-
segregation of disease alleles at a marker locus in family pedigrees (more powerful with 
multi-generation pedigrees). The linkage of markers to a disease mutation is quantified by a 
logarithm of the odds’ (LOD) score. A LOD score of ≥3 is considered to be significant 
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evidence of linkage. Parametric linkage analysis requires a certainty of the correct disease 
model, the frequency of disease allele(s) and the penetrance* for each genotype. Non-
parametric linkage analysis does not take into account these factors. This is because either 
the disease model is unknown, or as in the case of myopia and high myopia, the disease does 
not follow normal Mendelian inheritance. If an incorrect model is specified for parametric 
analysis, linkage analysis could not only miss true linkage, but moreover perhaps result in 
false significant linkages. Non-parametric analysis can be carried out on smaller nuclear 
families, but power is lost. The affected sibpair (ASP) analysis is the simplest type of allele-
sharing method commonly used to map genes in complex eye diseases [137, 138, 144-146]. 
Both parametric and non-parametric linkage analyses have been used to identify myopia and 
high myopia genetic loci, parametric linkage analysis assuming an autosomal dominant 
inheritance in most cases [136, 139-142, 149-152, 162, 163]. Note two X-linked myopia 
localisations have been identified [143, 150, 151]. 
 
 5.3.5 Association Analysis 
Association analysis is considered a more powerful method for detecting multiple 
small gene effects in complex diseases (Fig.8) [164]. Association analysis is based on 
significantly increased or decreased frequency of an SNP marker allele in a disease phenotype 
compared to a control phenotype. Association analysis takes into account tagSNP LD, thus 
associated SNPs can actually be located in DNA sequences far from the original associated 
SNP marker. There are two different cohort-based association analyses that can be carried 
out: 
 
 A  Population-based Case Control Analysis 
This is the most widely used method for common complex trait genetic studies. SNP 
frequencies are compared between a set of disease affected subjects and a set of unaffected 
control subjects. Both cases and controls must be unrelated, but come from the same 
population (similar age, gender repartition, ethnic and geographical background). A greater or 
reduced % of SNP frequency in the cases compared to controls is considered to be an 
association of the SNP marker allele with the disease phenotype. The chi-square (χ2) test is 
used to measure statistical significance of this association. Human subject recruitment for this 
method is easier and quicker as family pedigrees are not required. However, inappropriate 
matching between case and control populations can result in false positive associations due to 
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different allele frequencies between different populations (population stratification). This 
method has been widely used recently in myopia and high myopia candidate gene analyses.  
 
 
Fig.8. Gene Mapping Strategies for Diseases with Different Gene Effect Sizes. Genes involved in 
rare Mendelian diseases show large effects and are best mapped by parametric linkage analysis in 
large families. Genes involved in common complex diseases exhibit small effects and are best 
identified by genetic association studies using cases and controls [118]. 
 
  B Family-based Association Analysis 
 This can be used to overcome population stratification issues sometimes encountered 
in population-based association analysis as this method requires small nuclear families, with 
both affected parents and offspring. The parents provide internal control data, assuming that 
non-transmitted alleles to offspring are not associated to the disease phenotype. The 
transmission disequilibrium test (TDT) is the most widely used version of this method, testing 
for distortion in the transmission of alleles from a heterozygous parent to an affected child. 
The frequency of the transmitted allele is compared to that of the non-transmitted allele [165]. 
Again, this method has been used as a myopia candidate gene search approach.  
 
5.3.6 Candidate Gene Approach 
Candidate genes are selected according to prior known biological function and 
expression in tissues associated to the disease phenotype [166]. Myopia and high myopia 
candidate gene analyses have predicted mutations in genes expressed in eye tissues, in many 
cases having previously shown a potential role in myopia development in animal 
experimentation models as previously described in section 4 page 22.   
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It does appear more logic to start by a whole genome search to identify chromosomal 
regions with a potential collection of human myopia susceptibility genes in order to then 
conduct grouped candidate gene scans. However, genome scans are very expensive and time 
consuming in human subject recruitment, resulting in replacement by simple candidate gene 
scans in smaller cohorts. This has similarly been carried out for complex diseases such as 
diabetes and hypertension [118]. The most common analysis method for this candidate gene 
method is case-control association analysis. TGFβ1 [167] and Lumican (LUM) [168] were 
identified as myopia susceptibility genes by this method. These candidates were initially 
considered interesting candidiates from previous animal models, demonstrating a potential 
role of TGFβ signaling in retinal growth signals [81], and LUM proteoglycan, as the myopic 
sclera shows a reduction in proteoglycan quantity [57].  
Candidate gene analyses have also been carried out on potential genes identified in 
chromosomal regions localised by intital whole genome scans [167, 169-173]. These studies 
can be considered as follow-up, or replication studies. For example, genes in the MYP2 
locus underwent a replication study, but disagreed with previous significant association 
shown between the high myopia phenotype and the Transforming factor β-induced factor 
(TGIF) gene [169, 171]. To date only 3 candidate regions/genes have survived a total of 
approximately twelve high myopia gene replication studies [174-179].  
  
5.3.7 Genome-wide Association Analysis (GWAS) 
  A  The Principle of GWAS  
The goal of GWAS is to find the variants that are statistically more prevalent in 
individuals with a disease than in individuals free of the disease. A study typically entails 
collecting large numbers of affected (cases) and unaffected (controls) individuals, and running 
the DNA of all individuals on SNP arrays. Genotyping data is then mined for statistically 
significant differences in allele frequencies between the two groups. The associated variant is 
then either a disease predisposition allele, or in LD with such an allele. In recent years, 
GWAS has been facilitaed in majority by both the Affymetrix (Dr Stephen P.A. Fodor, Ph.D, 
Santa Clara, California, USA) and Illumina (CW Group, Larry Bock, San Diego, California, 
USA) genotyping platforms. A considerable factor for doing GWAS is the cost of genotyping 
enormous numbers of cases and controls. Large numbers of subjects are necessary due to the 
high density of the arrays, meaning hundreds of thousands of variants need to be tested, 
resulting in hundreds of thousands of significancy tests. In order to avert huge numbers of 
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false positive associations, the p-value threshold for statistical significance must be very 
stringent to accommodate this huge multiple testing burden; typically lower than 10-6. This 
problem was exemplified by the study performed by the Wellcome Trust Case Control 
Consortium [180]. Here, the authors performed GWAS on seven different diseases, 2000 
cases for each different disease. Rather than having separate panels of control individuals for 
each disease, the study shared 3000 unaffected controls across all the diseases. All 17 000 
individuals were genotyped using the Affymetrix 500K SNP array. The density of the array 
allowed the researchers to test an enormous number of SNPs, but the multiple tests meant that 
only associations with p-values less than 5 x 10-7 were reported as significant. The large 
sample sizes were therefore necessary for power sufficient to obtain such low p-values. A 
collaborative GWAS was also carried out on the quantitative trait of height among human 
adult subjects. This localised 20 different candidate loci, implying that a wide range of 
developmental and signaling molecules underly the height trait [181]. However, again cohort 
sizes were extensive, reaching 16 482 cases, and p-values were set to the 10-7 to 10-10 range.  
 
  B GWAS on all Refractive Error Phenotypes 
Two major successful GWAS were published in late 2010 based on global refractive 
errors, thus a range of hyperopic to myopic phenotypes [177, 178]. The Hysi et al., (2010) 
[177] study that made BBC (British Broadcasting Coproation) news headlines initially 
scanned the genomes of 4270 individuals from a UK-based twin cohort and found a 
consistency of SNPs localised in the 15q25 chromosomal region (low p-values of 10-8). A 
replication study in combined European cohorts meant a total of 13 414 individuals were 
scanned for the same SNP variations in this region. This resulted in identification of one 
particular associated SNP in the region with a 10-9 p-value threshold. This SNP fell in the 
transcriptional initiation site of the RASGFR1 gene, a gene known to be highly expressed in 
mouse neurons and the retina [182]. RASGFR1 protein was then found to be expressed in 
human retinas [177]. Mouse RASGFR1 knockout mice showed heavier crystalline lens, and 
mouse RASGFR1 knockdown mice imply that RASGFR1 is required for normal retinal 
function. Thus, could the RASGFR1 gene disrupt the human lens contribution to ocular 
refraction, or play a role in defect retinal signaling pathways that could lead to myopia? [177].  
Similarly, Solouki et al., 2010 [178] carried out an initial genome scan on 5328 Dutch 
individuals, followed by replication studies in 4 independent cohorts (total of 10 280 
individuals). This identified an SNP in the 15q14 chromosomal region (p-value of 10-14), 
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adjacent to the SNP localised by Hysi et al., (2010) [177] on 15q25. The associated SNP fell 
between the genes ACTC1 and GJD2, also found to be expressed in the human retina [178]. A 
role for ACTC1 in ECM remodelling, and a role for GJD2 in retinal transmission have been 
put forward, but not proven. Will future high myopia GWAS show association to these same 
genes suggested to underlie general refractive error phenotypes?  
 
  C GWAS on the High Myopia Phenotype 
Collecting thousands of high myopic subjects is much more demanding than 
individuals with general refractive error pehnotypes from the general population. To date 
there has only been one GWAS study carried out on the high myopia phenotype using a 
Japanese population-based case-control cohort [183]. This study was split into a 3-step 
association analysis: 
 
• Step 1: Genome scan of 297 cases with a high myopic phenotype (axial length 
≥28mm) and 934 controls from a Japanese SNP database. This identified 29 SNPs 
with a set p-value ≤10-4 (less stringent than GWAS previously mentioned) (Fig.9). 
• Step 2: Replication genotyping step with 533 cases with a less severe high myopic 
phenotype (≥26 mm) and 977 matched Japanese controls recruited by the authors 
themselves. 22 SNPs from the first stage in strong LD were genotyped using custom 
SNP TaqMan genotyping (Cetus Corporation, Emeryville, USA). Again less stringent 
p-values of 10-3 were set. 
• Step 3: Analysis of both steps combined (Joint analysis): 1 SNP with a more stringent 
p-value of 2.22 x 10-7 was identified in chromosome 11q24. This SNP fell within 200 
kb of two uncharacterised genes (Fig.10). Their expression in the human retina was 
however consequently confirmed.  
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Fig.9. Manhattan Plot of 1st Stage Results. Chart of adjusted p-values obtained by the trend χ2-test 
plotted in 2log10 scale according to their chromosome location. The dots above the line correspond to 
the 22 SNPs with a p-value ≤10-4 [183]. 
 
 
Fig.10. Joint Analysis (3rd stage) Results. The 11q24.1 locus is in proximity to the BLID and 
LOC399959 genes. Structures, orientations and locations of the BLID and LOC399959 genes on 
NCBI Reference Sequence Build 36.1, together with pair-wise LD estimates of the SNP markers 
located within a 200-kb region encompassing the associated rs577948 marker (red box) (adapted 
from [183]). 
 
 
As required for all candidate genes identified by GWAS, the next step in this study is 
to deduce the true functionality of the SNP variation in the underlying high myopia disease 
phenotype. Consequently, replication studies in cohorts of different ethnic origins, and then  
grouped cohorts of multiple ethnic origins (meta-analyses) should be carried out to test for 
candidate gene extrapolation between different populations [118].  
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 5.3.8  High Myopia Genetic Loci  
Linkage and association studies have identified to date 18 myopia (MYP) loci that 
have been approved by HUGO Gene Nomenclature Committee in 15 different chromosomes, 
although some of these remain to be confirmed [184] (summarised in table 1 page 41). 
Approximately 16 chromosomal localisations have been described for high myopia from 
studies based on a range of different ethno-geographic populations. Note that loci 7p15 [162], 
14q22.1-q24.2 (MYP18) [135], 11q24 [183], and adjacent loci 5p15.33-p15.2 [185] and 
5p13.3-p15.1 [176] have also been identified for high myopia. The MYP1 high myopia locus 
is the only locus to have been replicated in an independent significant linkage study [186], 
and the 5p15 region replicated in an independent population-based association analysis [179]. 
In some cases moderate myopia mapping has been found to coincide with high myopia 
mapping localisations; a strongest linkage signal for moderate myopic subjects was localised 
within the MYP12 high myopia locus by two different groups [174, 187]. It would seem that 
chromosome 2 could harbor both myopia and high myopia susceptibility genes.   
Only a handful of these genome wide studies have been able to localise specific gene 
variations associated with the high myopic phenotype; Han et al., (2006) [12] localised a 
polymorphism in the hepatocyte growth factor (HGF) gene, Wang et al., (2006) [168] a 
polymorphism in LD in LUM, and Tang et al., (2007) [188] identified an association with the 
myocilin gene (MYOC) [189-191].  
Replication studies have in majority been frustrating, resulting in contradictory reports 
published for specific loci and genes, even among studies carried out on the same population. 
First identifications are often greeted with enthusiasm and then disappointment as follow-on 
studies fail to replicate results. Attention to the interpretation of multiple and conflicting 
findings of association studies is required.  
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Table.1. Myopia and High Myopia (indicated by arrows) Loci mapped by linkage and association analysis (adapted from [118]). The missing MYP18 locus 
(14q22.1-q24.2) corresponds to the recently identified autosomal recessively transmissed locus of high myopia [135]. Note that some statitstical significance 
levels are not always attained (right-side column: LOD/p-values), meaning replication studies are required for confirmation.  
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6 Revision: Human High Myopia Genetics 
High myopia is due to image focalisation in front of the retina and in most cases a 
significant increase in the axial length of the eye. For analysis in genetics studies the high 
myopia phenotype has been clinically defined as an error of refraction ≤-6 D or by an axial 
length ≥26mm. High myopia is due to both a combination of multiple genetic defects and 
multiple environmental factors, and their interactions between them. This makes high myopia 
a complex, polygenic and hetergenous disease, thus difficult to analyse in terms of searching 
for its multiple small gene effects. Several genomic regions have however now been 
identified as harbouring potential high myopia candidate genes, but the same genes have been 
rarely identified in different high myopic populations. More up-to-date population genotyping 
genome scans with increased speed of analysis and increased coverage of genetic variation 
using SNP markers are making the analysis of complex diseases more feasible. However, 
these studies require large cohorts, with the requirement of replication and functional-variant 
studies before confirmation of the identification of genuine high myopia genes.  
 
6 Récapitulatif: La génétique de la myopie forte humaine 
La myopie forte est caractérisée par la focalisation des images devant la rétine et dans 
la plupart des cas, par une augmentation importante de la longueur axiale du globe oculaire. 
Pour des analyses génétiques, le phénotype de la myopie forte est classé par une erreur de 
réfraction ≤-6 D ou par une longueur axiale ≥26mm. La myopie forte est due à des anomalies 
génétiques, aux facteurs environnementaux, mais ainsi aux interactions environnementales-
génétiques. Par conséquent la myopie forte est une maladie complexe et polygénique dont la 
recherche des multiples gènes causants modestes est laborieuse. A ce jour, plusieurs régions 
chromosomiques ont été identifiées comme comportant des gènes responsables de la myopie 
forte. En revanche, les mêmes régions ou gènes ont été rarement identifiés dans des études de 
réplication sur d’autres populations de myopes forts. Les techniques de génotypage modernes, 
plus rapides, prennent en compte l’augmentation de la couverture des variations génomiques à 
l’aide des marqueurs SNPs, rendant l’analyse des maladies complexes plus accessible. Ces 
analyses nécessitent tout de même de grandes cohortes, avec l’obligation de poursuivre des 
études de réplication et des études fonctionnelles des variations potentielles. 
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II Aims 
 
 
1 Previous Work on High Myopia Genetics in the French Caucasian 
Population 
The laboratory began the recruitment of a human high myopic cohort in 1998 
following the identification of two different chromosomal localisations for high myopia on 
18p11.31 and 12q21.23 in American and German/Italian cohorts resepectively [148, 163]. 
From here, a flow of studies have led to the conclusion of the intervention of multiple genes 
in the high myopia phenotype in the French Caucasian population: 
 
A. The very first study was a segregation analysis on a cohort of 32 French families 
showing that 58.4% of the high myopic subjects favoured an autosomal dominant 
transmission with weak penetrance [134].  
B. The laboratory’s first localisation on chromosome 7q36 for high myopia gave only 
suggestive linkage upon assumption of autosomal dominant transmission with weak 
penetrance (parametric LOD score=2.81) [139]. This study incorporated 23 
multigeneration high myopic French families, a total of 140 participants. The subject 
inclusion phenotype was ≤-5 D. Not only did this study include 2 Algerian families, 
only one suggestive localisation was identified, suggesting that a larger cohort was 
required for such analysis.    
C. The cohort was extended between 2003 and 2004 by new subject recruitment of pre-
existing multigeneration families and recruitment of new families that harboured at 
least 2 high myopic subjects. This resulted in a total of 26 multigeneration families, a 
total of 445 subjects, of which 136 were high myopes. The same high myopic 
phenotype of ≤-5D was used for the high myopia phenotype threshold. This cohort 
was then used for two studies: 
 
1. A Candidate Gene Search 
337 autosomal microsatellite markers were used from the ABI PRISM linkage 
mapping set for genotyping. Parametric linkage analysis again showed 
suggestive linkage to several chromosomal localisations (genome hot spots). 
This confirmed multiple gene intervention in the French population, and the 
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requirement of larger cohorts for multiple but small gene effects. Only non-
parametric linkage analysis retained a significant linkage on chromosome 7p15 
(LOD score=4.07) (Fig.11.) [162].  
 
  
Fig. 11. Non Parametric Multipoint Linkage Analysis Results [162]: Significant linkage to 
7p15, but also suggestive linkage (several smaller peaks).  
 
The 7p15 region was a 6.65 Mb segment harboring 67 genes. Several “top 
genes” were considered to potentially play a role in eye structure, function 
and/or development, one of them being Neuropeptide VF Precursor (NPVF). 
NPVF is a neurotransmitter expressed in the CNS and retina [192, 193]. It has 
shown a capacity to inhibit GABA neurotransmission [192]. As previously 
mentioned (section 4 page 24) agonists and antagonists of GABA have 
previously demonstrated retinal go/stop growth signals during animal 
experimental myopia development [72], making NPVF mutations an 
interesting candidate for high myopia.  
 
2. Determination of the Genetic Heratibility of High Myopia  
As parametric linkage analysis did not give significant results, analysis of the 
genetic influences on ocular refraction and axial length was carried out 
assuming a polygenic inheritance of high myopia. Estimates for both refractive 
error (20%) and axial length (20%) showed equally mildly to moderate 
inheritance in this French cohort [194]. This confirmed again that multiple 
genes with small effects underlie the phenotype, as well as considerable 
environmental influences.  
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D. The whole high myopic and control family cohort participated in Terri Young’s 
multinational linkage analysis that led to confirming the COL2A1 gene as a myopia 
susceptibility [195]. However, the French families were not linked to this locus, 
excluding this as a candidate gene in the French population, and further demonstrating 
heterogeneity in the myopia phenotype between different ethnic populations. 
 
2 New Aims for the Study of High Myopia Genetics in the French Caucasian 
Population 
The identification of the 7p15 region left the laboratory with two different possibilities 
for the next step upon my arrival in the laboratory; a replication genotyping study in the 7p15 
linked region in order to either narrow down the selection of candidate genes, or exclude the 
region, or; try to overcome the problem of low power of detection of multiple small gene 
effects to capture all genome hot spots.  
 
2.1 Management versus Scientific Decisions 
Initial views were to progress in further confirming or excluding the 7p15 
chromosomal localisation in the French population using custom tagSNP genotyping in a 
population based case-control association analysis. This was supported by a newly suggested 
linked region in to the moderate myopia phenotype in an African American cohort [196] that 
overlapped with the 7p15 region identified by Paget and Julia., 2008 (Fig.12). This further 
suggested an implication of this chromosomal region in the myopia and high myopia 
phenotypes.  
 
 
Fig.12. Schematic Representation of the 7p15 Region Overlap. Blue overlap: The suggestively 
linked region to the moderate myopia phenotype in the African American population [196] overlaps in 
part with the region identified by Paget and Julia., 2008 [162].  
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Confliction with my initial progress made on the 7p15 replication approach was the 
requirement to once again launch a recruitment scheme to create unrelated case and control 
cohorts. Recruitment of human subjects is a time-consuming and exerting process. A special 
offer fom Affymetrix whole genome high-throughput SNP genotyping ensured my final 
decision to reconduct a genome-wide scan with a new population. This time by means of a 
population-based case-control SNP association analysis to: 
 
1. Increase the power in the detection of multiple small gene effects, meaning more 
chance this time of localising all gene effects that could have been only 
suggestively linked in the previous study. As SNP association analyses take into 
account LD, they are considered the most powerful method to date for detecting 
multiple gene effects [164].  
2. Eliminate family recruitment constraints by recruiting unrelated subjects.  
 
2.3 Aims of Project 1 
The aim of Project 1 was to carry out a new genome scan in order to localise candidate 
genes associated to the French Caucasian high myopic phenotype using a population-based 
case-control SNP association analysis. The study required a design based on increasing the 
power of the analysis, while taking into consideration realistic time and financial limiting 
factors. Thus, we analysed the advantages of using axial length as a less complex phenotype 
inclusion criterion, we determined an approach to limit cohort admixture and we launched a 
new subject recruitment scheme to establish a new DNA and phenotype data bank.  
 
2.3 Résumé des objectifs 
 Les objectifs du premier projet étaient de répliquer un génotypage pangénomique afin 
de localiser de gènes de susceptibilité à la myopie forte par une analyse d’association cas-
témoin à l’aide de marqueurs SNP dans une nouvelle population française caucasienne non-
apparentée. Cette étude à été conçue pour améliorer la puissance statistique de l’analyse, tout 
en respectant les contraintes de temps et l’aspect financier. Nous avons employé la longueur 
axiale comme critère d’inclusion phénotypique moins complexe, recherché une approche pour 
limiter la stratification de la cohorte et lancé un nouveau système de recrutement clinique 
pour établir une nouvelle banque d’ADN et de phénotypes. 
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III Material and Methods 
 
 1  Axial length as the High Myopic Sujbect Phenotype Criterion 
Axial length is the largest determinant for non-syndromic myopia [6] as a negative 
relationship is observed between axial length and refractive error [17, 18]. As axial length 
increases, the more negative the refractive error is. To date the majority of myopia and high 
myopia genome scans have used refractive error data to create artificial phenotype boundaries 
for high myopic subjects [118]. Only one GWAS study has used axial length regardless of 
refractive error data to include subjects in their study [183]. We analysed the benefits of using 
the axial length phenotype as the deciding factor for the inclusion of high myopic subjects in 
our GWAS.  
The most important point to make is that heritability* of axial length is more 
consistent among different ethnic and geographical populations than refractive error [129, 
197, 198]. Twin studies demonstrated that axial length is highly heritable and genetic effects 
can explain up to 88% of this parameter [199, 200]. Nuclear family studies also showed 
higher concordance of the heritability of axial length than refractive error [130]. Heritability 
of axial length versus refractive error is summarised in table 2 below. In the minority, the 
French cohort was the only study showing exactly the same heritability of axial length and 
refractive error in multigeneration families including high myopic subjects [194]. However, 
this cohort was small.  
 
Table 2. Heritability of Axial Length (AL) versus Refractive Error (RE) in A: Different geographic 
and ethnic cohorts. B: Different family-based analyses (A: [129]; B: [198]; C: [197]; D: [194]; E: [201]; 
F: [130]). 
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Secondly, segregation analyses suggested that AL is under polygenic control [194]. 
However, the idea that the axial length heritability remains more stable across populations 
suggests that axial length may have less underlying genes encoding for the phenotype than 
refractive error does. Polygenic traits with less encoding genes are easier to analyse in terms 
of searching for their underlying genes [194]. On the other hand, the heritability of myopia 
was found to be vary significantly among twin, sibling and nuclear family studies as 
manifested by Table 2.B. [202]. The more distant the samples were, the less heritability they 
possessed. Even though case-control studies using unrelated subjects obviously do not share 
inherited myopia genes, on the whole the fact that there is a correlation between myopia and 
axial length suggests that both phenotypes share some common gene effects across subjects 
[201], meaning that we would not be searching for different genes using either of the two 
phenotypes in unrelated subjects.  
Furthermore, a litterature review on the trait variance of axial length caused by 
environmental factors has been found to be only around 6%, different from that of refractive 
error ranging from 14%-33% [130, 201]. As myopia is a complex trait influenced by both 
genetic and environmental factors and their interactions [109, 203, 204], limiting the 
environmental influences as much as possible is beneficial in GWAS aimed solely at 
localising gene effects associated to the phenotype. 
Nowadays, modern ultrasound velocity reading machinery allows ophthalmologists to 
use optical partial coherence interferometry to determine the axial length of their patients to 
clarify the severity of axial length myopia. These machines are now widely present in most 
hospital ophthalmology services, meaning recording axial length data of recruited subjects is 
not an over demanding criterion and can be easily integrated into a clinical protocol.  
Overall, using axial length as the subject phenotype inclusion criterion should help 
reduce the number of genes underlying the phenotype and reduce the environmental 
influences, thus minimising bias caused by the more complex refractive error trait. We can 
say that axial length can be used as an endophenotype for the myopia phenotype [205]. This 
means axial length can be used as a concept to distinguish the more complex myopia trait 
with a more simple genetic connection. Clinically defined high myopia corresponds to an 
axial length of at least 26 mm [11]. Thus, we set a minimum axial length of 26 mm for the 
new recruitment criterion of high myopic patients in the new GWAS. Please refer to 
Annex 1 (page 226) and Annex 2 (page 228) for our published reviews on the use of axial 
length myopia as a GWAS subject phenotype inclusion criterion. 
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2  Genetic Heterogeneity Limitation  
An important factor to take into account when designing a population-based case-
control GWAS is the propensity for population substructure, known as population 
stratification [206]. Systematic differences in allele frequencies occur between different 
populations due to different ancestry. The problem for GWAS is stratification can lead to 
spurious claims of association to an SNP variant that in fact arises from case and control 
genetic background admixture, and not an association to a real disease-causing SNP variation 
[207, 208]. Consequently, it is widely appreciated that successful GWAS requires case and 
control subjects to be well matched for their ethnic and geographic backgrounds (Wellcome 
Trust Case Control Consortium [180]).  
 Several studies have been carried out using recent SNP genotyping arrays to 
specifically compare allele frequencies between different ethnic populations and to test for the 
possibility that false claims of association can arise due to population admixture [209-215]. 
Significant differences in allele frequencies were more manifest between populations with 
increasing numbers of SNP markers used to scan the genomes [211, 212]. Grouping of 
population allele frequencies was found to form clusters depending on geographic location of 
the subjects. In Europe, the population clusters were said to mirror identically distinct 
geographical regions in the continent (Fig.13).  
 
Fig.13. Population Admixture in Europe. Statistical summary of genetic data from 1 387 Europeans genotyped using the Affymetrix 500K array. 
PC1 and PC2 refer to principal component analyses used to produce a 2D visual summary of genetic variation, corresponding to a schematic 
representation of the map of Europe. AL, Albania; AT, Austria; BA, Bosnia-Herzegovina; BE, Belgium; BG, Bulgaria; CH, Switzerland; CY, Cyprus; 
CZ, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; FI, Finland; FR, France; GB, United Kingdom; GR, Greece; HR, Croatia; HU, 
Hungary; IE, Ireland; IT, Italy; KS, Kosovo; LV, Latvia; MK, Macedonia; NO, Norway; NL, Netherlands; PL, Poland; PT, Portugal; RO, Romania; 
RS, Serbia and Montenegro; RU, Russia, Sct, Scotland; SE, Sweden; SI, Slovenia; SK, Slovakia; TR, Turkey; UA, Ukraine; YG, Yugoslavia 
(adapted from [213]). 
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 Admixture can be found within the French population [216]. The best method for 
eliminating this effect would be to use the French Basque population isolate that has shown 
very limited population admixture (Fig.14) [211, 216]. However, recruiting subjects from this 
population from Toulouse would have been complicated. Instead we aimed to firstly limit 
population admixture by recruiting only subjects “claiming” to be of European French 
ancestry. This was monitored by recruiting only subjects that could precise that both their 
maternal and paternal grandparents were of European French origin. I put emphasis on the 
“claiming” as we can never be certain, we have to assume that subjects recruited are accurate 
regarding their family history. As shown by Fig.13. there is some overlap between Spanish, 
Belgian and Swiss population allele frequencies with those of the French population, but we 
decided to eliminate subjects with these origins in order to retain the most homogeneic 
population as possible.  
 
 
Fig.14. Estimated Population Structures within Europe. K represents a model population clustering 
system for the partition of means of allele frequencies. K1>K6:Increasing population clustering 
resulting in coverage of the means represented by the appearance of different colours. At K=6  the 
French population shows several mixed population ancestries, whereas the Basque population shows 
next to no admixture (adapted from [216]). 
 
 Secondly, we decided to check the extent of population stratification in our new French 
Caucasian cohort using multidimensional-scaling (MDS) on our final genotyping data. This 
method uses identity by state (IBS); calculation of the sharing of alleles between unrelated 
individuals without prior knowledge of pedigree structure [175, 217]. MDS then represents 
IBS as a position with a pre-specified dimension. The genetic background of other subjects is 
represented as a distance from other subjects in relation to both sharing and differences in 
alleles [218]. MDS plots allow visualisation of clusters of individuals with similar allele 
frequencies, and dispersed individual points correspond to subjects with distinct differences in 
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allele frequencies. This allowed us to remove individuals with outlier genetic admixture from 
our genotyping data analysis, reducing false positive associations. 
 
3  Subject Recruitment  
A part-time research assistant was responsible for the recruitment of high myopic 
patients 2.5 days per week from the general flow of patients in the Ophthalmology Service, 
CHU Purpan, Toulouse. Recruitment entailed subject agreement to participate upon signing of 
a consent form, a brief ophthalmology examination, completion of a personal and medical 
questionnaire, and finally a venous blood sample donation was taken. A new recruitment 
protocol based on axial length phenotypes was carefully designed in order to maximise the 
simplicity of the recruitment procedure for both clinicians and patients.  
 
3.1  The Recruitment Protocol 
A simple protocol (Annex 3 page 236) was established among ophthalmologists 
working in the service to make them familiar with the study underway and to explain their 
role in the selection of high myopic and control subjects for the research assistant. Patients 
corresponding to the criteria were then fully examined by the research assistant. 3 x 10 ml 
EDTA tubes of venous blood were collected from each subject once the recruitment 
procedure was complete.  
 
3.1.1 The Recruited Phenotypes 
A High Myopic Subjects 
Firstly, patients claiming not to have maternal and paternal grandparents of European 
French origin were not recruited. If the patient was not fully certain of a European French 
origin, it was clearly stated in the patient file (Annex 4 page 240) and the patient preceded the 
recruitment procedure.  
Secondly, a medical questionnaire was completed and excluded patients that were 
aware of any affection by diabetes, syndromic myopia or other eye diseases including retinitis 
pigmentosa, retinopathy of prematurity, corneal dystrophy, keratoconus, congenital and 
closed-angle glaucoma and Wagner’s disease. Severely anisometropic and strabismic 
amblyopic patients were also excluded. Only patients having undergone cataract surgery for 
whom we had access to pre-operative refractive values and axial length measurements were 
recruited.  
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Thirdly, it was also checked that the myopia development started before or around the 
age of 12 years old. Briefly the ophthalmology examination entailed measurement of 
refractive values using standard autorefractometry after dilation with cyclopentolate 10% (age 
≤16 years) or tropicamide (≥16 years). Patients with astigmatism ≤-2 D were excluded from 
recruitment. Visual acuity, intraocular pressure and eye fundus examination was performed to 
be certain of no syndromic forms of high myopia. Axial length was evaluated by A-scan 
ultrasonography. A total of 3 readings were taken for each eye and the average value was 
recorded. Only patients with a bilateral axial length of ≥26mm proceeded to blood 
sample donation and inclusion in the cohort.  
Finally, a genealogical tree including as much detail as the patient could provide on 
family history of myopia and high myopia was noted in the patient file, along with the patient 
contact details and ophthalmology information. 
 
  B Control Subjects  
Control subjects were often unrelated friends accompanying patients being examined 
in the Ophthalmology Service. In addition to the exclusion criteria mentioned in section 3.1.1 
page 51, any known first, second and third degree family history of high myopia resulted in 
exclusion of the subject. Subjects underwent exactly the same ophthalmology examination as 
high myopic patients. Subjects with bilateral axial lengths ≥24 mm were excluded from the 
study. A second inclusion criteria was added of an error of refraction between -0.5D and 
+0.5D to prevent recruitment of weak-moderate hyperopic and myopic patients.  
 
 3.2       Recruitment Constraints  
 Recruitment capacity of CHU Purpan Toulouse was overestimated. An average of 
only 4 high myopes was recruited per week, meaning only small cohort sizes were attained 
between 2007 and mid-2009. Several steps were thus required to accelerate recruitment: 
 
1. We extended the recruitment procedure by collaborating with public hospital 
Ophthalmology Services throughout France (CHU Rangueil (Toulouse), 
Bordeaux, Montpellier, Marseille, Nice, Strasbourg, Lille, Amiens). A simple 
protocol and simplified version of the patient file was presented, along with a 
supply of blood sample equipment to each service. Afterwards, blood samples and 
53 
 
patient files were sent to our laboratory. Telephone conversations with the patients 
allowed completion of the phenotype database.  
2. A press campaign was launched to incite general public volunteer high myopic and 
control subjects in Toulouse. This included a hospital internet page, public journal 
articles, radio and television edits (Annex 5 page 243). Volunteer phenotypes were 
initially analysed by telephone conversation. Corresponding volunteer phenotypes 
to the inclusion criteria led to a private appointment with the research assistant for 
collection of the full patient profile and blood donation. Volunteers were not 
rewarded.  
3. Collaboration with the Centre National de Génotypage (CNG) in Paris was 
accepted to provide us with Affymetrix Array 6.0 genotyping data for 500 French 
control subjects (unpublished data) in the near future. Private ophthalmology 
services did not wish to collaborate. 
4. By the beginning of 2010 a Centre d’Investigation Clinique (CIC) protocol was 
well established for the recruitment of high myopic and control patients in concert 
with the CHU Purpan Ophthalmology Service. Anonymous patient files could be 
obtained from the CIC to maintain our laboratory phenotype database.  
 
     4    Power Calculation Estimations   
 The power is the probability of successfully detecting a gene effect of a particular 
size upon elimination of type I (false-positive association) and type II (false-negative 
association) error rates [219]. In other words, the number of samples required to avoid claims 
of spurious association and to avoid neglecting true association. The statistical power to detect 
association between genetic variation and a phenotype is a function of several factors 
including [220]: 
 
• The frequency of the risk allele (RAF). 
• The Odds ratio (OR); a descriptive statistic for the effect size of the associated allele or 
genotype. 
• Penetrance; the proportion of individuals carrying the particular real risk allele that 
also express the associated phenotype.  
• Sample size. 
• Genetic heterogeneity of the study population. 
54 
 
 
 Obviously, statistical power is enhanced when RAF is higher (the risk allele has a 
relatively strong effect) and a large sample size from the same ethnic and geographical 
background is available (Fig.15.A). P-values for GWAS have to be stringent to adjust for 
multiple testing [164, 221, 222]. However, associations that are not statistically overwhelming 
(p<0.05) can be taken into account considering that type I error rates would be high, and that 
a replication step would be necessary before confirming an association [223]. An example of 
such a study is the GWAS on the high myopia phenotype by Nakanishi et al., 2009 [183] 
(Introduction section 5.3.7 page 38).  
 In common complex diseases, such as myopia, most susceptibility variants have 
modest effect sizes with ORs of 1.1 to 1.5 [224]. Power calculations can be implemented to 
give us estimates of the number of subjects required for a case-control association analysis 
with a reasonably high statistical significance, usually set at least 80% [225]. Free accessible 
on-line calculator softwares are readily used (examples, Genetic Power Calculator and CaTS; 
[219, 226]). Typically, it was calculated that sample sizes of approximately 1000 cases and 
controls were required to detect ORs of approximately 1.5 with at least 80% power using a 
additive model* (Fig.15.B). This was also assuming a non-stringent p-value <0.01. Thus these 
results, along with limited subject recruitment, suggested the requirement of an alternative to 
very large cohort sizes in order to increase the power of the GWAS study.  
 It is known that more penetrant alleles with larger effects require smaller samples 
[220]. Thus, we aimed to include only the most severe axial length myopia phenotypes for 
the GWAS. This was an attempt to increase the power of the study by increasing the OR, 
penetrance and RAF. On the other hand it was estimated that a severe high myopic phenotype 
inclusion would further limit subject inclusion, increasing the time taken to reach sufficient 
cohort sizes. Thus, in addition we also opted for a multi-step association analysis to overcome 
small cohort effects.  
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Fig.15. Power Calculations. A: Graphical representation of how statistical power is enhanced when disease allele frequency (DAF; RAF) is higher and 
Genotype Relative Risk (GRR; odds ratio) has a stronger effect (calculated using Genetic Power Calculator [219]). B: Calculation of estimations of sample 
sizes required to detect ORs of approximately 1.5 with at least 80% power depending on the p-value. High myopia prevalence of 0.03 (approximately 3%) and 
an estimated DAF of 0.05 were taken into account in the calculations. Lowering the p-value redues the overall power of the study to detect an association, but 
reduces type I error rates (Genetic Power Calculator; [219]). 
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 5    Multi-step Association Study Design 
Well constructed multi-stage design GWAS maintain the same power as a single step 
GWAS, but reduce genotyping requirements [227-229]. Moreover, while genotyping and 
analysis of earlier recruited subjects is underway, recruitment of new subjects can continue 
simultaneously for the following step(s). In order to retain the power of the study, care is 
needed in the division of subjects between each stage and the number of markers analysed in 
each stage, as well as consideration into how testing for significant association between the 
different steps should be carried out [226, 230].   
Two-stage GWAS, as introduced by Satagopan et al., 2002 [227], is based on 
genotyping part of the samples using a commercial high-density panel (in most cases 300 000 
to a million SNPs), followed by genotyping the most significant SNPs using a customised 
SNP panel on the remainder of the samples. The remainder of the samples must be from a 
new cohort, but of same ethnic origin. A final analysis combining the information from both 
steps (joint analysis) is more powerful than treating the design as independent replication 
steps [226]. This is because joint analysis exploits the additional information about how 
significant the first stage associations are combined, not just the fact that they exceed 
independent p-value thresholds [230]. 
Two-stage design GWAS can be extended to multi-stage designs, with successively 
smaller proportions of significant SNPs being tested in new samples at each subsequent stage. 
Indeed, earlier studies have been conducted in this manner [231]. Hirschhorn and Daly (2005) 
[231] implemented the idea that a more modest threshold for ‘passing’ markers as significant 
can be used during the evaluation of the initial scan of the genome [232-234]. This requires 
bearing in mind that a large, but reasonably controlled number of false-positive results also 
pass this threshold. All markers that pass the first threshold must then be tested in a second, 
independent population sample. Hirschhorn and Daly (2005) declare that the second 
population must be similar in size, or larger than the initial population.  
The second stage is carried out for only a small fraction of the markers that were 
contained in the initial screen, and it is also suggested that marker genotyping should be 
carried out using a different method, as different technologies are better suited for SNP sets of 
different sizes. A third stage can also be used for even greater stringency. This once again 
requires a new cohort for genotyping of candidate regions or genes (Fig.16).  
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Fig.16. Mulit-step GWAS Design minimises sample sizes at each stage, thus genotyping costs [231]. 
 
The third step of a GWAS can be carried out by deep sequencing of genome hot spots 
identified in a second replication stage [230]. Due to the high cost of sequencing it is 
advisable to do the fine mapping first to narrow down the region or groups of genes of 
interest. On the other hand, next generation sequencing DNA “bar coding” and DNA pooling 
method costs are at the moment reducing rapidly. We may soon want to soon proceed directly 
to sequencing with larger chromosomal candidate regions [235]. 
Taking these points into consideration we opted for a multi-step three stage design. 
The first scan being a whole genome scan with a modest p-value cut-off using 192 cases and 
3000 controls from the United Kingdom in the Wellcome Trust Case Control Consortium 
[180]. Cases included in this stage corresponded to the extreme axial length high myopia 
phenotype. The second stage will entail a customised SNP replication stage of regions 
identified in the first scan on a similar size cohort with either the same inclusion phenotype, or 
less severe high myopic phenotype (depending on recruitment progression). A more stringent 
p-value would be required in this step to eliminate type I and type II error rates before the 
final step. Finally, in the third stage we aim to deep sequence smaller candidate regions or 
candidate genes directly identified by: 1. The second stage hot spot regions and/or 2. Joint 
analysis of both the first and second stages. Candidate genes will be prioritised according to 
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known or potential roles in structure, development and/or function of the eye, thus myopia 
and high myopia development. I have summarised the stages of our current GWAS in Fig.17. 
 
 
                                Fig.17. Our Multi-step High Myopia GWAS Design 
 
6  DNA and Phenotype Bank 
6.1 Blood DNA Extraction 
Double stranded DNA was extracted from the venous blood samples within 72 hours 
following standard proteinase K and Salting out methods. Briefly, cells were lysed using 2.5% 
Nonident P40 (Roche, UK). Nuclei were pelleted and resuspended in 20% sodium lauroyl 
sarcosinate (Sigma, France) and proteinase K (Eurobio, France). This was to lyse the nuclear 
membranes and digest proteins. DNA released into solution was precipitated from the 
aqueous layer by the addition of 95% ethanol and 7.5 M ammonium acetate. DNA was then 
resuspended in 15mM NaCl, and finally re-precipitated by washing with 70% ethanol. DNA 
was resuspended and dissolved in 10 mM Tris HCl and 1 mM EDTA (TE) buffer at +4°C. 
DNA concentration was only determined prior to genotyping sample preparation due to 
ongoing dissolving of DNA. DNA concentration was determined by measuring absorbance 
(OD) at 260nm in a cuvette spectrophotometer. A separate DNA sample for each patient was 
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also stored at -20°C in 95% ethanol. Patient files were transformed into anonymous database 
phenotypes in the laboratory.  
 
 6.2 Failed Blood DNA Extraction  
 Failure of DNA extraction from blood samples was overcome by using Oragene® 
saliva buccal cell DNA extraction kits (DNA Genotek, Canada). These were sent as individual 
kits with instructions to the subject households and returned by post (nonhazardous). The 
commercial DNA extraction protocol was followed. Buccal cell-extracted DNA quantity and 
quality was analysed by: 
 
1. Comparing 260nm OD absorbencies to an internal blood-extracted DNA control. 
2. Comparing human RNA polymerase 2 (RNA Pol II) primer PCR amplification 
products to an internal blood-extracted DNA control by agarose gel electrophoresis. 
3. Visually checking for DNA degradation by migration of genomic DNA on 1% agarose 
gels.  
 
7 Genotyping Technology 
7.1  Affymetrix Array 6.0 
Affymetrix® Genome-wide Human SNP Array 6.0 is a probe array containing in total 
approximately 1.8 million genetic variation detectors. These are split into 906 000 SNP and 
946 000 CNV probes. Together, this makes this genotyping array high-throughput in terms of 
physical coverage of the genome, with an inter-marker spacing of 680 bp (basepairs). 
Approximately 482 000 SNPs are derived from the previous 500K mapping array 
(Affymetrix® SNP 5.0). The remaining 424 000 SNPs include new tagSNP markers derived 
from the International HapMap Project, better representation of SNPs on chromosomes X and 
Y, mitochondrial SNPs, SNPs in recombination hotspots and new SNPs added to the SNP 
database after completion of the Mapping 500K Array. For this project I was fortunate to 
negotiate a special offer for batches of genotyping to be progressively carried out (giving time 
for subject recruitment) by Affymetrix® at Atlas BioLabs GmbH, Berlin, Germany.  
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7.2  The Protocol 
A  Preparation of DNA Samples 
Genotyping required pre-preparation in the laboratory of total double-stranded 
genomic DNA (50 ng/µl) dissolved in TE buffer (0,1 mM EDTA, 10 mM Tris HCl, pH 8,0). 
In order for the acception of DNA sample genotyping, Atlas BioLabs GmbH Microarray 
Service Unit requested confirmation for each DNA sample that: 
 
• An approximate 10-20 kb major genomic DNA band was observed on 1% agarose 
gels. 
•  OD 260/280 nm purity ratio was between 1.8 and 2. 
 
This was a test for high quality non-degraded DNA. 30 µl of pre-selected DNA samples 
were then anonymously numbered in 96 well microtiter plates (BIORAD, Cat no. MLP9601) 
according to Atlas BioLab service instructions and delivered at -20°C.  
 
  B The Affymetrix® Technology Protocol 
The principal steps of the genotyping protocol included DNA sample preparation 
(fragmentation and labeling), DNA hybridisation to the chip, followed by washing and 
staining, and finally chip scanning (Fig.18).  
 
 
Fig.18. Affymetrix® Array 6.0 Gene Chip Work Flow with adapted equipment. 
 
Briefly, the Affymetrix® Genome-Wide Human SNP Nsp/Sty 6.0 Assay Kit contained 
reagents for the critical steps in the assay. Atlas BioLabs GmbH Microarray Service Unit 
carried out 3 negative controls (water) per plate. The genomic DNA was digested with Nsp I 
and Sty I restriction enzymes and ligated to adaptors that recognised cohesive 4 bp overhangs. 
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All fragments resulting from restriction enzyme digestion, regardless of size, were substrates 
for adaptor ligation. A generic primer that recognised the adaptor sequence was used to 
amplify adaptor-ligated DNA fragments. PCR conditions have been optimised to 
preferentially amplify fragments in the 200 to 1 100 bp size range. PCR amplification 
products for each restriction enzyme digest were combined and purified using polystyrene 
beads. The amplified DNA was then fragmented, labeled and hybridised to the array chips for 
scanning. Washing steps eliminated subject DNA that did not bind to specific SNP/CNV 
probes. Simplified versions of the protocol are represented in Fig.19.  
 
C  Data Handling 
The Genome-Wide Human SNP Array 6.0 was used in conjunction with Affymetrix® 
Genotyping Console, which implements a novel genotype calling algorithm called Birdseed. 
Birdseed performed a multiple-chip analysis to estimate signal intensity for each allele of each 
SNP. Genotyping Console is designed to streamline genotyping calling and genotyping 
quality control. In addition to the algorithm, features include automated quality-control that 
sorts samples by quality-control call rate, visualisation of quality-control metrics across 
samples and SNP cluster visualisation. Atlas BioLabs GmbH provided us directly with 
quality-control call rates for all DNA samples, SNPs and CNVs.  
 
I attended a 4 day training scheme at the Génopole Biopuce plateforme, Rangueil, 
Toulouse. I genotyped 3 spurious DNA samples using Affymetrix® Array 6.0 assay protocol 
and adapted Affymetrix® equipment. I also learnt the global data handling methods required 
for data handling of raw data chip scan reads.  
 
8  Revision: Methods 
For GWAS analysis we opted for a design to increase power by recruiting subjects 
based on their axial length phenotype, considered to be a less complex trait than the more 
commonly used refractive error phenotype. We also aimed to limit case-control population 
admixture by excluding subjects not of European French ethno-geographical origin. 
Inadequate recruitment, meaning smaller cohorts than anticipated, implied the requirement of 
using a more severe axial length phenotype and a multi-step association analysis approach to 
increase the power. 
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8 Récapitulatif: Les Méthodes 
 Pour améliorer la puissance de l’étude pangénomique, nous avons opté pour un 
recrutement des patients selon leur phénotype de longueur axiale, considéré comme un trait 
phénotypique moins complexe que celui de l’erreur de réfraction. Nous avons aussi limité la 
stratification de notre cohorte cas-témoin en excluant des sujets n’étant pas d’origine 
française européenne. Un recrutement insuffisant de myopes a imposé l’utilisation d’un 
phénotype de longueur axial extrême et une analyse d’association multi-étape pour 
augmenter la puissance de l’étude. 
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Fig.19. Affymetix Array 6.0 Genotyping at the Molecular 
Level.  
A: DNA sample preparation (Index C)  
B: Diagramatic representation of fragmented and labelled 
subject DNA specifically binding to known SNP/CNV 
variations, or being washed away, before scanning of the 
hybridised DNA fragments and transformation of signal 
intensity into allele frequency data. (Adapted from Index D).  
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IV Results 
 
1  Recruitment Outcomes 
1.1  High Myopic Cohort 
To date a total of 406 European French high myopes with an axial length ≥26mm have 
been recruited. All data is represented as the average of right and left eye measurements. 
Axial length ranged from 26mm to 37mm within this cohort. The mean axial length was 
29.05mm. The majority of recruited subjects had an axial length between 26-27mm.  
Refractive error ranged between -5D and -31D. A few (n = 7) myopes with ≥-6 D 
refractive errors were recruited using this axial length phenotype inclusion criteria, meaning a 
total of 98.3% recruited phenotypes were included in the final cohort. The mean refractive 
value was -12.1D. Cohort axial length and refractive error phenotypes are summarised in 
Fig.20. 
The age range of the cohort was from 18 to 86 years old, but subject inclusion was 
based on the age of onset of myopia development, not the current subject age in order to 
eliminate subjects with age-related high myopic development.  
The female to male ratio was 61% to 39% respectively (Fig. 20.C). 
The majority (84.5%) of the cohort was recruited at Purpan Hospital, Toulouse. 
Subjects from the other ophthalmology services in collaboration accounted for: Rangueil 
(0.7%), Bordeaux (1.5%), Montpellier (1.7%), Marseille (2.5%), Nice (2.5%), Strasbourg 
(3.7%), Amiens (1.2%) and Lille (1.7%) of the total recruited subjects.   
 
1.2  Control Cohort 
Unfortunately to date only 90 control subjects have been recruited by CHU Purpan, 
Toulouse. Cohort axial length and refractive error data is summarised in Fig.20. The mean 
axial length was 23.07mm and mean refractive error was -0.006D. This corresponds to an 
emmetropic phenotype. The female to male ratio is approximately equal, 52% to 48% 
respectively (Fig.20.D) and the age range was similar to that of the high myopic cohort. 
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Fig.20. Distribution of Axial Length and Refractive Error Phenotypes in the High Myopic and Control Cohorts. A: Axial length. B: 
Refractive error.  Data is an average of subject right and left eye measurements. C: Female to male ratio in the high myopic cohort; 0.61:0.39 
respectively. D: Female to male ratio in the control cohort; 0.52:0.48 respectively. 
 
Refractive error (D) 
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1.3  DNA Bank 
The laboratory owns genomic DNA for all subjects in these cohorts. Only 0.6% of 
high myopic subject DNA was extracted using saliva kits, the remainder by blood. An 
average final DNA concentration of 300ng/µl was extracted from blood samples. Final DNA 
concentration from saliva kits was found to be approximately 3-fold lower (~100ng/µl) than 
DNA extracted from blood. This concentration is still largely adequate for genotyping 
methods. UV visualisation of human RNA Pol II PCR amplification products and genomic 
DNA migration on 1% agarose gel showed both efficient PCR amplification and little 
degradation of saliva-extracted DNA (data not shown). On the other hand, external work has 
shown subject-specific DNA degradation by DNA extracted from saliva buccal cells, 
resulting in the suggestion of DNA degradation screening before use in high-throughput 
genotyping methods [236]. Furthermore, buccal cell aneuploidy* related to age and lifestyle 
environmental factors [230, 237] could influence CNV genotyping results (no observation). 
To date, our saliva-extracted DNA samples haven not been genotyped, and will only be 
genotyped in the future if the cohort is lacking in blood- extracted DNA.  
 
1.4   Extreme Axial Length High Myopic Cohort 
Within our high myopic cohort, 190 subjects had an axial length exceeding 28.5mm, 
and 280 subjects with a refractive error below -10D. Thus, a first set of subjects were 
genotyped (1st stage) based on the inclusion criteria set at an axial length ≥27.5 mm and 
refractive error ≤-10D. The corresponsing axial length and refractive error phenotypes of this 
extreme high myopic cohort are summarised in table 3. Female to male partition was however 
not equal (64% and 36% respectively). Only extreme cases recruited at CHU Purpan, 
Toulouse, were genotyped in this group. Control genotypes will be supplied later by the CNG 
to perform the association analysis.  
 
Phenotype  Mean  Standard deviation  
Axial length (mm)  30.17  2.32  
Refractive error (D)   -15.43  5.05 
 
 
Table 3. Axial Length and 
Refractive Error Phenotypes of 
the First 192 Extreme High 
Myopes Genotyped. Data 
represents the mean of subject 
right and left eye measurements.   
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2 Genotyping of the First 192 Extreme High Myopes  
The first 192 subjects with the most extreme axial length phenotypes have been 
genotyped. This is stage 1 of our GWAS.  
 
2.1  Genotype Filtering Procedures 
Raw genotyping data underwent a series of SNP, CNV and DNA sample filtering 
procedures carried out by Dr Meng and Dr Macé (biostatisticians) in the laboratory. This 
resulted in elimination of SNPs, CNVs and subject samples at several stages.  
 
A SNPs, CNVs and DNA Sample Quality-Control 
Three of the 192 DNA samples were below the Birdseed quality-control call rate 
threshold of ≥86% and were thus excluded from further analysis. Otherwise, the remaining 
samples had a mean call rate of 99.65%. SNPs and CNVs with a quality-control call rate 
threshold of ≤97% were eliminated.  
 
B DNA Sample Filtering 
A sample DNA gender check tested that subject DNA sex was in agreement between 
genotyping results and initial gender phenotype status. A Kinship examination eliminated 
closely shared extended LD blocks between individuals that suggested subjects were related. 
One subject was found to be a sibling of another, resulting in elimination of one of these 
subjects.  
 
C SNP Filtering 
 The following SNPs were removed from analysis: 
 
• Monomorphic SNPs*. 
• X and Y chromosome SNPs. 
• SNPs with extreme minor allele frequencies of (<0.01).  
• SNPs with Hardy Weinberg equilibrium (HWE) p<1 x 10-4. The HWE principle 
considers that in large randomly mating populations, allele genotype frequencies 
should remain constant [238]. Thus, SNP allele frequencies that showed deviation 
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from HWE were removed. This could be regarded as an internal control test [239]. 
HWE was calculated using the Fisher’s exact test.
 
 
 
D CNV Filtering: 
Quanti-SNP software assigned allele frequencies to SNPs within CNVs. Afterwards the 
following CNVs were removed from analysis: 
 
• CNVs that overlapped chromosome centromeres. 
•  Different CNVs that overlapped (forming clusters) by 70% with each other were 
considered as one CNV. 
• DNA samples with more than 20 CNVs. 
 
2.2 Population Stratification 
Preliminary population stratification was analysed among the 192 extreme subjects 
using the MDS method by Dr Meng in the laboratory (Fig.21). This resulted in elimination of 
a further 6 individuals in order to maintain a homogenic population, limiting admixture but 
unfortunately reducing the total number of subjects analysed. Unsurprisingly, one outlier was 
found to originate from the Basque population isolate.  
 
 
 
 
Fig.21. MDS Plot of Extreme High Myopic Cohort (192 subjects). A cluster of subjects 
with similar genetic background (allele frequencies) can be visualised (green box). These 
individuals are from the same population. Green arrows represent outlier subjects with 
different allele frequencies to subjects in the cluster. These subjects are from different 
population admixture and were eliminated from the study. V4 and V5 correspond to the two 
main dimensions used to form a presentable visualisation of the cluster and outliers. 
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2.3  Overall Genotyping Outcomes 
Filtering resulted in genotype data for a totoal of 182 extreme high myopes with 704, 
325 SNPs. This represents 95% of total initial subject DNA samples and 77% of total initital 
SNPs that were genotyped. 937 CNVs were identified within the 182 extreme high myopes, 
of which 62 have not been annotated by Affymetrix®, implying these could be de novo CNVs. 
10% of the extreme high myopic subjects harbored these CNVs. 
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V Perspectives 
 
1 Completion of All GWAS Stages  
A second replication stage will be carried out to genotype the “top” SNPs from this 
first stage. Custom SNP genotyping using Illumina BeadXpress® Veracode technology at 
Génopole, Toulouse, will be used on cohorts of approximately 200 high myopes (axial length 
≥26mm) and 200 controls. To increase coverage of candidate regions/genes, tagSNPs will be 
selected in LD blocks. A case-control association analysis for stage 2 genotyping data alone, 
as well as a joint association analysis of stages 1 and 2 data, will be performed; both with a 
more stringent p-value to select associated SNPs. Associated SNPs should indicate specific 
candidate region(s) and/or will be located within or in proximity to associated genes. 
Candidate regions and/or genes will then proceed to a final deep sequencing stage. 
Sequencing will also be carried out at Génopole, Toulouse, using the Roche 454 GS Flx 
sequencer. We aim to sequence 200 high myopes (axial length ≥26mm) and 200 controls. 
Cohort sizes will however depend on recruitment progression. Dr Meng (biostatistician) in the 
laboratory will work on the statistical association analyses.  
Given the possibility that candidate gene expression in human eye tissues could be 
unknown, this experimental data would be required to confirm that the candidate gene could 
play a structural and/or functional role(s) in the eye, thus a role in human myopia 
development [177, 178]. Candidate regions and/or candidate genes identified will also be 
compared to candidate genes already identified in previous genome scans for myopia and 
high myopia, and genes identified as potentially playing a role in the development of myopia 
in animal models. Finally, candidate gene interacting partners will be elucidated in order to 
decipher the gene networks at play. This is known as data mining and is based on the use of 
free on-line software that combines all literature observations, for example Ensembl, Gene 
Ontology [240] and Human Interactome [241]. From here, we could predict roles for 
candidate gene(s) identified in our GWAS in myopia development.  
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2 Confirmation of a Role for GWAS Candidate Genes in Human Myopia 
Development 
 Firstly, our genotype data will be included in other myopia and high myopia GWAS in 
collaboration with other laboratories that posses human cohorts recruited in terms of their 
refractive error phenotypes. Meta-analyses will confirm or reject the implication of the same 
gene(s) in myopia development in different populations, indicating the same or different 
molecular mechanisms underlying refractive error phenotypes.  
 Secondly, after confirmed replication studies an animal gene knock-out or knock-in 
model of the candidate gene(s) could be developed. Likewise, analysis of the changes in 
expression of the candidate gene(s) identified in our study in eye tissues of form-deprived or 
defocused myopic animal models could be carried out. On the whole, such animal models 
would allow the comparison of structural eye phenotypes (axial length, sclera thickness…) 
and gene expression changes (upregulation, downregulation) with normal eye tissues in an 
attempt to determine a mechanistic role of the candidate gene(s) in myopia development.  
 
 
 3 Conclusion: Project 1 
  To overcome the problem of difficult familial subject recruitment and the high 
heterogeneity underlying the high myopic phenotype, previous genome scans were replaced 
by a new whole genome SNP population-based case-control association analysis. This study 
design takes into account LD, a more powerful method for detecting multiple small effects in 
complex diseases. A new recruitment scheme was launched to include unrelated subjects 
based on axial length phenotypes, potentially reducing the number of genes underlying the 
phenotype and reducing the environmental influences compared to the more complex 
refractive error trait. Genetic admixture of the population was limited by excluding subjects 
not of French Caucasian origin. Unfortunately we overestimated subject recruitment capacity, 
thus to overcome the problem of a small cohort effect power calculations indicated the 
requirement to carry out a multi-step study. The first step was based on an initial whole 
genome scan of subjects with a severe axial length phenotype and with a modest p-value 
threshold. Today subject recruitment is ongoing to complete the next two stages in order to 
identify candidate chromosomal regions and/or genes. Replication of the associated candidate 
gene(s) and or mutation(s) will be required in different ethno-geographic populations to 
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confirm a role in myopia development. The identification of genes involved in myopia 
development is the first step in the comprehension of the physiopathology of the disease, and 
also in the development of new therapeutic treatments for severe vision threatening myopias 
that today can only be improved by wearing spectacles, contact lenses and intra-ocular lens 
implant surgery.  
 
1 Conclusion: Projet 1 
 Pour surmonter les problèmes de recrutement des cas familiaux apparentés et 
l’hétérogénéité élevée du phénotype de la myopie forte, les anciennes analyses de criblage 
génomique ont été remplacées par une nouvelle étude d’association pangénomique sur une 
population cas-témoin non-apparenté en utilisant des marqueurs SNP. Ceci prend en compte 
le LD, une méthode plus puissante pour détecter plusieurs effets modestes dans des maladies 
complexes. Un nouveau recrutement basé sur le phénotype de la longueur axiale à été 
constitué en comparaison au phénotype plus complexe d’erreur de réfraction, permettant de 
réduire potentiellement le nombre de gènes causants et les influences environnementales. La 
stratification de la cohorte a été limitée en excluant des sujets n’étant pas d’origine 
caucasienne. Malheureusement, nous avons surestimé les capacités de recrutement. Les 
résultats de calculs de puissance ont donc indiqué le besoin d’effectuer une analyse 
d’association multi-étape pour contrer la problématique posé par une petite cohorte. Ceci 
implique un premier scan pangénomique dans une cohorte avec un phénotype de longueur 
d’axial extrême, ainsi qu’un seuil de valeur de p modeste. A ce jour un recrutement est en 
cours pour compléter toutes les étapes de l’étude. Finalement, une réplication d’un ou 
plusieurs gènes ou d’une ou plusieurs mutations associées serait nécessaire dans d’autres 
populations d’origines différentes afin de confirmer un rôle dans le développement de la 
myopie forte. L’identification des gènes impliqués dans le développement de la myopie est un 
premier pas pour comprendre la physiopathologie de la maladie, mais également pour le 
développement de traitements thérapeutiques pour les myopies extrêmes menaçant la vision, 
qui sont à ce jour corrigées par le port de lunettes, lentilles ou par des implants intraoculaires. 
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VI Myopia and Corneal Refractive Surgery 
 
Nowadays refractive errors can be improved by refractive error surgeries. Corneal 
refractive surgery increases the quality of life of patients without actually curing the axial 
length defect. However, this requires altering the corneal shape which damages the corneal 
stromal and epithelial tissues. This can is some cases lead to corneal stromal opacities, known 
as ‘haze”, that reduce clear vision.  
 
1 Different Corneal Refractive Surgery Techniques 
All techniques function by flattening the corneal curvature, thus modifying the 
refractive index of the cornea, and in turn improving the overall refractive error. Nowadays 
surgical techniques are often based on the use of excimer lasers (focused beams of ultraviolet 
radiation) to ablate corneal stromal tissue.  
 
 1.1 Flap Procedures 
A flap in the corneal surface creates a hinged door effect so that corneal stromal tissue 
can be exposed. Stromal tissue can then be removed using either a microkeratome* (more 
traditional surgery known as automated lamellar keratoplasty (ALK)) or by using an excimer 
laser (surgery known as laser assisted in-situ keratomileusis (LASIK)) (Fig.22.A). Laser-
assisted sub-epithelial keratectomy (LASEK) functions by alcohol solution weakening of 
some of the outer epithelial cells in order to create an outer epithelial cell flap, followed by 
excimer laser stromal ablation. Afterwards, the flap can then be repositioned in its original 
place for wound healing.  
 
1.2 Incision Procedure 
This technique is based on the use of spoke-shaped incisions made into the cornea 
(Radial keratotomy (RK)) (Fig.22.B). This method has now been largely replaced by excimer 
laser methods. 
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1.3 Surface Procedures 
Unlike the other techniques that require physical contact with the corneal tissue, this 
method consists of direct ablation of anterior stromal segments without any direct contact 
with the cornea. An example is photorefractive keratectomy (PRK) that functions by excimer 
laser removal of some of the outer epithelial cells so that small amounts of stromal tissue can 
then be ablated. C-Ten (customized transepithelial non-contact ablation) is a refinement of 
LASEK and PRK. It is the newest and the fastest laser treatment. “C” for “customised” refers 
to the individualisation of the treatment for each patient, conforming to each individual’s 
requirements determined by the topography of the corneal surface, the extent of the 
correction, pupillary size and the patient’s lifestyle requirements. “Ten” for transepithelial 
non-contact. This refers to the non-contact ablation of the epithelial layer (Fig.22.C). After the 
laser treatment the epithelium regenerates within a few days, all the while being protected by 
a contact lens.  
  
Fig.22. The Different Techniques of Corneal Refractive Surgery.  A: The flap procedure. B: The 
incision procedure; creation of radial incisions in the cornea. C: The surface procedure; direct ablation 
of anterior stromal segments without any eye contact (A: Index E. B: Index F. C: Index G).  
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2 Secondary Complications 
Based on a worldwide literature review on the quality of life and patient satisfaction 
following myopia LASIK surgery, an average of 95.4% of patients are satisfied with their 
outcome [242]. Although the risk of complications is decreasing compared to earlier 
days, there is still a small chance for serious patient-specific problems following corneal 
refractive surgery. The ability to anticipate confounding biological responses at the level of 
the individual patient remains limited. In some cases, a predisposition to mechanical 
instability or abnormal regulation of corneal healing can lead to serious complications such as 
keratectasia* or loss of corneal transparency, known as haze or opacity (Fig.23.B) [243]. 
Nowadays a minorority of myopic patients, less than 3.5% (average 1.75%) undergoing PRK 
develop significant late-onset clinical corneal opacities that result in permanent visual defects 
[244, 245]. Other symptoms, such as corneal starbursts (Fig.23.C), double-vision, cornea 
neovascularisation and dry-eye syndrome* can develop following corneal refractive surgery.  
 
 
Fig.23. Secondary Complications following Corneal Refractive Surgery. A: Normal cornea. B: 
Corneal opacity formation (Index H). C: Corneal starburst effect: blurred vision and patterns around 
lights in dim light following LASIK (Index I). 
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3 Current Research on Corneal Opacity Formation  
Animal models have been largely based on the capacity of haze formation following 
corneal refractive surgery. It has been shown that higher rates of haze formation is manifested 
by rabbits having undergone PRK compared to LASIK for equivalent high myopia [243, 
246]. This is due to highly invasive PRK damage to the epithelium and stromal layers, 
whereas LASIK leaves these structures relatively undisturbed apart from at the flap margin. 
Refractive surgery nowadays is rarely used to treat high myopic patients as the required 
corneal remodelling amplifies the stromal damage, and thus the wound healing response, 
accounting for higher rates of haze [244].  
 
There is also a research area based on haze formation following epithelial 
scraping/rubing and more severe alkali burns, traumas (lacerations), and bacterial, viral or 
fungal infections (Kerititis). These injuries result in more acute corneal wound responses and 
hypertrophic scarring (Fig.24). Tissue scarring, which in some cases can lead to blindness, 
remains a major challenge for both clinicians and researchers at the cellular level. A worrying 
consequence is the lack of efficient therapies to treat and to prevent the condition. Once a 
corneal scar develops, surgical management remains the only option for visual rehabilitation, 
the definitive treatment being corneal transplantation. As our understanding of corneal wound 
healing and haze formation improves, so will our ability to offer interventions for preventing 
and restoring corneal haze. The main goal of research in this area is to improve the 
understanding of the biomechanical and wound healing pathways at play in the corneal 
wound response [243]. 
 
 
       
Fig.24. Corneal Scarring due to A: Herpes zoster keratitis viral infection (Index J). B: Alkali burning 
(Index K).  
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The Identification of Stromal Cells Expressing Stem Cell Markers throughout in vivo 
Adult Murine Corneal Wound Healing 
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I Introduction 
The Cornea: A Transparent Window 
In all species the cornea is a highly specialised transparent structure located at the 
anterior most surface of the eye giving a window to the outer world. 
 
1 The Cornea: Structure, Function and Development 
1.1 Gross Anatomy  
The cornea is an external transparent dome-shaped projection from the spherical 
scleral eyeball tissue (Fig.1.A). The thickness of the central human cornea is 0.52mm and 
increases toward the periphery. The diameter of the adult cornea is about 11mm, being 
slightly larger horizontally than vertically. In contrast, many animal corneas have a similar 
thickness over a considerable area (i.e. the mouse). The relative size of the cornea varies 
among animal species depending on the animal size (increase size, increase corneal size) and 
environmental conditions, being generally larger in nocturnal animals than those active in 
daylight (i.e. the mouse; note the similar eye ball:corneal size ratio) (Table 1) [247]. The 
cornea receives nutrients and oxygen via diffusion from the tear fluid on the outside, and from 
the aqueous humour on the inside [248].  
  
 
 
 
Table 1. Relative ocular and corneal dimensions of different speices (adapted from [247]). 
                
Fig.1.A: The Transparent Corneal Structure located at the most anterior surface of the eye (index 
A). B: A zoom on the epithelial, stromal and endothelial cell layers of the human cornea.  
Species Diameter (mm) Corneal 
 
Eye ball  Cornea thickness (mm) 
Man 24 11 0.52 
Cynomolgus monkey 18 9 0.4 
Rabbit 17 12 0.4 
Rat 6 5.5 0.2 
Mouse 3.5 3 0.15 
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Functional and mechanical structural aspects of the human cornea have been studied in 
animal corneas and findings can be extended to all other species [247]. Otherwise, known 
differences are stated. 
 
1.2 The Function of the Cornea 
The cornea provides two-thirds of the optical power of the eye [249]. The lack of 
blood elements in the central corneal tissue allows light to pass through, be refracted and 
inverted upon accompanying action of the lens, and focused on the retina to form clear vision. 
The cornea also has a protective role by acting as an external barrier to infectious agents. Thin 
nerve leashes are present in the corneal epithelial layer that contain nociceptors that are 
sensitive to touch, temperature and chemicals; touching the cornea causes an 
involuntary reflex to close the eyelid. The cornea is one of the most densely innervated organs 
of the human body [250], and is considered to have 3–400 times more nerve endings than the 
skin epidermis (outer skin cell layer). Together the transparency, avascularity and the 
presence of resident immune cells [251] that promote immunologic privilege* [252] makes the 
cornea an original and well-adapted tissue for clear vision.  
 
1.3    Mechanical Structure of the Cornea 
The cornea is a simple, but good model example of an organ composed of multiple 
cell types that are required to cooperatively maintain corneal structural integrity, transparency 
and prevent invasion from outside pathogens. The cornea is composed of three main cell 
layers (Fig.1.B):  
 
1. An outermost squamous tight stratified epithelium which is in contact with the tear 
film. This is composed of 3-7 cell layers depending on the species [253]. The mouse 
corneal epithelium is 3-6 cells in thickness [254], wheras it is is 5-7 cells in thickness 
in humans [255]. The epithelium provides the external barrier to the outside. 
2. The innermost layer is a mono-endothelial cell layer. This is required for fluid 
transport pumping out of the stroma and into the aqueous humour. Note that these are 
non-vascular endothelial cells.  
3. The intermediate layer is the corneal stroma. This accounts for 90% of the total 
corneal thickness [247]. The corneas combination of strength and transparency is due 
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to the highly organised micro- and nano-scale structure of the stroma [253, 256]. On 
the micro-scale, the stroma is comprised of chiral 250-400 lamellae of heterodimeric 
collagen fibrils in majority of type I, V and VI collagens [257-259]. These lamellae 
bundles are arranged in parallel and tightly packed. Nano-scale hydrophilic 
proteoglycans surround the collagen fibrils. These impose a uniform spacing of 
collagen fibres, giving the cornea the capacity to reduce light scatter and promote 
corneal transparency [260]. Keratoan sulphate and dermatan sulphate proteoglycans 
are the predominant proteoglycans in the human stroma. These belong to the family of 
small leucine-rich repeats and contain core proteins lumican, keratocan, mimican and 
decorin [259]. Nerves innverate the peripheral stroma from the cornea-scleral border, 
and then extend into the central stroma in decreasing branch sizes, where the majority 
then penetrate into the corneal epithelium [261]. Finally, adult keratocyte cells are 
sandwiched between the stromal lamellae, completing the molecular source of what 
we call the corneal stromal ECM [262] (Fig.2.A). The biochemical stromal structure 
and function is considered very similar across different species [263].  
 
The Bowman’s layer is a smooth collagen adhesion layer found below the epithelial 
basement membrane in the superficial stroma. It is considered important for additional 
structural support of the outer epithelial cell layer via attachment of basal epithelial cells 
through cell-matrix adhesion structures called hemidesmosomes [264]. More recent debates 
imply more important roles for this layer in epithelial-stromal cell interactions [265]. In 
humans the Bowman’s layer is composed of condensely packed type V collagen fibres. This 
layer is not to be mistaken as a thicker epithelial basement membrane; even though collagen 
compositions and functions appear similar between the two structures, it is a separate and 
additional layer to the basement membrane. It is absent from tadpole and carnivore corneas. It 
is thicker in higher mammals (cat, cattle, human) and thinner in lower mammals (rat, guinea 
pig, mouse,rabbit) [266].  
 
The Descemet’s membrane is named after the French physician Jean Descemet 
(1732-1810) and can be considered as an exaggerated basement membrane of the corneal 
endothelium that retains endothelial cell structure and organisation [267]. The Descemet’s 
membrane is composed of a different collagen type to the normal stroma, notably type III 
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collagen [268]. 
 
1.4 The Adult Keratocyte Cell 
Adult keratocytes are cranial neural crest mesenchymal-derived fibroblast cells that 
are flattened and sparsely arranged in the normal adult corneal stroma [262]. They form an 
interconnected cellular network with one another through dendritic processes* that form gap 
junctions* (Fig.2.B) [269]. Cell activity coordination is via these communications. It is even 
said that keratocyte cells form a syncytium (a large cytoplasmic structure with many nuclei) 
[270]. Keratocyte cells are poorly supplied with organelles and have small elongated nuclei, 
but contain rough endoplasmic reticulum and golgi apparatus, characterising a slow turnover 
(quiescent) with an active protein synthesis function [269]. Lumican, keratocan and mimican 
mRNA has been localised in keratocytes, giving these cells the role of stromal ECM collagen 
and proteoglycan synthesis and maintenance [271]. Keratocyte cells also show high 
expression of water-soluble crystalline proteins which are fundamental for the transparency of 
the cornea [272]. In the mammalian cornea, these proteins include aldehyde dehydrogenase 
isozymes [273], the prominent isoforms being ALDH1A1 and ALDH3A1 [274]. These 
enzymes eliminate insoluble protein aldehyde groups, minimising fluctuations in refractive 
indexes within keratocyte cell cytoplasms so that they match the refractive index of the 
surrounding ECM, thus rendering the cornea transparent [272].  
 
Fig.2.A: In vivo confocal microscopy of a section of a human cornea (arrowheads: keratocyte cells) 
(adapted from [275]). B: Schematic representation of the human keratocyte network (adapted from 
[275]).  
 
 1.5 Embryonic Development of the Cornea 
Embryonic eye development is throughout early developmental stages, with corneal 
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development also starting within these early stages of development. I have summarised 
vertebrate corneal development with references to the different stages of chick corneal 
development as this is the most studied embryonic corneal development model [262].  
Initally, the cornea is comprised of a surface ectoderm overlying the lens vesicle. 
Subsequently, at embryonic day 3 (E3) in the chick, separation of the surface ectoderm from 
the lens gives rise to a primitive epithelial cell layer that synthesises a primary stroma (loosely 
arranged collagen fibrils) [276, 277]. This is followed by two mesectoderm neural crest-
derived mesenchymal cell migration waves between the ectoderm and the lens. The first wave 
forms the endothelial cell layer, and the second wave at E4 gives rise to the stromal 
keratocyte cell population. Note that both endothelial and stromal keratocyte cells are 
neural crest-derived mesenchymal cells, whereas epithelial cells are of surface ectoderm 
origin, thus two different cell lineages [278, 279]. 
By E6 in chick embryos, keratocyte stromal cells begin to secrete ECM components of 
collagen and proteoglycans [262, 280-283]. Between this stage and eyelid opening, the stroma 
dehydrates, thus becoming thinner and transparent. Keratcoyte cell density declines and they 
resume their adult flattened cell morphology, and form an interconnected keratocyte cell 
network. They enter a quiescent state, residing in G0 phase. However, note that keratocyte 
cells do not complete terminal differentiation. Finally, the eyelids fuse in front of the eye, 
cutting off the epithelial cornea surface’s amniotic fluid supply before birth [284, 285]. This 
final development stage is the same for all species. Vertebrate cornea development is 
schematically summarised in Fig.3 page 83. 
 In humans, corneal development starts as early as the 6th week of early-stage 
embryonic development, with the neural crest-derived mesenchymal cell waves occurring in  
the 7th embryonic week of development [262]. In rodents however, there is only a single 
neural crest-derived mesenchymal cell migration influx that forms the endothelial and stromal 
cells, but the structural and cellular outcomes are identical [286]. Human stromal cells begin 
to secrete ECM components in the 8th week in human embryonic development, with  eyelid 
fusion between 3-6 months, meaning that the corneal stroma is completely developed pre-
natally [284, 285].  
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Fig.3. Development of the Vertebrate Cornea. The cornea begins to develop when the surface 
ectoderm closes and after lens vesicle detachment from the surface ectoderm. Afterwards, neural 
crest mesenchymal cells invade the provisional stromal ECM and form the corneal stroma (adapted 
from [287]).  
 
2 Normal Adult Corneal Renewal 
Tissue-derived stem cell populations have now been characterised in many adult tissues.  
They are able to maintain and regenerate a given tissue for the organism’s lifetime. However, 
before we start discussing adult corneal tissue renewal, we need a set of properties so we can 
distinguish stem cells from normal somatic cells (definitions reviewed in [288, 289]). 
 
 2.1 Stem Cell Definitions  
 
• Stem cell: Can be viewed as a cell that can self-renew many times without executing 
certain gene programs associated with a special function.  
• Self-renewal: At least one daughter cell remains a stem cell. 
• Slow cell cycle: Most of the time stem cells are in the G0 growth arrested state but can 
easily resume the cell cycle in demand to give rise to differentiating and highly 
proliferative progeny. 
• Stem cell niche: Stem cells usually require a specific micro-environment that provides 
external factors required for maintaining “stemness”. 
• Stem cell markers: A combination of negative expression of known differentiated 
stem cell markers and positive expression of known undifferentiated markers is used 
to experimentally identify stem cells. For examples see table 2 page 87.  
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• Multipotent: The ability to differentiate into different cells of the same tissue of 
embryonic origin. These can be judged as pre-determined cell types.  
• Pluripotent: Ability to differentiate into any cell type, not just those of their tissue of 
origin.  
• Progenitor cells: Similar to stem cells, but their progeny in most cases does not renew 
and the cell population becomes terminally differentiated after a limited number of 
cell divisions. In terms of stem and progenitor cells, both can be expanded under 
correct circumstances.  
 
2.2 Corneal Epithelium Turnover 
A high rate of adult epithelial cell renewal is required to maintain a stable and 
continuous contact of the corneal outer layer with the tear film layer to assure a smooth 
refractive surface. Renewal is also required to sustain a tight barrier integrity, necessary for 
preventing infiltration by pathogens and fluid loss [254]. Like the skin, corneal epithelium 
turnover is sustained upon a fine balance between cell loss by desquamation at the outer most 
surface, and cell replacement by migration and proliferation of epithelial stem cells [290-292]. 
It is assumed that all mammalian species normal epithelial surface turnover is completed 
within 7 to 14 days [291].  
 
2.2.1 Corneal Epithelial Stem Cells 
A  Populations and Localisations 
The limbal region is the tissue in the cornea-scleral transition zone (Fig.4.A.B). In the 
limbus the epithelial tissue thickness increases (approximately 10-12 cell layers in humans), 
and the endothelial cells are larger and flatter and connect with the trabecular meshwork 
(mesh-like drainage canals). The Bowman’s layer and Descemet’s membrane are no longer 
present. The epithelial basement membrane lies directly on the stroma, and the stromal 
collagen structure is less organised with decreased keratocyte abundance. This overall 
structure forms unique ridge-like constructions, named the limbal palisades of Vogt [293]. 
The limbal region is also vascularised, providing nutrients and support factors for cells [293-
296]. Limbal basal epithelial stem cells are thought to reside in this protected limbal niche 
(Fig. 4.C) [297, 298]. Here these cells cycle slowly throughout life, maintaining a small but 
highly proliferative characteristic [294, 297, 299-301]. Their daughter cells, known as 
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transient amplifying cells, migrate centripetally into the basal layer of the corneal epithelium 
(Y component), where they then differentiate into the upper layers of the corneal epithelium 
(X component), with desquamation of outer epithelial layers occuring in order to replace the 
outer surface layer (Z component). This maintains the balance between cell production and 
cell loss [302], and is known as the X, Y, Z hypothesis (Fig.5.A).  
The limbal niche was the only known epithelial stem cell niche until 2008 when new 
findings showed evidence of epithelial stem cells throughout the epithelial surface itself [291, 
303]. Moreover, Chang et al., (2008) [303] found that epithelial surface stem cell proliferation 
and migration in the corneal centre was as vigorous as stem cells from the limbus in an ex 
vivo human donut limbal ablation model (removal of the limbal epithelium). This indicates 
that the limbus may not be the only region enriched in stem cells (Fig.5.B). 
 
Fig.4. The Corneal Limbus. A: The corneal limbus is localised to the corneoscleral border. The upper and lower regions most 
protected by the eyelids contain the Vogt’s palisades [304]. B: Cross-section of the corneoscleral transition. The corneal 
epithelium is contiguous with the conjuctiva, the corneal stroma transits into the sclera, whereas the corneal endothelium links 
with the trabecular meshwork [304]. C: Hematoxylin and eosin staining (HE) of a normal human corneal limbus demonstrating 
the palisades of Vogt with small putative residing stem cells (arrows in indent). Small nuclear:cytoplasm represents stem cells 
[305]. 
 
Fig.5. Epithelial Stem Cells. A: X, Y, Z hypothesis of limbal basal epithelial stem cell epithelial renewal. Limbal basal epithelail 
stem cells (red) generate transient amplyfing cells (purple) that migrate into the epithelium and differentiate into outer surface 
epithelial cells [291]. B: Epithelail surface stem cells are distributed throughout the whole ocular surface [291].  
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B Molecular Markers of Limbal Basal Epithelial Stem Cells 
For three decades now work has been progressing on the identification of stem cell 
markers for limbal basal epithelial and transient amplifying stem cells. Markers recognised 
are briefly summarised in table 2 page 87. Please note that in studies aimed to determine 
epithelial stem cell marker profiles, known markers of stem cells from other ectoderm-derived 
tissues (such as the epidermis) are good candidates as tissues from the same embryonic origin 
generally give rise to stem cells with at least partially overlapping marker profiles [306]. This 
idea of comparative study is now starting to be successfully applied to identify different stem 
cell populations from the same embryonic origins even across different species [307].  
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Molecule Expression 
+ / - 
Brief description/role 
∆Np63α + Cell maintenance 
ABCG2 + Universal stem cell marker, cell membrane transport protein 
C/EBPδ/Bmi-1 + Self-renewal 
Calizzarin + Cell growth 
Catenin α2 + Linking protein between cadherins 
Collagen VI, α1 and α2 chains + Structural 
Connexin 43 - Keratin-containing intermediate filament                         
Cytokeratin 12  - Keratin-containing intermediate filament 
Cytokeratin 14 + Keratin-containing intermediate filament 
Cytokeratin 15 + Keratin-containing intermediate filament 
Cytokeratin 3  - Keratin-containing intermediate filament 
Disabled 2 + Integrin binding molecule 
Epiregulin + Member of the epidermal growth factor family 
Glial cell-derived neurotrophic factor (GDNF) and their 
corresponding receptors TrkA and GDNF family receptor 
alpha (GFRα)-1  
+ Inflammatory mediators 
Heat shock protein 70 + Heat shock response 
Hes1 + Major Notch target 
Inhibitor of DNA binding molecule 4 + Inhibit/promote DNA binding  
Integrin α9 + Cell membrane receptor 
Integrins α2, α6 and β4 - Cell membrane receptor 
Involucrin - Structural component of mature squamous epithelial cells 
Musashi-1  + Cell differentiation  
N-cadherin + Cell adhesion 
Notch 1  + Progenitor cell maintenance  
P-cadherin + Cell adhesion 
Spondin-1 + Intestinal growth factor  
Superoxide dismutase 2 + Enzyme;  dismutation of superoxide 
Tissue inhibitor of metalloproteinase 2 + Stem cell regulator 
Transglutaminase 2 + Regulates protein cross linking 
Wnt-4 + Progenitor cell maintenance 
Importin 13 + Nuclear transport 
 
Table 2. Limbal Basal Epithelial Stem Cell Markers: p63 is considered a reliable marker for both 
active and resting epithelial stem cells (adapted from [304]).  
 
Adheshion 
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2.3 Corneal Endothelium Turnover 
It is considered that human corneal endothelial cells no longer divide beyond an adult 
age of approximately 20 years old, the endothelium thus being a stable structure [308]. The 
potential existence of endothelial precursor cells has only been investigated in corneal 
endothelial wound healing (section 3.4 page 96).   
 
2.4 Corneal Stroma Turnover 
Stromal ECM maintenance is required to retain corneal transparency. However, 
keratocyte turnover is very, very low (2-3 years) and mitosis cannot be traced. Remodelling of 
a normal, healthy stromal ECM is not even detectable over time [309], with early experiments 
using radioactive markers estimating a 2-3 month turnover time for the production of 
sulphated polysaccharides, and even longer for collagen [310]. Only following corneal injury 
do keratocyte cells become mitotically active.  
 
3 The Corneal Wound Healing Response  
The idea of a tissue repair mechanism replacing normal homeostatic tissue 
regeneration events in mammalian wound healing initially derives from the idea of selective 
pressure and evolution. In most wounded organs, fast fibrotic repair of the damaged tissue 
saves lifes, but results in at least partial loss of the original fucntion of the tissue. This is not 
always the case for the cornea. Clear vision is crucial for survival in most species. In animals 
the corneal repair events are more self-regenerative than fibrotic, restoring clear vision. 
However, wether regenerative versus fibrotic corneal repair events occur is dependent on the 
species, the extent of the corneal wounding and regulation of the keratocyte phenotype 
throughout the wound healing process [311]. 
 
3.1 The Cascade of Cellular Events in Corneal Wound Healing  
Following corneal injury cells in the epithelium and stroma, as well as nerves and the 
ocular surface tear film participate in a cooperative orchestrated response to restore corneal 
structure and function. Many different cytokines*, growth factors, chemokines* and their 
receptors that are involved in cell-cell regulatory interactions and immune cell functions that 
are required to not only heal the wound, but to eliminate debris and microbes that must not 
gain entry into the stromal layer. Many of these responses occur simultaneously or at least 
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overlap. In this section I focus on the keratocyte cell wound responses (as do many review 
authors on this subject) in respect to findings using mammalian corneal injury models. We do 
however need to consider the totality of the contribution from the different components of the 
wound healing pathway to appreciate the efficiency of the overall wound response.  
The most recent overview of the corneal stromal wound response was made by Dupps 
and Wilson., (2006) [243] (Fig.6). Briefly, outer corneal epithelial injury is the initial trigger 
of the corneal wound response. This is followed by almost instantaneous apoptosis* of 
keratocyte cells in proximal stromal tissue underlying the wounded epithelial zone. Shortly 
afterwards keratocyte cells in the stroma neighbouring the wound zone begin to migrate and 
proliferate into the wound zone devoid of keratocyte cells. These are known as activated 
keratocytes, and consequently adopt a repair fibroblast cell phenotype. These cells are 
responsible for the synthesis and deposition of the new stromal ECM, thus stroma repair (also 
known as stroma remodelling). Bone marrow-derived magrophage cells also migrate into the 
cornea to elicit phagocytosis of apoptotic and necrotic debris. (I will not focus on the roles of 
these cells in this project). Depending on the extent of the injury, activated keratocyte cells 
can also differentiate into myofibroblast cells. These cells are associated with corneal opacity 
formation. 
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Fig.6. Schematic Events of Corneal Wound Healing put forward by Dupps and Wilson. (2006) 
[243]. A: Human corneal section having undergone epithelial scrape prior to enucleation for choroidal 
melanoma. Arrows: TUNEL staining assay reveals keratocytes undergoing apoptosis. X500. B: 
Immunostaining carried out with Ki67 marker for mitosis in the peripheral and posterior cornea of a 
rabbit cornea epithelial scrape injury model. Arrows: Cells undergoing mitosis 24h following injury. 
X400. C: GFP-positive bone marrow-derived cells can be seen migrating into the cornea at 24h after 
injury in a chimeric mouse (whole flat-mount). D: Myofibroblast development in the stroma near the 
injured surface epithelium in a rabbit cornea at one month after PRK. Arrows: Myofibroblasts detected 
by alpha-smooth muscle actin (α-SMA) immunostaining. The slit lamp photos of a clear cornea and a 
cornea with haze are both from humans (X5). 
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3.2 The Epithelial Wound Response  
The epithelium being the outermost corneal layer is subject to insult from abrasions, 
scrapes and chemical exposures [243]. Epithelial wound repair is the same regardless of the 
extent and type of the injury (excluding complete epithelial removal) and can be separated 
into three phases. These phases are considered to be the same events as those in normal 
corneal epithelial homeostasis previously described in section 2.2,1 page 85, and can be 
separated into a latent phase, a cell migration phase and a cell proliferation  phase [312, 313]. 
The latent phase refers to the direct movement, sometimes referred to as a sliding 
effect, of basal epithelial cells next to the wounded zone that cover the denuded area. In rabbit 
and monkeys this occurs as early as 4-6 hours following injury [314]. This forms a monolayer 
of epithelial cells over the wound zone, also referred to as the “fibrin plug”. It has been 
proven that desmosome cell adhesion proteins between the basement membrane and epithelial 
basal cells are completely lost in proximity to the wound zone in order to diminish the normal 
tight stratified epithelial structure and to promote this basal cell sliding effect [314-317].  
The migration phase involves migration of epithelial cells across the whole wound 
zone before mitosis commences, producing a linear arrangement of cells across the wound 
zone. The migration of cells is mediated by formation and contraction of their actin filaments 
[318, 319]. Upon completion of cell migration and complete covering of the wound zone by 
serial epithelial cell layers, it is important to regenerate tight adhesion between the epithelium 
and underlying stroma layer to begin stroma remodelling. Synthesis of new desmosomes and 
gap junctions* accomplish this [320].  
In the proliferation phase, we return to the X, Y, Z function of limbal basal epithelial 
stem cells localised in the limbus. Once these cells migrate into the wound zone, they 
proliferate until normal thickness of the epithelium layer is regenerated (re-epithelialisation).  
Reports using animal models show that this is generally complete within 1-7 days, depending 
on the species and the extent of the injury [311, 321].   
Damage to the epithelium, and essentially damaging the epithelial basement 
membrane and Bowman’s layer, results in changes in epithelial-epithelial cell and epithelial-
stroma cell signaling via changes in release of cytokines*, growth factors and chemokines* 
compared to release under normal homeostatic conditions [322]. An example is the 
Interleukin (IL)-1 cytokine regulator. This cytokine comes into play in normal epithelium 
homeostatic regeneration, but does not enter the normal stromal layer due to epithelial 
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basemement membrane and Bowman’s layer integrity [323]. In the wounded stroma, not only 
does IL-1 activate keratocyte apoptosis, but IL-1 is also capable of regulating other growth 
hormones (Keratinocyte growth factor (KGF), HGF) [324] that themselves regulate 
keratocyte migration and proliferation [325]. Similarly, expression of cytokines* [323] and 
growth factors [326] in tear fluid have also been reported to increase shortly following corneal 
injury [322]. In the case of incision wounding, these factors would penetrate into the corneal 
stroma to trigger a variety of keratocyte cell proliferation, migration, and differentiation 
responses [327].  
 
3.3 The Stromal Wound Response 
3.3.1 Keratocyte  Apoptosis 
Earlier work shown by animal corneal incision models (that penetrate into the stroma) 
showed that keratocyte cells neighbouring wound zone edges disappeared after only a few 
hours post-wounding [328-332]. Similarly, Wilson et al., 1996 [332] demonstrated that 
keratocyte cells in proximity to animal epithelial surface scrape injuries involving damage to 
the epithelial basement membrane also disappeared. This group was the then first to prove 
that keratocyte cells disappear by apoptosis, and that this is the first event in the stromal 
wound healing cascade [333]. Apoptosis of keratocyte cells prevents further corneal 
inflammation and subsequent loss of clear vision. Afterwards, experimentation carried out on 
animal models implied that stromal keratocyte apoptosis is ongoing in the stromal wound 
zone for approximately 1 week [334, 335]. This suggests that earlier keratocyte cells that 
migrate and proliferate into the direct wound zone could also apoptose once [323]. 
Additonally it was found that stromal cells also begin to undergo necrosis after a first wave of 
cell apoptosis [323]. Necrosis has been characterised as a passive, accidental cell death 
resulting from environmental perturbations with uncontrolled release of inflammatory cellular 
components [336].  
Up to 25-50% of stromal keratocyte cells can apoptose following corneal injury, 
depending on the extent of the injury, the species and indeed if the epithelial basement 
membrane and stromal layer itself are also directly injured [337]. Epithelial scraping, 
mechanical epithelial pressure and epithelial viral infection have shown to only cause 
superficial keratocyte apoptosis and necrosis. Differently, incision wounding has 
unsurprisingly shown more anterior keratocyte apoptosis and necrosis, posterior to the 
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incision made. This was believed to be due to increased diffusion of pro-apoptotic cytokines* 
into the central stroma [323].  
 
3.3.2 Keratocyte Activation, Migration and Proliferation: Stroma Remodelling 
Following keratocyte apoptosis, the corneal stroma is left with a stromal “gap” which 
is relatively devoid of keratocyte cells [323]. The process of repair begins with the activation 
of keratocyte cells adjacent to this cellular-emptiness. These cells are detectable as early as 6 
hours following injury in humans. An activated keratocyte cell phenotype can be 
distinguished by an increase in size and an increase in the number of nucleoli. The 
morphology of the cells at this stage resembles that of fibroblast cells with a fusiform shape 
[311]. Furthemore, the cell cytoskeleton is found to be similar to that found in skin fibroblasts 
in repair tissue [338]. Zieske and coworkers [339] demonstrated that these cells migrate into 
the direct wound zone devoid of cells. Repair fibroblast cells show also synthesis of α5 
integrin chain which results in the formation of α5  (beta) 1 integrin heterodimers, known as 
the classic fibronectin receptor that mediates cell-ECM attachments. This occurs at the same 
time as fibrin plug deposition in the stromal wound zone [340], suggesting that this receptor 
may be responsible for the formation of repair fibroblast focal adhesion that enable these cells 
to migrate on the fibronectin “provisional” matrix into the wound zone [338]. 
Prolifeartion of repair fibroblasts occurs approximately 3 days following injury at the 
wound zone periphery. Mitosis in rodent corneal incision models peaks after about 6 days 
following injury. These accumulated cells invade the fribrin plug in the wound zone [311]. 
Proliferation continues for several days [335, 339].  
An active synthesis function of repair fibroblast is implied as they exhibit an enlarged 
cytoplasm and contain many organelles; rough endoplasmic reticulum, mitochondria, free 
ribosomes, golgi complexes. They are also capable of incorporating radiolabelled (with 
sulphate) macromolecular structures [341]. Active synthesis at this point is involved in 
production of repair ECM [342]. This new ECM is not only deposited in a disorganised 
manner, it is of a different composition to the normal corneal stromal ECM as the ratios of 
collagen types differ [343, 344]. With this, an increased compaction and alignment of 
collagen fibrils has been observed (Fig.7) [345]. This contributes to a reduction in corneal 
transparency.  
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ECM degradation enzymes are also switched on in wounded corneal stromas. 
Enzymes involved are principally MMPs, a family of zinc-containing endopeptidases known 
to be active in corneal stromal wound healing [346, 347]. MMP-1, MMP-3 and MMP-9 are 
not present in the normal corneal stroma, but synthesis is activated in repair fibroblasts [348-
351]. Similarly, synthesis of MMP-2 (the only MMP found in the normal corneal stroma) is 
upregulated and the majority is converted into functional protein in repair fibroblasts [348, 
350, 351]. These proteinases may play a role in the degradation of damaged or provisional 
ECM, but their expression patterns correlate with the stroma remodelling process, suggesting 
they may also play a role in the deposition of new ECM [258].  
 
 
Fig.7. Corneal Keratocyte (A) and Repair Fibroblast (B) Cells. 3D matrice cell culture of primary 
rabbit keratocyte cells in serum-free medium (A) and in 10% FBS (B). Immunostaining with f-actin 
(green) and collagen fibrils (red). Keratocytes harbour a stellate morphology with numerous cell 
processes that run a tortuous path between and along collagen fibrils without any apparent impact on 
their alignment. Repair fibroblasts typically have a bipolar morphology with thin pseudopodial 
processes and increased compaction and alignment of collagen fibrils parallel to the pseudopodial tips 
(adapted from [345]).  
 
Beyond approximately day 10 post-wounding (again depending on the species and 
extent of injury), a more quiescent repair fibroblast cell state is restored, even though new 
ECM repair tissue is continuously synthesised over many months in order to restore a normal 
ECM for correct vision. Firstly, collagen is deposited in a lamellar pattern [352], followed by 
graduly interweaving of collagen lamellae into the wound edge [309]. The collagen fibril 
sizes become more regular and organised, clearing the opaque repair ECM tissue and 
regenerating normal corneal transparency [353, 354]. This is a normal repair pathway, but 
afterwards, what cell phenotype is derived from the repair fibroblast cells?  
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3.3.3 Myofibroblast Formation: Regeneration versus Fibrosis 
There is a delicate balance between stromal regeneration (repair fibroblast cells) and 
fibrosis (myofibroblast cells). Stromal repair that restores a transparent stroma is based on the 
hypothesis that repair fibroblast cells could revert back to thier normal quiescent keratocyte 
phenotype, but this has not yet been confirmed [323, 355]. Alternatively, fibrosis can occur 
when repair fibroblasts differentiate into myofibroblast cells. This usually occurs in response 
to more acute corneal injuries that cause damage to the epithelial basement membrane, 
resulting in increased signal release into the stroma. A role for TGF signaling in 
myofibroblast formation is well established [344], giving TGFβ siganling a key role in 
corneal opacity formation. Note that there are significant species-related differences in the 
tendency to generate myofibroblast cells [243]. 
α-Smooth Muscle Actin (SMA) is a an intracellular structural intermediate filament in 
myofibroblast cells [356, 357], allowing us to distinguish these cells from active fibroblast 
and keratocyte cells. Between one and two weeks following such injuries, stromal cells can 
stain positive for α-SMA in the stroma below the wound zone [358]. Expression of α-SMA 
also mirrors the invasion of stromal wound zones by repair fibroblasts (see Fig.20 page 128), 
but expression continues in each cell over the weeks, even years, of wound contraction [356]. 
α-SMA can also be used as a marker of partially committed embryonic progenitor cells [359], 
implying that myofibroblast cells are undifferentiated cells.  
Comparison of ex vivo keratocyte and myofibroblast cells has deduced that 
myofibroblast cells produce additional growth factors [324] and collagen [337, 360, 361], as 
well as glycosaminoglycans (also known as mucopolysaccharides), collagenases and 
gelitinases, indicating a crucial role for these cells in the stroma remodelling process [362-
367]. On the other hand, myofibroblast cells have reduced transparency due to reduced water-
soluble corneal protein crystalline production compared to normal keratocyte cells, resulting 
in less transparent cell properties [272]. Large numbers of myofibroblasts reduces corneal 
transparency [344, 358].  
In most cases myofibroblast cells disappear once stroma remodelling is complete. 
Spontaneous disappearance of myofibroblasts has been observed even years following injury 
and corneal transparency can de regenerated. Again, this is a normal repair pathway but it is 
still unclear how the myofibroblast cell phenotype disappears from the remodelled stroma. 
Some reports claim that myofibroblasts gradually disappear by apoptosis [358]. This is 
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thought to be post-stroma remodelling myofibroblast apoptosis and resorption of the 
disordered matrix is thought to be carried out by the repopulating keratocyte cells [368]. 
Supporting this idea was very recent work reporting that inflammatroy cells, and even adult 
keratocyte cells, may produce IL-1α and/or IL-1β cytokines* that could act in a paracrine* 
fashion to regulate myofibroblast apoptosis in regions of corneal haze [369]. Moreover, 
myofibroblasts were shown to produce themselves IL-1α and/or IL-1β , suggesting 
modulation of apoptosis via autocrine* suicide [369].  
On the other hand, it has been reported that myofibroblasts are not terminally 
differentiated and possess the ability to restore keratocyte phenotypes [355]. However, further 
work is still required to verify if myofibroblasts directly regenerate keratocyte cells in stromal 
wound healing. It also remains unclear if all activated keratocyte cells transform into 
myofibroblast cells, or if there is a subpopulation of original keratocyte cells that possess this 
transformation capacity [311, 333].  
In some cases, myofibroblast cells remain permanently in the corneal stroma following 
injury, causing a constant reduced vision, or in the worst cases blindness. The cellular events 
and mechanisms that underly this myofibroblast persistance are not characterised. This is a 
pathological, fibrotic repair pathway.  
 
3.4 The Endothelial Wound Response 
Earlier work attributed a non-self regenerative characteristic to adult corneal 
endothelial cells and it was considered a stable structure with no known stem cells. 
Observation of corneal endothelial wound healing indicated a morphological cell enlargement 
and migration function, which were considered the major means of endothelial repair [370, 
371]. These theories are now under debate considering that several in vitro and ex vivo studies 
have shown endothelial cell mitotic changes and proliferation in response to stimulation by 
growth promoting agents, such as serum [372-374], EGF (Epidermal growth factor) [370, 
372, 375] or a combination of the two [373]. Moreover, in vitro human endothelial cells from 
both young and old donors have shown the capacity to proliferate in response to growth-
promoting agents [376]. Consequently, in 2005 the potential presence of multipotent 
endothelial precursor cells was suggested by a handful of groups. It was discovered that ex 
vivo human endothelial cell colonies expressed both mesenchymal and neuronal markers. 
Differentiated progeny showed corneal endothelial cell-like morphology and pump functions 
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[377]. These cells however were considered only progenitor cells as they were no longer 
capable of growing clonally beyond passage 3. Interestingly, McGowan et al., (2007) [378] 
showed that exposed damaged endothelial cells from human corneal graft beds demonstrate 
increased expression of a range of adult progenitor and undifferentiated embryonic stem cell 
markers. This supports the idea of an endothelial progenitor cell population required for adult 
endothelial cell regeneration, residing in the posterior limbus as hypothesised by the authors 
[378]. This correlates with former work claiming the migration of endothelial cells from the 
wounded peripheral into wounded endothelial areas to afflict a repair role [374, 379, 380].  
 
3.5 The Wounded Corneal Stromal Inflammatory Response  
Rodent corneal wound healing models show that within the first 24 hours following 
corneal injury an influx of inflammatory cells migrate into the stroma [381]. These originate 
from the limbal blood vessels and aqueous tears [382]. This is due to epithelial and keratocyte 
cell responses to elevated cytokine* levels, triggering infiltration in majority by 
macrophages/monocytes and T cells [243]. The function of inflammatory cells in the wound 
healing response is a scavenger effect for release of keratocyte cellular components following 
necrosis and invasion of pathogens from the injury. These are phagocytosed by inflammatory 
cells [243]. Exploration into inflammatory cell types and signaling pathways involved in the 
stromal inflammatory response is still at the beginning of research experimentation and there 
still remains a lot to unravel. 
 
3.6 Corneal Wounding and Angiogenesis 
Angiogesis is the process by which new blood vessels derive from endothelial cells of 
pre-existing blood vessels (hemangiogenesis) [383, 384]. Lymph vessel formation 
(lymphangiogenesis) is also an angiogenic process where new lymph vessels arise from 
endothelail cells from primitive veins, local lymphangioblasts* or bone marrow-derived cells 
[385]. Both processes are regulated by pro-angiogenic and anti-angiogenic factors [386]. 
Examples of pro-angiogenic factors previously identified in the cornea are FGF-2 and 
Vascular endothelial growth factor family members (VEGF). Examples of anti-angiogenic 
factors include Angiostatin (recognised as endothelial cell migration and proliferation 
inhibitor) [387] and Pigment epithelium-derived factor (PEDF) [386]. The maintenance of 
corneal avascularity is an active process of production of anti-angiogenic factors that 
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counterbalance the pro-angiogenic factors. However, pro-angiogenic factros are upregulated 
following more severe corneal injuries from trauma, infection and inflammatory or 
degenerative disorders [388, 389]. This can cause in a minority of cases the dual invasion of 
the cornea by both blood and lymph vessels [386].  
 
3.6.1 Hemangiogenesis in the Wounded Cornea 
Blood vessels in humans and animal corneal wound healing models are usually visible 
to the naked eye (Fig.8). The blood vessels normally grow inferiorly into the central cornea 
from the limbus, sclera or conjunctiva, and then usually extend between the stromal collagen 
lamellae and the corneal epithelium and Bowman’s layer [390]. The idea of a circular ring-
like system around the cornea to promote communication has been put forward [391]. To 
date, work on animal model hemangiogenesis is in majority based on elucidating mechanisms 
aimed at understanding the growth factor signaling pathways that promote this response 
[386].  
 
 
Fig.8. Clinical Appearance of Human Corneal Hemangiogenesis in corneal infection 
Acanthamoeba Keratitis. Corneal vessel growth inferiorly into the central cornea from the sclera [392]. 
(Acanthamoeba Keratitis is a rare disease in which amoebae invade the cornea).  
 
3.6.2 Lymphangiogenesis in the Wounded Cornea 
Unlike blood vessels, lymph vessels cannot be observed by the naked eye in the 
cornea. Recent studies have developed experimental models to analyse lymph vessels 
separately from blood vessels. This is using Lyve-1, a lymphatic vessel endothelial cell-
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specific hyaluronan receptor antibody that has been successfully used by immunostaining 
techniques to localise lymph vessel ultrastructural features in corneal wound healing animal 
models and human corneas exhibiting neovascularisation (secondary to keratitis, transplant 
rejection, trauma, and limbal stem cell insufficiency). Results indicate that lymph vessel 
outgrowth into the stroma towards the central corneal wound from the limbal region can occur 
within 2 days following mouse corneal suturing (corneal incisions with nylon/silk sutures). 
Moreover, lymph vessel formation has been found to be correlated with the degree of 
hemangiogenesis in both wounded mouse and human corneas (Fig.9.) [393, 394]. Lymph 
vessels however were found to regenerate earlier than blood vessels, at approximately 14 days 
following suturing injury, whereas blood vessels were still observed 6 months post-wounding 
[393].  
Interestingly, a handful of reports claim that lymphangiogenesis in wounded mouse 
corneas can occur in the absence of hemangiogenesis, depending on the inflammatory stimuli 
used [395, 396]. Chimeric mouse models have shown that corneal stroma bone marrow-
derived cells can incorporate to form lymphatic vessels following suturing injury. It was 
suggested that these lymphatic endothelial precursors may be macrophages that 
transdifferentiate into lymphatic endothelial cells [385, 397].  
 
 
Fig.9. Parallel Outgrowth of Blood Vessels (CD31+++/Lyve-1-) and Lymphatic Vessels 
(CD31+/Lyve-1+++) from the mouse limbus to the central corneal inflammatory stimulus (suture–
incision). A: Whole cornea flat mount 3 days after injury. X100. B: Frozen sections 3 weeks following 
injury. X40. C: Frozen sections 3 months following injury. X40 (Adapted from [393]). CD31 is 
expressed by bone marrow-derived and endothelial cells [398, 399]. 
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Experimentation aimed at determining a role for lymph vessels in the wounded cornea 
is just emmerging. Ideas are particularly focused on a role of antigen-presenting cell 
trafficking from the the cornea into lymph nodes [400]. Co-localisation of blood and 
lymphatic vessels could be based on their complementing functions of tissue fluid and protein 
balance, as well as this immune cell trafficking in wound repair [400].   
Very recent work has proven differences in the extent of lymph vessel formation 
following injury between different mouse strains [401]. Moreover, different patterns of 
corneal hemagngiogenesis and lymphangiogenesis were identified using different wound 
models on the same mouse species [402], indicating high variation in corneal lymph vessel 
formation which is species and wound-nature dependent.  
 
4 Revision: Corneal Stromal wound  Healing 
Across different species corneal stromal wound healing follows the same flow of 
events (summarised in Fig.10 page 101). Keratocyte cells apoptose in the wound zone, then 
neighbouring keratocyte cells migrate and proliferate into the stromal cell gap, where they 
adopt a repair fibroblast cell phenotype for stroma remodelling. Increasing wound size and 
depth, damaging the epithelial basement membrane and Bowman’s layer, increases the extent 
of keratocyte apoptosis and leads to more fibrotic stromal wound healing responses. 
Keratocyte cells differentiate into myofibroblast cells, leading to reduced corneal transparency 
and corneal opacities. Further work is required to deduce if repair fibroblast cells and 
myofibroblast cells regenerate normal keratocyte cells, or apoptose following stroma 
remodelling to restore normal stromal transparency. It is unclear why in some cases 
myofibroblast cells can persist in the corneal stroma once stroma remodelling is complete.  
 
 4 Récapitulatif: La cicatrisation cornéenne stromale 
  Parmi les différentes espèces, l’enchainement des événements de la 
cicatrisation cornéenne stromale est identique (résumés dans Fig.10 page 101). Les 
kératocytes entrent en apoptose dans la zone blessée, puis les kératocytes voisins migrent et 
prolifèrent dans la zone de blessure stromale, où ils adoptent un phénotype de fibroblastes 
réparateurs pour le remodelage du stroma. En augmentant la taille et la profondeur de la 
blessure, et en blessant essentiellement la lame basale épithéliale et la couche de Bowmann, 
cela provoque la différenciation des kératocytes en myofibroblastes, conduisant au 
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développement des opacités cornéennes et à une réduction de la transparence de la cornée. 
D’autres travaux sont nécessaires pour déterminer si les cellules fibroblastiques réparatrices et 
myofibroblastiques se transforment en kératocytes normaux, ou s’ils entrent en apoptose après 
le remodelage du stroma pour restaurer la transparence de la cornée. Dans une minorité des 
cas, une fois le remodelage achevé, des myofibroblastes persistent dans le stroma par un 
mécanisme inconnu, provoquant alors une réponse cicatricielle anormale, plutôt fibrotique 
que réparatrice. 
  
 
 
Fig.10. Schematic Representation of the Corneal Stromal Wound Response, taking into account 
both normal repair and fibrotic pathways (intermittent arrows).  
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5 Identification of Corneal Stromal Cells Expressing Stem Cell Markers 
Much more attention has been placed on the definition and behavior of corneal 
epithelial stem cells for their self-regenerative ability in corneal wound healing than stromal 
cells. However, more recently several studies have indicated the localisation of a corneal 
stroma cell subpopulation that can grow clonally, express known adult and embryonic stem 
cell markers, exhibit multipotent characteristics and then switch phenotype to a functional 
keratocyte-like cell. This is not characteristic of the quiescent adult keratcoyte cell phenotype, 
thought to be the cell population that exclusively preoccupied the stroma. This suggests for 
the first time the localisation of a novel population of cells in the normal corneal stroma with 
stem cell characteristics.  
 
5.1 In vitro and ex vivo Corneal Stromal Cell Studies  
The first reports raising the question concerning the existence of corneal stromal stem 
cells were made in 2005. These theories were discovered upon the use of modified versions of 
previously developed cell culture models for culture medium-free stem cell “spheroid” 
formation with normally adherent corneal stromal cells [403-405]. Spheroids refer to grouped 
cells that expand in cell aggregates [406-410]. Funderburgh et al., (2005) [404] were the first 
to report that cloned stromal cells formed cell aggregates that continued to grow as free-
floating spheroids (Fig.11). It was then found that spheroids could be in vitro amplified and 
maintained multipotency even after several passages. Changes in cell morphology, mRNA 
and protein expression were analysed in spheroids compared to primary stromal cell cultures 
in order to deduce the potential existence of stem cell characteristics and deduce where these 
cell might originate from.  
 
Fig.11. Spheroid Formation by Corneal Stromal Cells. A: Primary keratocytes in mitogen-free 
medium exhibiting a dendritic morphology. B: Aggregates become spherical and could be readily 
separated from individual cells following culture in supplemented medium (FGF, insulin, transferrin, 
selenous acid). Scale bars represent 100 µm (adapted from [404]). 
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5.2 The First Report of Corneal Stromal Stem-like Cells by Funderburgh et 
al., (2005)  
A Localisation of a Clonal Stromal Progenitor Subpopulation 
Funderburgh et al., (2005) [404] showed that approximately 3% of freshly isolated 
bovine stromal cells were able to grow clonally for 65-70 population doublings under 
spheroid culturing conditions. Selected spheroid clones displayed a keratocyte-like dendritic 
morphology and expressed high levels of keratocyte-specific markers keratocan, keratocan 
sulphate and ALDH3A1 throughout their life spans. Similar to in vivo keratocyte cells, cloned 
cells were thought to secrete keratocan sulphate as immunostaining found protein expression 
localised to peripheral cell structures. Generally, adult tissue stem cells show a replicative life 
span of 200-300 cumulative population doublings (CPD). This gave the idea that clonal 
bovine stromal cells were more likely to be progenitor cells rather than stem cells [411].   
 
  B Upregulation of Stem Cell Markers 
This group showed that cloned stromal cells demonstrated an upregualted expression 
of several genes known to be expressed by multiple adult tissue restricted stem cell lineages 
and by embryonic stem cells derived from neural crest tissues (Fig.12). Among adult tissue 
stem cell gene markers were genes Bmi1, SCF, FHL1, Abcg2, CD73, CD90 and CD166: 
 
Bmi1 is a member of a polycomb group of transcription factor repressors that regulate 
chromatin modification for gene silencing [412, 413]. Bmi1 is necessary for efficient self-
renewal and division of adult hematopoietic stem cells, as well as adult peripheral and CNS 
neural stem cells. Alternatively it is also crucial for the differentiation of progeny cells [414, 
415].  
SCF ligand, also known as Kit-ligand, binds to a transmembrane growth factor known 
as kit (or CD117). Kit contains an intracellular kinase domain. Upon SCF binding, both SCF 
and Kit domains can be cleaved proteolytically. Depending on the resulting isoform, SCF can 
either activate or inhibit self-renewal of hematopoietic stem cells [416-418]. SCF has also 
been shown to be produced by in vitro mesenchymal stem cells when differentiated toward 
stromal and osteogneic lineages [419].  
Fhl1 is Four and a half LIM1, a transcription factor identified as being upregulated in 
both adult and embryonic neural, hematopoietic and dermal stem cells [420, 421]. 
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Abcg2 (ATP-binding cassette sub-family G member 2) is a member of a family of 
multidrug transporter proteins already known to be expressed by many kinds of stem cells 
such as hematopoietic [422-424], mesenchymal [424], muscular[424], neural [425, 426], 
cardiac [427], pancreatic islet [428], skin [428-430] and corneal limbal epithelial stem cells 
[297]. Isolation of rich stem cell side populations from adult tissues can be yielded after 
Hoechst 33342 dye incubation and isolation according to cell surface expression of Abcg2 by 
flow cytometry. This side population was attributed an Abcg2 transporter protein function 
(also known as BCRP1) [424, 431-433]. Cells expressing Abcg2 show high clonogenic 
potential [434].  
CD90 and CD166 are cluster of differentiation cell surface molecules used for cell-
sorting of bone marrow-derived mesenchymal stem cells [435, 436].  
 
Among the genes expressed by corneal stromal clonal cells were also embryonic stem 
cell markers expressed throughout neural crest and/or ocular tissue development. These were 
genes Notch1, Pax6, Six2, Six3: 
 
Notch1 protein is a Notch homologue (Notch 1-4). Notch interacts with a number of 
cell surface-bound ligands (Delta-like 1, 3, 4 and Jagged 1 and 2). Upon Notch binding to its 
receptor, a downstream cascade of cleavage events are activated, resulting in nuclear 
translocation of Notch. Here, Notch acts on downstream targets to regulate cell fate* 
decisions, meaning Notch plays a role in stem and progenitor cell self-renewal and expansion, 
as well as differentiation [437, 438]. Notch1 is primarily expressed during neural and 
hematopoietic development, but has also now been identified in regenerating adult tissues 
[439].  
Pax6 is a highly conserved homeobox* transcription factor expressed widely 
throughout nervous system development, and essentially throughout development of the eye; 
the lens, corneal epithelium, iris, ciliary body, all neural retinal layers and the retinal pigment 
epithelium [440, 441]. In Pax6-/- mice, eye and olfactory system development stops at an early 
stage [440, 442, 443]. Pax6 misexpresison shows ectopic eye formation (not in usual tissue 
locations) in drosophila and vertebrates [444, 445]. Pax6 is thus known as the “master 
regulator of eye development” and was not considered to be expressed in adult tissues until 
more recently. Later work has now shown a role for Pax6 in adult regenerating tissues, for 
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example in neural and retinal progenitor cells, mirroring its cell fate* roles found as in 
embryonic tissues [446-448].  
Six2 and Six3 also code for homeobox proteins essential for eye development [449]. 
Six2, Six3 and Pax6, along with Bmi1 and Notch1, are expressed in the neural plate of early 
vertebrate embryos. After migration of neural crest cells, Six2 transcripts are found in a 
variety of non-neuronal connective tissues, including the eye [450]. Afterwards, Six2 
expression was considered to be localised only in the adult retina [451]. In the same 
developmental stages, Six3 expression is limited to the retina, lens, hypothalamus, and 
pituitary [452]. Six3 expression diminishes, or is absent in most adult ocular tissues, except 
for the retina [451]. 
 
Fig.12. Relative mRNA Upregulation of Stem Cell Markers by Corneal Stromal Progenitor Cells 
normalised to primary keratocyte cells. Expression of known keratocyte markers is reduced (Kera and 
Aldh) [404].  
 
 C Pax6 and Corneal Stromal Progenitor Cells 
Finally, this same group demonstrated by flow cytometry that 4% of adult bovine 
corneal stromal cells express Pax6 protein. Immunostaining of primary stromal cells 
confirmed this by showing that rare corneal stromal cells expressed Pax6 protein, whereas 
cloned progenitor cells however showed high levels of nuclear-localised Pax6 protein. This 
indicated the presence of a previously unrecognised population of Pax6-positive cells in the 
adult corneal stroma.  
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This study gave first suggsestions for the existence an adult corneal stromal progenitor 
cell subpopulation expressing both adult tissue and embryonic stem cell markers, thus a distinct 
population from adult keratocytes, with a possible keratocyte replenishment function.  
 
5.3 Corneal Stromal Progenitor Cells show Multipotentency 
Du et al., (2005) [403] found expression of ABCG2 protein by a few cells in the 
peripheral (adjacent to the corneal limbus) and central corneal stroma of human cadaver 
corneas. Moreover, ABCG2-positive stromal cells coexpressed PAX6 protein (Fig.13).  
 
Fig13. Stromal Cell ABCG2 (red) and PAX6 (green) coexpression in central human cornea. Scale 
bar represents 30 µM. X40 (adapted from [403]).  
 
From here, cadaver human corneal stromal cells were expanded in conditions to 
promote cell proliferation and not differentiation, and were then isolated as a side population 
of ABCG2-expressing cells. Further cloning of this cell side population resulted in loss of 
AGBCG2 and PAX6 expression, but upregulation of keratocyte-specific markers (including 
KERA, keratocan sulphate and ALDH3A1). Moreover, under different cell culture conditions 
the cloned cell side population differentiated into different cell lineages. Under chondrogenic 
conditions, cells expressed cartilage specific markers; collagen type II, cartilage oligomatrix 
protein and aggrecan. Cartilage oligomatrix protein in humans produces a noncollagenous 
structural ECM protein found in cartilage [453]. Aggrecan is a large aggregating dermatan 
sulphate proteoglycan that forms a major structural component of cartilage [454]. Under 
neurogenic cell culture conditions, neural cell-specific mRNA and protein expression was 
found for neurofilament protein and β-tubulin II. Neurofilament proteins are comprised of 
cytoskeletal elements that preserve the neuronal structure [455]. β-tubulin III is the protein 
component of neuronal microtubules [456].  
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Simultaneous to this work carried out by the Du et al., (2005) group [403], the 
Yoshida et al., (2005) group [457] discovered that addition of serum and stimulation with 
TGF-β resulted in α-SMA expression by mouse corneal stromal progenitor cells spheres. This 
suggested that stromal progenitor cells could differentiate into myofibroblast-like cells, 
further implying a possible repair function of these cells in the stroma.   
 
Together these results imply that stromal progenitor cells exhibit a multipotent 
differentiation potential under correct conditions, characteristic of mesenchymal stem 
cells in other adult tissues required for somatic cell regeneration.  
 
5.4 In vitro ECM Production by Corneal Stromal Progenitor Cells 
Du et al., (2007) [458] demonstrated for the first time that isolated human stromal 
progenitor cells were capable of forming an in vitro matrix containing keratocan, keratocan 
sulphate, collagen type V and collagen type VI. The secretion of ECM components by stromal 
progenitor cells was found to be denser than secretion by stromal fibroblasts, and isolated 
regions of the matrix showed parallel alignment of collagen fibrils, characteristic of the 
normal corneal stromal lamellar organisation. This indicated that in vitro stromal 
progenitor cells have the ability to secrete an organised ECM.  
Secondly, cadherin 11 cell-cell adhesion proteins and connexin 43-containing gap 
junctions* were more abundant in stromal proegnitor cell populations compared to corneal 
stromal fibroblast cell populations. This suggests not only a role for cell-cell interaction in 
directing ECM secretion between wounded stromal cells, but also that stromal ECM secretion 
could depend on stromal progenitor cell activity, and not just that of repair fibroblast cells. 
Finally, loss of expression of both adult tissue stem cell and embryonic stem cell 
markers was found progressively throughout spheroid culture passaging, followed by an 
upregulation of keratocyte-specific markers. This indicates that stromal progenitor cells 
caould switch phenotype to functional keratocyte-like cells, again implying a keratocyte 
regeneration role of progenitor cells.  
 
5.5 Attempts to Identify Neural Crest-derived Stromal Progenitor Cells 
In order to test for the presence of progenitor cells that could originate from a 
permament corneal stromal cell population, Yoshida et al., (2006) [457] isolated a spheroid 
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side population of neural-crest derived mouse corneal stromal precursors (corneal precursors; 
COPs). These were isolated from primary stromal cells according to cell surface expression of 
stem cells markers Abcg2 and Notch1, but also Nestin and Musashi-1 (described below): 
 
Nestin is a type VI intermediate filament protein expressed in rapidly dividing cells of 
the embryonic developing cerebral cortex* [459], CNS and peripheral nervous system stem, 
and some myogenic tissues [460-462]. Nestin is found abundantly expressed in 
neuroepithelial progenitor cells and reflects an undifferentiated cell state [463]. The loss of 
Nestin expression is linked to differentiation [463]. It has been suggested that Nestin plays a 
role in distribution of vimentin* filaments to daughter cells during progenitor cell division 
[460, 464]. It is also worth mentioning that it has been reported that Nestin expression is 
transiently induced in regenerating adult tissues, essentially in the same tissues Nestin is 
expressed throughout embryonic development [465, 466]. Nestin is not expressed by adult 
keratocyte cells and is best known as a marker of neural stem cells [467]. 
Musashi-1 (Msi-1) was first reported to be required for correct neural sensory organ 
development in Drosophila [468]. Now in adult mammals it is commonly considered a 
specific marker for stem/progenitor cells of neural origin [469, 470]. Msi-1 is a translational 
suppressor of specific mRNA targets within the Notch signaling cascade, maintaining neural 
stem cell proliferation [471].    
 
Yoshida et al., (2006) [457] validated these results using a transgenic mouse carrying a 
Nestin-GFP enhancer, considered to act selectively in neural stem/progenitor cells [472]. GFP 
expression was observed in the mouse corneal stromas. Isolation of these cells found 
expression of both adult tissue neural stem cell (Sca-1+/CD34+/CD45-/c-kit-) and 
embryonic neural stem cell (Twist+/Snail+/Slug+/Sox9+) marker profiles. These markers are 
described below in this respective order: 
 
Sca-1 is a cell surface-anchored protein of the lymphocyte antigen family found in the 
majority of cases on hematopoietic stem cells in the mouse [473-476]. Sca-1 has been proven 
necessary for hematopoietic stem cell self-renewal [477]. Reports indicate a role of Sca-1 in 
progenitor/stem cell lineage fates. Sca-1 expression by mesenchymal-derived corneal stromal 
cells is unsurprising, and a precise role remains unclear.  
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CD34 is a cell surface glycosylated transmembrane protein used for isolating 
hematopoietic stem cells [478, 479]. Interestingly, CD34 was first reported to be found on all 
keratocyte cell surfaces of normal human corneal stromas. Then, this stromal CD34 
expression was found to be lost in several types of corneal diseases [480, 481]. CD34 
expression is constant upon expansion of human keratocytes, but CD34 expression is lost 
when keratocytes differentiate into myofibroblasts [482]. Thus, CD34 has since been 
considered a specific in vivo and in vitro normal keratocyte marker. This implies that COPs 
retain some keratocyte-like phenotype characteritics.  
CD45 is a type 1 transmembrane protein tyrosine phosphatase enzyme and was first 
identified as a major surface protein on hematopoietic cells, making up approximately 10% of 
the total cell surface area of B and T cells [483]. CD45 has been found to not only regulate 
activation and proliferation of lymphocytes, but it also plays a role in regulation of immature, 
undifferentiated hematopoietic stem cells and their progeny [484]. This implies a non-
hematopoietic origin of COPs.  
C-kit is the receptor for the SCF ligand (section 5.2 page 103), again implying that COPs 
are not likely to be bone marrow-derived progenitor cells. 
Twist transcription factor family is best known as a regulator of proliferation and 
differentiation of mesenchymal cells in mesodermic embryonic tissues, but expression in 
adult tissues has been identified [485-493]. Twist2 regulates stromal mesenchymal cell 
proliferation [494] and differentiation upon downstream transcriptional repression [485, 488]. 
Loss of Twist2 activity in the normal adult mouse corneal stroma leads to corneal thinning 
due to keratocyte cell loss, confirming the need for Twist2 in adult keratocyte turnover [495].  
Sox9 is a member of the HMG-box* transcription factor family [496].  Sox9 belongs to the 
subgroup E of the Sox protein family that are essential involved in many aspects of nervous 
system development in vertebrates [497, 498]. However, more recent reports show expression 
of Sox9 mRNA during human adult neurogenesis. Inhibition of Sox9 function leads to 
increased neurogenesis and simultaneous loss of dividing precursors, showing Sox9 protein 
levels are a prerequisite for regulating adult neuronal differentiation [497]. Similarly, reports 
made by Poché et al., (2008) [499] showed that Sox9 was also essential for post natal mouse 
survival and differentiation of retinal Müller glial cells.  
Snail and Slug belong to the same family of transcription factors that are best known as 
transcriptional repressors. Their functions are involved in both embryonic and adult cell 
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events, ranging from apoptosis to cell division. They are known to control the more general 
epithelial-mesenchymal transitions (EMT), during which epithelial cells lose their cell-cell 
junctions and acquire mesenchymal cell characteristics. This leads to cell migration. These 
transcription factors have been well studied in human cancers where EMT is promoted [500]. 
Their role in the corneal stroma remains undetermined.  
 
In summary, at least a proportion of corneal stromal progenitor cells could be in situ 
neural crest-derived progenitor cells that express an intriguing array of adult tissue and 
embryonic stem cell.  
 
5.6 The Corneal Stroma Harbours Bone Marrow-derived Progenitor Cells  
Bone marrow stroma contains mesenchymal and hematopoietic stem cells. These cells 
are multipotent stem cells that can differentiate into a variety of cell types, notably blood 
cells, but also osteoblasts, chondrocytes, myocytes, adipocytes, and β-pancreatic islet cells. 
They can also transdifferentiate into neuronal cells. New roles in adult tissue repair for these 
stem cell populations are emerging, considering their ability to enter the blood circulation, 
followed by homing to injured tissues [501, 502]. 
 
5.6.1 Bone Marrow-derived Hematopietic Progenitor Cells 
Bone marrow-derived cells have been identified in the normal mouse corneal stroma, 
particularly macrophages and CD11c+ dendritic cells [503-505]. Dendritic cells refers to 
stellate-shaped cells that recognise foreign antigens and control T-cell activation [506, 507]. 
CD11c belongs to the β2 integrin family of receptors that mediate cell-cell interactions [508]. 
It has been found at high levels on most human dendritic cells, but also on monocytes, 
macrophages, neutrophils and some B cells [509]. Nakamura et al., (2005) [510] transplanted 
wild-type C75BL/6 mice with bone-marrow derived and bone marrow-derived hematopoietic 
stem/progenitor cells from enhanced GFP transgenic mice. It was found that GFP-positive 
cells migrated into both peripheral and central corneal stromas (Fig.14). 
Immunohistochemistry analyses showed that GFP-positive cells were in fact CD11c+/CD11b+ 
or CD11-/CD11b- bone marrow-derived cells (Fig.15). CD11c+/CD11b+ cells were likely to 
account for bone marrow-derived antigen-presenting cells or macrophages. On the other hand, 
CD11c-/CD11b- cells could have been progenitor cells that migrated into the corneal stroma.  
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Fig.15. CD11b Staining (red) of GFP-positive Bone-marrow Derived Hematopoietic 
Progenitor/Stem Cells (green) in Host Mouse Corneas. Only some GFP cells immunostained with 
CD11b (arrows), giving rise to the possibility of migration of progenitor cells into the corneal stroma. A 
similar result was obtained for staining with CD11c. Dotted lines: corneal tissue outline. Scale bars 
represent 100 µm [510].  
 
Sosnova et al., (2005) [511] took these findings further and identified a major 
population of  CD34+/CD11b+ bone marrow-derived cells cells, and a minority population of 
CD45+/CD34+ bone marrow-derived cells in normal mouse and rat corneal stromas. A small 
proportion of these latter cells were also Sca-1+. This gives evidence for the possibility of the 
localisation of two distinct bone-marrow derived cell populations in the normal corneal 
stroma; not only CD11b+ macrophages, but also progenitor/stem cells that express bone 
marrow-derived stem cell markers. More recently a proportion of stroma myofibroblast cells 
generated following epithelium scraping in C57BL/6J-GFP chimeric mice were found to be 
bone marrow-derived cells that migrate into the wounded cornea [512]. 
 
5.6.2 CD133-positive Stromal Cells 
Thill et al., (2007) [513] found that 5.3% of normal human cadaver corneal stromal 
cells isolated by flow cytometry express CD133. CD133 is a transmembrane 
glycoprotein which was initially considered to be localised exclusively to cellular protrusions 
of immature hematopoietic stem cells [514, 515]. In humans CD133 expression has now been 
detected in endothelial progenitors, and stem cells from other epithelia, glia, glioblastomas 
and neurons. CD133 is also regarded for the moment as a general marker of undifferentiated 
adult cancer cells [515-518]. At the transcript level several different CD133 isoforms exist, of 
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which isoform CD133-2 has been found expressed in a variety of adult tissues [519, 520], 
including the human corneal epithelium [521].  
Thill et al., (2007) [513] found that in vitro CD133-positive normal stromal cell-
derived colonies demonstrated a uniform morphology. This morphologic phenotype is said to 
be typical of macrophage/monocyte lineage cells, giving rise to a possible source of resident 
CD133-positive cell-mediated immunity during corneal infection or injury. Furthermore, 
under clonogenic conditions this macrophage lineage differentiated into lumican-expressing 
keratocyte cells. Afterwards, further surface marker expression analyses revealed different 
CD133 marker profiles of normal stromal cells: 
 
• CD133/ABCG2-positive: CD133-positive cells costained positive for ABCG2 protein 
in the normal central cornea, reinforcing the idea that CD133-positive cells have 
clonogenic potential.  
• CD133/CD34-positive: 3.6% of CD133-positive cells coexpressed keratoycte-specific 
CD34 marker, and co-protein expression was found in the normal central cornea 
(Fig.16). This subpopulation could be keratocyte precursor cells. 
 
Fig. 16. Normal Human Central Cornea Coimmunostaining with CD34 (red) and CD133 (green). 
The right column photograph shows the merged images of red and green fluorescence, and nuclear 
staining with DAPI. Triple-positive cells are indicated by arrows. X20 (adapted from [513]). 
 
• CD133/CD45/CD14-positive: 20-80% of CD133-positive normal stromal cells 
coexpressed CD45 and CD14. Different research findings has shown that peripheral 
blood CD14-positive monocyte cells possess the potential to differentiate into 
endothelial-like cells [522, 523]. This suggests this stromal cell population could be 
an undifferentiated repair cell population.  
• CD133/CD14-positive, CD45-negative: A small CD133+/CD14+/CD45- normal 
stromal cell population was also isolated.  
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Stromas from diseased human corneas were removed from patients receiving 
keratoplasty* surgery due to herpes keratitis infection, keratoconus* or graft failure. It was 
found that CD133-positive cells accounted for up to an average of 26.8% of these corneal 
stromal cells, and virtually all these cells were CD14-positive, but CD45-negative. Thus, this 
CD133+/CD14+/CD45- cell population was suggested to be an intermediate stage of 
differentiation into the final CD133+/CD45+/CD14+ repair cell phenotype, and that these cells 
would eventually differentiate into keratocyte cells. On the whole, even though corneal 
stromal CD133 expression colocalised with expression of other known hematopietic stem cell 
markers, given the known wide adult tissue-derived stem cell expression of CD133, the 
origins and functions of the stromal cells that express CD133 in human corneas remains 
unclear.  
 
This collection of studies shows that corneal stromal progenitor cells may not be 
only recruited locally, but also from external bone marrow-derived cell lineages that 
migrate into and reside in the normal corneal stroma for a potential keratocyte cell 
regeneration fucntion. This would explain the identification of different, and in some 
cases overlapping, bone marrow-derived and neural stem cell marker expression 
profiles for stromal progenitor cells.  
 
 
6 Stem Cell Injection Studies; Taking it One Step Further 
Due to the shortage of cornea donors for cornea keratoplasty* and high immune 
rejection rates, stem cell-based therapy to correct exclusively the defected corneal stromal 
layer (harbouring myofibroblast cells) became of great interest after the discovery of potential 
corneal stromal progenitor cell populations. Animal models so far have been based on the 
outcomes of directly injectecting corneal stromal progenitor and bone marrow-derived 
mesenchymal stem cells into the corneal stroma, and the effect this has on stroma remodelling 
of mice harbouring disorganised corneal stromal structures. Mesenchymal stem cells can be 
obtained in large quantities from plentiful tissues sources, often autologous* tissue sources, 
such as adipose and new born umbilical stem cells. This avoids the requirement of stem cell 
subculturing of normal corneal stromal progenitor cells. Corneal stromal disorganised mice 
are generated by lumican null (Lum-/-) mice. Lum-/- mice corneal stromas show loss of 
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specialised corneal keratin sulphate proteoglycans, notably lumican, resulting in largre and 
altered collagen fibril diameters and organization [524, 525]. This increases light scattering in 
the cornea, resulting in corneal opacities [526], similar to those caused by trauma, 
inflammation and infection in humans via differentiation of keratocyte cells into 
myofibroblasts, and altered secretion of ECM components. Lum-/- mice are therefore a good 
animal model for testing the restoration of corneal transparency via cell injection. 
 
 6.1     Corneal Stromal Progenitor Cell Injection 
Normal human corneal stromal progenitor cells were isolated, cloned and tagged with 
membrane dye before direct injection into the corneal stromas of Lum-/- mice [527]. The cells 
were rapidly distributed throughout the murine stromas within 48 hours following injection, 
and were still stable in the corneas for up to 10 weeks. Human (not mouse) KERA protein 
expression was localised in the stromas of injected mice, showing survival and correct 
functioning of the injected human stromal cells in the murine corneas. The absence of an 
immune response is consistent with reports that adult stem cells induce immune suppression 
[528]. Finally, the Lum-/- mice injected corneas regained a stromal ECM indistinguishable 
from that of wild type mice, demonstrating restoration of corneal transparency. These results 
imply firstly that adult human corneal stromal stem cells are suitable for and survive 
xenograft transplantation. Secondly, these findings further imply that in vivo corneal stromal 
wound healing could harbour a stroma remodelling contribution from stromal progenitor cells 
that differentiate into functional keratocyte-like cells.  
 
6.2 Different Tissue-derived Bone Marrow-derived Stem Cell Injections 
Human processed lipoaspirate derived (PLA) cells possess stem cell characteristics; 
they show extensive proliferative capacity and give rise to differentiated progeny [529]. 
Several in vivo studies have shown PLA cells to be suitable for cell fillers in plastic surgery 
[530], muscle tissue engineering [531], bone defect reconstruction [532] and cardiac tissue 
regeneration [533]. Bone marrow-derived mesenchymal stem cells are present in adipose 
tissue [534]. Arnalich-Montiel et al., (2008) [529] investigated the ability of human PLA cells 
to promote rabbit corneal stroma regeneration. Firstly, immunogenicity of human PLA cells 
was tested upon injection into a rabbit corneal stromal incision pocket created by excimer-
induced stromal ablation. Still 10 weeks following surgery, the PLA cells had intermingled in 
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the stromal ECM, sustaining stromal structural integrity and corneal transparency. Human 
PLA cell regeneration capacity was then tested upon injection into a more acute epithelial 
layer flap opening with a 50µm deep stromal incision made with a microkeratatome. 
Afterwards, the flap was replaced. 12 weeks following surgery the human PLA cells again 
manifested integration into the corneal stroma in multilayers. Moreover, human PLA cells 
expressed markers of functional keratocyte cells, demonstrated by mRNA and protein 
expression of human (not rabbit) ALDH3A1 and KERA. In the host rabbit corneal stromas 
the PLA cells obtained a flattened and elongated keratocyte-like morphology (Fig.17).  
 
 
Fig.17. PLA Cells Three Weeks after Corneal Stromal Injection. A: Corneal stromal nuclei staining 
showing indistinguishable human and rabbit cell nuclei. B: Fluorescent CM-DiI (water-soluble 
fluorescent tag)-labeled human PLA cells interwoven into the corneal stroma showing a keratocyte-like 
morphology. X200 [529].  
 
 Newborn human umbilical cord-derived mesenchymal stem cells (UMSCs) show 
fibroblast-like cell morphology and express markers expressed by known mesenchymal stem 
cells. Newborn human umbilical hematopoietic stem cells (UHSC) also show expression of 
typical hematopoietic stem cell markers. Both cell populations are capable under correct 
conditions to differentiate into multiple cell types [535]. Liu et al., (2010) [535] transplanted 
both newborn human UMSCs and UHSCs into the corneal stromas of Lum-/- mice. Still three 
month following surgery UMSCs survived in mouse corneas and proliferated in the corneal 
stromas for up to 8 weeks following surgery, a feature of adult keratocytes in the corneal 
wound healing response. Lum-/- mice corneal transparency improved as corneal stroma 
thickness was increased. Collagen fibres were longer and more intact and UMSCs expressed 
markers of functional keratocyte cells. They assumed a flat, dendritic morphology and protein 
expressions of human (not mouse) LUM, KERA, CD34 and ALDH3A1 were elevated.  On 
the other hand, UHSCs transplanted into mouse corneas began to apoptose as of 1 week 
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following surgery, as well as eliciting a significant immune response. Transparency was not 
restored in Lum-/- mice corneas. Overall this study further implies that bone marrow-derived 
mesenchymal stem cells even from different species can incorporate into the adult murine 
corneal stroma, without triggering graft rejection and improving corneal stroma transparency. 
UHSCs trigger an immune response and do not survive in the corneal stroma suggesting that 
previous expression of hematopietic stem cell markers may be from intermediate stages of 
progenitor cell differentiation pathways [513] and/or that hematopoietic progenitor cells 
differentiate early upon migration into the corneal stroma.  
 
 7 Implications of the Expression of Embryonic Stem Cell Markers by 
Corneal Stromal Progenitor Cells 
As well as more restricted adult tissue stem cell markers, expression of a selection of 
embryonic stem cell markers (Pax6, Nestin, Six2, Six3, Notch1, Twist, Snail, Slug, Sox9) 
involved in neural crest and/or ocular tissue development were also found to be upregulated 
by normal adult corneal stromal progenitor cells [404, 457, 458]. Today, the reexpression of 
embryonic stem cell markers by “embryonic–like stem cells” in adult tissues is a captivating 
research area.  
 
 7.1  Embryonic-like Stem cells 
Human pluripotent embryonic stem cells that derive from the inner cell mass of the 
blastocyst* can be propagated indefinitely in an undifferentiated state [536, 537]. Ethical and 
political issues concerning the use of human embryonic stem cells for research purposes led to 
the discovery that embryonic-like pluripotent stem cells can be generated directly from adult 
tissues. These cells have already been identified in several tissues, such as bone marrow [538, 
539], amniotic fluid [540] inner ear [541], skeletal muscle [542, 543] and hair follicles [544]. 
The pluripotency of these cells can be easily demonstrated when they are grown in 
suspension, where they spontaneously differentiate and form cell aggregates named embryoid 
bodies in modes which recapitulate early events of embryonic development [545, 546]. 
Additionally, they can be differentiated into multiple cell lineages in vitro and in vivo that are 
not necessarily their cell lineage of origin, including mesenchymal, hematopoietic and neural  
tissues [547-552]. Transcription factors Sox2, Oct-3/4 and Nanog are required to maintain 
pluripotency of embryonic stem cells, independently and cooporatively [553-557]. 
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 7.2 Sox2, Oct-3/4 and Nanog Transcription Factors 
 Sox2 (HMG box gene*) is a member of a 20 member transcription factor family that 
are expressed in a variety of both embryonic and adult tissues [558, 559]. Sox2 is a member 
of Sox group B genes that participate in the earliest events of CNS differentiation in 
drosophila, xenopus, chick and mouse species [560]. During embryonic eye development, 
Sox2 expression is wide-spread and involved in optic vesicle, lens and neural retina formation 
[561, 562]. Co-operative expression of Pax6 and Sox2 is required for lens formation [561, 
563, 564]. Concerning progenitor cells, Sox2 functions to maintain pluripotent neural stem 
cells. It is considered a marker of undifferentiated cells [553].  
 Oct-3/4 (also known as Pou5f1) is a transcription factor involved in self-renewal and 
proliferation of embryonic stem cells. Several studies have now shown that Oct-3⁄4 is 
expressed by a variety of adult tissue stem cells and in multipotent progenitor cells (i.e. stem 
cells from epithelium, bone marrow, liver) [565]. It has been suggested that it functions to 
sustain a self-renewal capacity in a manner analogous to its role in embryonic stem cells  
[566-568]. It is also used as a marker for undifferentiated cells [557].  
 Nanog is a recently identified transcription factor that is also expressed by embryonic 
stem cells, but not by differentiated mature somatic cells [555, 569]. It is thought to be a key 
factor in maintaining pluripotency [570], and when embryonic stem cells lose Nanog 
expression, they begin to differentiate [571].  
 A combination of Sox2, Oct-3/4 and Nanog transcription factors has been proved to be 
capable of inducing the expression of each other, and are essential for maintaining the self-
renewing undifferentiated state of the inner cell mass of the blastocyst, as well as of 
embryonic stem cells  [572]. 
 
 7.3  Induced Pluripotent Stem Cells  
 Studies today based on embryonic-like stem cells and expression of Sox2, Oct-3/4 and 
Nanog is based on the recent ground breaking news showing that pluripotent stem cells can be 
induced directly from somatic adult cells upon addition of only Sox2, Oct-3/4 and Nanog 
factors (induced pluripotent stem cells). This was first discoved when isolated adult mouse 
fibroblast cells were transformed directly into embryonic stem cell-like cells once induced 
with Sox2, Oct-3/4 and Nanog [573]. Induced pluripotent stem cell generation is viewed as a 
multiple-step action mediated by these transcription factors that induce reverted expression of 
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embryonic stem cell markers, while at the same time suppressing the somatic cell genetic 
program. This highlights the potential importance of these factors for self-renewal and 
differentiation roles in maintaining pluripotency of adult stem cells.  
 
 7.4  Neural Crest-derived Embryonic Stem Cells 
Embryonic neural crest mesenchymal cells, as well as participating in embryonic 
corneal stroma development, yield neuronal and glial* cells of the entire peripheral nervous 
system and in the head, they also give rise to cephalic tendons, cartilage, bone, dermis, 
vascular smooth muscle and adipocytes [574]. Original neural stem cells were considered to 
disappear upon differentiation as the neural tube* matures and neural crest cells mix with 
other cell types. However, it has been found that adult tissue locations such as the intestinal 
ganglia* [575], the spinal ganglia [576], the hair follicle [544, 577, 578], the tooth [579] and 
even bone marrow [580, 581] appear to be later niches for the maintenance of multipotnet 
neural crest-derived stem cells. This gave insights into the idea that the initial embryonic 
neural crest cell population could be constituted by a large proportion of lineage-restricted 
progenitor subpopulations with distinct cell fates* in adult tissues [582].  
 
7.4.1 Embryonic Neural Precursor Characteristics of Late Embryonic 
Keratocyte Cells   
Little is known about the relationship between adult corneal stromal keratocyte cells 
and their neural crest precursors. The Lwigale et al., (2005) [284] group used quail/chick 
chimeric grafts* to visually trace the invasion of and contribution of donor quail neural crest 
stromal cells in embryonic developing chick corneal stromas. Recipient chick embryos were 
first delivered quail dorsal neural tube grafts (Fig.18). Quail corneal stromal embryonic neural 
crest stromal cells (just before eyelid opening) were then injected under the chick embryo 
ectoderm at either side of the dorsal neural tube graft before the development of their 
secondary stroma (E8-9). Injected embryos were re-incubated from 0 hours to 15 days before 
being cryosectioning for immunohitochemical analyses.  
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Fig.18. Schematic diagram illustrating the method for dorsal neural tube transplantation from quail to 
chick embryos (adapted from [284]). 
 
Quail nucleus-specific antibody (QCPN) demonstrated contribution of quail donor 
neural crest cells to chick endothelial and stromal secondary layers during corneal 
development. Some donor keratocyte cells injected into the chick cornea migrated out of the 
injected cell mass, where they migrated alongside host migratory neural crest cells and 
proliferated in the surrounding head mesenchyme. Unlike the keratocyte cells that remained 
in the injected cell mass, the migratory cells ceased to synthesis keratin sulphate. However, 
the migrating quail cells did not mix with endogenous neural crest cells or express the neural 
crest cell marker (known as HNK-1). This suggests that the migratory quail donor keratcoyte 
cells did not fully lose their keratocyte phenotype, similar to keratocytes in the corneal wound 
healing process when they migrate into the wound zone, proliferate and differentiate into 
fibroblast-like cells and cease temporarily to produce and secrete keratocan sulphate [356].  
Some injected donor quail keratocyte cells additionally contributed to the smooth 
muscle of cranial blood vessels. This was confirmed by expression of α-SMA by quail 
keratocyte cells. This suggests that the quail keratocyte cells responded to embryonic 
signaling events (such as TGF-β signaling) to acquire myofibroblast cell morphology, again 
similar to keratocyte responses following corneal wound healing.  
The donor quail keratocyte cells failed to contribute to neurons in ganglia or branchial 
arch cartilage, illustrating that keratocyte cells are partially restricted progenitor cells rather 
than stem cells. This data demonstrates that at least some late-embryonic stromal keratocyte 
cells may not be terminally differentiated cells, but maintain a certain degree of plasticity and 
multipotency. These finding also suggest that some adult stromal keratocytes may retain more 
characteristics of their embryonic developmental potential than previously believed, and this 
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could be correlated with the different cell phenotypes identified in the corneal stromal wound 
healing cascade (repair fibroblasts, myofibroblast) [284].  
Adding to these findings from the Lwigale et al., (2005) group [284], a new study 
demonstrated that late human embryonic neural crest cells were found to not only express 
partially committed progenitor cell markers, such as α-SMA protein, but they also synthesised 
Sox2, Oct-3/4 and Nanog proteins. These expressions were lost as neural crest cells 
developed into somatic cells [359]. Sox, Oct-3/4 and Nanog expression being emblematic of 
pluripotent embryonic stem cells implies that at least some adult neural crest cells could retain 
more of their embryonic precursor characteristics than previously thought [359].  
Adult mesoderm progenitor cell lineages that differentiate into mesenchymal stromal 
progenitor cells from human bone marrow and umbilical cord have shown different 
progenitor lineage commitments, one being a Nestin expressing neural cell population. This 
was shown to be regulated by an Oct-3/4 molecular program [583]. This suggests that Sox2, 
Oct-3/4 and Nanog regulatory mechanisms for maintaining plasticity in embryonic stem cells 
could be similar in a range of adult stem cell lineages [584].  
This same theory could be applied to the expression of embryonic-like developmental 
markers in the adult corneal stroma. For example, Pax6 is regarded as a multifunctional player 
regulating proliferation and differentiation of embryonic stem cells in a highly context-
dependent manner [446, 585]. Recent work has now shown expression of Pax6 in 
regenerating adult neural crest-derived tissues, for example by neural and retinal progenitor 
cells [446, 447, 585]. Similarly, in vitro work on the adult mammary gland confirmed an 
important role for Notch signaling in cell fate* decisions, showing a role in stem cell self-
renewal and expansion, as well as differentiation of specific progenitor cells [437]. 
Furthermore, Notch-dependent regulation of neural progenitors has already been discovered 
in the adult rat spinal cord [586], showing an important role for Notch signaling in mature 
neural crest-derived tissues. Expression of such markers in the adult corneal stroma could 
similarly correspond to neural crest-derived progenitor cell regulation of corneal stromal cell 
regeneration.  
 
7.5  Sox2, Oct-3/4 and Nanog in Adult Tissue Regeneration 
Most studies have investigated the role of Sox2 alone in adult tissue regeneration 
taking into account its well documented and wide CNS and ocular expression patterns 
121 
 
 
throughout embryonic development [560-564]. Sox2 mirrors the same roles for cell survival 
and cell differentiation in adult tissues as those identified in embryonic cells. Millimaki et al., 
(2010) [587] demonstrated that in adult zebrafish Sox2 is required for both adult hair cell 
survival, as well as for transdifferentiation of support cells* into hair cells during adult hair 
regeneration. Considering that aspects maintaining stem cell pluripotency in embryonic stem 
cells and adult stem cells have some parallels, the role of Sox2, Oct-3/4 and Nanog as a trio-
transcription factor network in stem cells involved in adult tissue regeneration soon and lately 
became a curiosity. A small handful of reports have demonstrated expression of Sox2, Oct-
3/4 and Nanog in adult stem cells, emerging new roles for these transcription factors in adult 
tissues homeostasis and repair [588]. 
 
8  Revision: Cornea Stromal Progenitor Cells 
Several in vitro cell studies have tried to characterise an adult corneal stromal 
progenitor side population with a potential keratocyte replenishment function. These 
progenitor cells could derive from at least neural crest-derived and external bone marrow-
derived mesenchymal lineages suggested by their expression profiles of a range of different 
stem cell markers. These progenitor cells also express embryonic stem cell-like markers 
usually expressed by neural and/or ocular tisssues. Evidence that some late embryonic neural 
crest-derived cells retain some cell plasticity, and express not only α-SMA, but also Sox2, 
Nanog and Oct-3/4, undifferentiated stem cell markers is interesting as we could also 
hypothesise a role of embryonic stem cell-like cells in adult corneal stromal wound repair. 
 
8 Récapitulatif: Cellules progénitrices cornénnes stromales 
 Plusieurs études menées in vitro, ont essayé de caractériser une sous population de 
cellules progénitrices du stroma cornéen adulte avec un rôle potentiel dans la régénération de 
kératocytes adultes. Ces progéniteurs expriment des marqueurs de cellules souches issus de 
tissus adultes variés, indiquant que ces cellules progénitrices dérivent au moins d’une 
population cellulaire mésenchymeuse de la crête neurale qui résident dans le stroma cornéen, 
et d’une population cellulaire mésenchymeuse de la moelle osseuse. Ces cellules progénitrices 
expriment aussi des marqueurs de cellules souches embryonnaires qui sont également 
exprimés lors du développement des tissus issus de la crête neurale et/ou tissus oculaires. Une 
partie des cellules souches embryonnaires tardives de la crête neurale maintiennent une 
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plasticité cellulaire et expriment des marqueurs de cellules souches pluripotentes (α-SMA, 
Sox2, Nanog, Oct-3/4). Ce constat est intéressant car nous pouvons émettre l'hypothèse de 
l'existence d'une population de cellules souches adultes qui adoptent un phénotype 
embryonnaire dans le stroma cornéen adulte lors de la cicatrisation. 
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II Aims  
 
Since 2005 several in vitro cell studies have suggested the localisation of clonal, 
multipotent stromal progenitor cells in the adult cornea that not only express a variety of 
known adult tissue and embryonic stem cell markers, but are also capable of expressing 
functional keratocyte-like markers [403, 404, 457, 458, 513]. Stem cell marker expression 
profiles suggest localisation of more than one progenitor pool in the normal corneal stroma; at 
least resident progenitors and external corneal recruited progenitors [510-513]. When I began 
studying mouse corneal wound healing in 2009, it was shown that in vivo injected human 
corneal stromal progenitor cells hold the ability to restore corneal stromal organisation and 
transparency in mice with strucurally disordered stromas [527]. Together, these studies 
provide evidence for the potential existence of progenitor cells in the stroma with keratocyte 
regeneration potential. Consequently, the important issue to determine was whether a 
subpopulation of corneal stromal progenitor cells exists in vivo. Thus, we aimed to use an in 
vivo adult mouse corneal wound healing model upon full thickness corneal incision to 
test for the localisation of cells expressing stem cell markers in stromal wound repair, 
and if so, what the tissue lineage origin of these cells could be. We compared changes in 
expressions of stem cell markers in control versus wounded stromas at various times 
throughout stromal repair. We selected the following stem cell markers known to be 
expressed in adult stem cells and/or pluripotent embryonic stem cells: 
 
1. Adult tissue stem cell markers: Abcg2, CD133, Pax6 and Telomerase Reverse 
Transcriptase (Tert). Of interest to us is that in normal human corneal stromal ABCG2-
positive cells were found to coexpress PAX6 [403], a marker also expressed throughout 
embryonic nervous system/ocular development [589]. Pax6 has now been found expressed by 
a range of adult ocular progenitor cells [446, 448, 585]. We also chose CD133 as it has been 
found to be expressed by a range of different tissue adult stem cells [515-518] and has been 
found to be increased in expression in human diseased corneal stromas [513]. Tert preserves 
telomere length during cell division-dependent DNA replication, and Tert activity is also 
considered a stem cell marker since it is upregulated in regenerative progenitor cells 
compared to somatic cells [590, 591]. 
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2. Neural stem cell marker: This was in order to check if the in vivo wounded stroma 
could harbour in situ corneal stromal progentior cells, or if the majority of progenitor cells 
were more likely to be from different tissue stem cell populations. The Nestin marker is of 
special interest to us regarding it is expressed by neural crest cells during early embryogenesis 
(thus keratocyte cells) [460-462], but also it has also been found to be expressed in several 
adult stem cells, including murine corneal stromal progenitor cells [457, 465, 466]. 
Additionally we investigated the possibility of external recruitment of different tissue 
progenitor cells via an in vivo wounded corneal lymphatic system. For this purpose we used 
the Lyve-1 lymphatic vessel endothelial cell-specific marker.  
3. Pluripotent embryonic stem cell-like markers: We wanted to test for the 
localisation of corneal stromal cells that revert to reexpressing their former embryonic 
precursor cell markers throughout the in vivo stromal wound response. These markers were 
embryonic stem cells markers Sox2, Oct-3/4, Nanog, known to be expressed by embryonic 
cells throughout the development of neural crest tissues [359].  
 
Les  objectifs 
Des études menées in vitro et des études de thérapie cellulaire suggèrent qu’une 
population de cellules progénitrices réparatrices située dans la cornée stromale adulte pourrait 
jouer un rôle dans la régénération des kératocytes. Par conséquent, il était important de 
déterminer si cette population de cellules progénitrices existe dans la cornée stromale adulte 
in vivo. Nous avons donc utilisé un modèle de cicatrisation cornéenne chez la souris adulte 
comprenant une blessure incisionnelle complète de la cornée, pour étudier la localisation des 
cellules exprimant les marqueurs de cellules souches lors de la réparation stromale. Nous 
avons aussi sélectionné des marqueurs pour essayer de déterminer les tissus d’origine de ces 
cellules. L’expression des marqueurs dans des stromas contrôles ont été comparés aux 
stromas blessés lors des différents stades de la cicatrisation stromale. Les marqueurs choisis 
sont des marqueurs de cellules souches connus et exprimés par des cellules souches adultes 
et/ou embryonnaires pluripotentes : 
 
1. Des marqueurs de cellules souches à l’origine des tissus adultes : Abcg2, CD133, 
Pax6 et la Télomerase Reverse Transcriptase (Tert). La colocalisation des cellules 
positives pour ABCG2 et PAX6 trouvées dans le stroma humain adulte peut être 
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intéressante [403]. Pax6 qui est un marqueur des précurseurs embryonnaires dans le 
système nerveux et tissus oculaires [589], mais aussi un marqueur des cellules 
progénitrices adultes dans des tissus oculaires [446, 448, 585]. CD133 est un 
marqueur exprimé par une variété de cellules souches adultes [515-518], et son 
expression est augmentée dans la cornée stromale humaine malade [513]. Tert 
préserve la longueur des télomères en ajoutant des répétitions télomériques aux 
chromosomes lors de la division cellulaire. Il est connu pour être un marqueur des 
cellules souches avec augmentation dans les progéniteurs par rapport aux cellules 
somatiques [590, 591]. 
2. Marqueurs de cellules souches exprimé par des tissus nerveux (issus de la crête 
neurale): Il était nécessaire de vérifier si le stroma blessé contient des cellules 
progénitrices in situ, d’origine cornéenne stromale, ou si la majorité des progéniteurs 
sont issus de tissus externes. Le marqueur de cellules souches neurales Nestin est 
intéressant car il est exprimé par des cellules issues de la crête neurale (notamment des 
kératocytes) dans le développement embryonnaire [460-462], mais aussi par plusieurs 
cellules souches adultes neurales lors de la régénération tissulaire [465, 466]. Pour 
vérifier l’hypothèse du recrutement des progéniteurs extérieurs à la cornée, nous avons 
étudié la formation des vaisseaux lymphatiques dans la cornée blessée à l’aide du 
marqueur Lyve- 1 (spécifique aux cellules endothéliales des vaisseaux lymphatiques). 
3. Marqueurs de cellules souches embryonnaires : Nous avons testé la localisation de 
cellules stromales dans le stroma blessé qui ré-expriment des marqueurs de leurs 
précurseurs embryonnaires. Les marqueurs sélectionnés sont les marqueurs 
pluripotents Sox2, Oct-3/4 et Nanog, connus comme étant exprimés lors du 
développement embryonnaire de la crête neurale [359]. 
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III Materials and Methods 
 
1 In vivo Animal Corneal Wound Healing Models 
The study of corneal wound healing and haze formation has been carried our using 
rabbit [358, 592-594], rat [595], hen [596] and monkey [597, 598] animal models. Different 
wound healing responses can be generated depending on the corneal wounding method used. 
Less acute stromal wound responses are generated using epithelial scrapes (not damaging the 
epithelial basement membrane/Bowman’s layer), compared to more acute responses 
following alkali burns and deeper incison techniques (direct incision, suturing). Jester et al., 
(1987) [357] were the first to report full thickness corneal incision in a rabbit model. Full 
thickness incision damages all layers of the cornea, including the endothelium. Briefly, these 
results report that within 4 hours following injury a fibrin plug was formed to close the 
opening of the wound zone. By seven days following injury, a matrix of stromal fibroblast-
like cells replaced the fibrin plug, and transition of these cells into myofibroblast cells was 
observed by α-SMA expression. These cells secreted an ECM consisting of proteoglycans that 
left an opaque scar. 
 
1.1 In vivo Mouse Corneal Wound Healing Models 
Mice have not been extensively used for the study of corneal wound healing as their 
corneas are small and relatively resistant to haze generation from less severe corneal 
wounding techniques, such as epithelial scraping and PRK*. Generation of corneal haze 
requires more acute corneal damage, such as full corneal thickness incision [337], or 
combinations of wounding techniques, such as epithelial scrape followed by PRK* [599]. 
Several groups have extrapolated the same wound response observed following rabbit full 
corneal thickness incision wounding to the in vivo wounded mouse corneal incision model 
(Fig.40. left panel) [600, 601]. Miyazaki et al., (2008) [601] found α-SMA expression as soon 
as 3 days following full corneal incision of C57BL/6 mice, leading to corneal scarring. 
Myofibroblast cells began to decline as of 21 days post-wounding (Fig.40. right panel). We 
opted for the development of a full corneal mouse incision wounding model as this method 
generates an acute stromal wound response, involving corneal haze formation and early 
stroma remodelling and wound contraction phases within 1 month. This gave convenient time 
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periods for the collection of corneal tissues throughout different stages of a complete stromal 
wound response. 
 
 
Fig.19. Corneal Wound Healing Following Full Corneal Thickness Incision of C57BL/6 Mice. Left 
panel: HE staining. Day 1: Wound zone occupied with epithelial cells in a fibrin plug. Day 7 and 14: 
Wound sealed with fibrotic scar tissue. Day 21: Scar tissue formed in the incision wound is more 
compact. Right panel: αSMA-positive stromal cells (green). Day 1: Almost no myofibroblasts are 
observed in the stroma. Day 3: Myofibroblasts are detected in the stroma. Day 7: Stromal wound zone 
is densely populated by myofibroblast cells. Day 21: Myofibroblast cell population has begun to 
decline. DAPI nuclei staining (blue) (adapted from [601]).  
 
2 Our in vivo Mouse Corneal Wound Healing Model 
2.1 The Surgery Protocol 
Female C57BL/6 mice 12-16 weeks old were purchased from Charles River France 
(Arbresle, France) and maintained in Claude Bernard animal experimentation centre, Hôpital 
Purpan, CHU de Toulouse, France. All animals were treated in accordance with the Ethical 
Committee of the CPTP (Centre de Physiopathologie Toulouse Purpan, France) and 
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guidelines provided in the ARVO Statement for the use of Animals in Ophthalmic and Vision 
Research. Atropine (atropine sulphate 1% faure, Europhta Laboratoires, Monaco) was applied 
topically to the left (incised) eyes 10-20 minutes before surgery to dilate the iris. Use on 
humans has onset anaesthesia from 30 seconds, persisting for a minimum of 15 minutes, thus 
covering the duration of the mouse corneal incision surgery. This prevented the surgeon from 
damaging the corneal iris and preventing iridocorneal synergy (when the iris and corneal 
stroma fuse together). General injection anaesthesia regimen (Ketamine/Xylazine) was 
injected intraperitonealy and a local anaesthesia of 1.6 mg/0.4 ml oxybucaine chlorhydrate 
(Théa Laboratoires, Clermont-Ferrand, France) was applied. All surgery was performed by 
the same ophthalmologist surgeon with the same equipment. The full thickness of the centres 
of the corneas of the left eyes were perforated with a trephine 0.75 mm in diameter using a 
Zeiss® OPMI® CS operating microscope (Germany). This removed a button of corneal tissue 
from all corneal layers (Fig.21). 1 drop of 1% fucithalmic acid eye drop (LEO Laboratoires, 
St Quentin en Yvelines, France) was applied following the surgery. This is an antibiotic 
treatment developed against eye surface bacterial infection. The right eyes of incised mice did 
not undergo surgery. Mice with no surgery in either their left or right eyes served as controls 
(both eyes) for all experiments. 1 drop/day of fucithalmic acid and atropine were applied to 
incised eyes for 5 days after incision wounding, as for both eyes of control mice. 
  
Fig.20. Our In vivo Mouse Full Corneal Thickness Incision Model. A: The incision penetrating all 
the corneal layers removing a button of corneal tissue (virtual incision). B: D14 stromal wound zone in 
the stroma remodelling process. (HE staining; X400). C: Corneal opacity developed by D14 post-
wounding (digital photographs).  
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2.2  Clinical Observations  
Corneal opacity levels were clinically measured with a slit-lamp* every week after 
wounding using a corneal transparency grade system [602]. Grade 0 describes a completely 
clear cornea, or with trace opacity obliquely illuminated with the slit-lamp. Grade 1 denotes 
less severe opacities that do not interfere with the visualisation of fine iris details. Grade 2 
denotes moderate obscuration of the iris and lens, and grade 3 denotes complete opacification 
of the stroma in the incised area. Opacity grading was performed in a masked manner by two 
independent ophthalmologists. The presence of corneal blood vessel formation was rare. The 
majority of mouse corneas developed maximal corneal opacity by Day 14 (D14) post-
wounding (Fig.21), showing an acute mouse corneal stromal wound healing response and 
upregulation of α-SMA confirmed myofibroblast generation [603]. Myofibroblast formation 
increased according with increasing opacity grade score (Fig. 22). In most mice both opacity 
formation and α-SMA expression gradually declined after D14 [603]. The morphological 
structures of wounded corneas from D7-D28 post-wounding corresponded to those in Fig. 23. 
D7 wounded corneas harbour a highly disorganised stromal cell and ECM organisation, and 
D14 wounded corneas show a dense population of stromal cells in the wound zone. By D21 
and D28 the tissue in the wounded stroma is in the process of remodelling, and the relative 
position of cells to each other resembles that of a normal cornea. The epithelial, stromal and 
endothelial cell layers are well-distinguished, and the stromal cells are more elongated 
between the collagen fibres than in the D7 and D14 wounded stromal zones. Note that some 
differences were found in the sizes of wounded corneal tissues, the time taken for opacity to 
form and decline, and for corneal wound zones to remodel. This can be explained by 
biological variation between mice even from the same strain in corneal wound healing 
responses, but also due to slight unavoidable variability in the surgical procedure [592]. Mice 
that did not develop any corneal opacity by D28 post-wounding, or mice that still showed 
grade 3 corneal opacities at D28 post-wounding were not used for analysis in this project.  
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Fig.21. Opacity Grading Scores with Corresponding Increase in Myofibroblast Formation. Each 
grade is presented with corresponding histological observations of α-SMA expression (brown staining, 
X400). Increased expression of α-SMA with higher opacity grading (adapted from [603]). 
 
                
Fig. 22. Morphological Structures of Wounded Corneas. Control versus D7, D14, D21 and D28 
wounded corneas following full thickness incision surgery (DAPI nuclei counterstaining). X100.  
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2.3 Tissue Collection  
Incision wounded and control mice were euthanised using isoflurane and cervical 
dislocation after D7, D14, D21 and D28 post-wounding. The eyes were carefully enucleated 
and either cryo-embedded for immunohistochemical analyses, or the stroma was recuperated 
by removal of the epithelial and endothelial layers by gentle scraping with sterile surgical 
tweezers. These tissues were snap frozen in liquid nitrogen and used for mRNA and protein 
expression, and telomerase activity analyses. All tissues were stored at -80°C.  
 
3 Quantitative RT-PCR 
 3.1 RNA Extraction and cDNA Synthesis 
Total RNA was extracted from corneal stromal tissue using a 1ml micro tissue grinder 
(Wheaton, USA) at +4°C and commerical protocol from the RNeasy® Mini Kit 50 (Cat. No. 
74104, Qiagen, USA). RNA quantity and quality was controlled using the Agilent 2100 
bioanalyzer with RNA 6000 nano chips (Agilent Technologies, USA). All RNA samples 
proceeded to cDNA synthesis, but RNAs with a RIN (RNA integrity number) ≥7/10 were 
preferentially used for qPCR analysis. Total cDNA was synthesised following the protocol 
from a commerically available SuperScript VILO Kit (Cat. No.v11754-250, Invitrogen, 
USA). Final 20µl cDNA volumes were stored at -20°C. Considering the small tissue size of 
the mouse corneal stroma, total cDNA concentrations were relatively low (approximately 
3000 pg/µl per stroma). 
 
 3.2 Quantitative PCR  
3.2.1  Principle 
QPCR is based on the possibility of tracing PCR amplification over time (“real time”) 
using fluorescence. Fluorescence data is collected throughout every PCR cycle and represents 
at the given time the quantity of primer amplified products. The higher the concentration of 
the amplicon under analysis in the cDNA sample, the lower the number of cycles required to 
obtain a fluorescent signal that is significantly higher than the background signal. This is 
defined as Ct, and relates to the beginning of the exponential (amplification) phase. qPCR 
does not study the concentration of final PCR products as do classical PCR methods, 
eliminating limiting factors during the plateau phase (notably primer and cDNA amount). 
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Thus, Ct readings are precise and reproducible for comparisons of concentrations of a gene of 
interest between cDNA samples. 
 
 3.2.2 Efficiency Calculations and Amplicon Specificity 
 For detection of small changes in expression it is required to calculate the efficiency 
(E) of the qPCR for a forward and reverse primer set. For this we carried out qPCR on a two-
fold serial dilution of cDNA template. In theory, dilutions of cDNA template should each 
have amplification curves each one cycle behind each other, corresponding to a 100% E 
(referred to as 2). Ct values were presented graphically on a log scale graph, where the slope 
of the graph (linear regression, (-(1/log(1+E)) corresponded to the E. A -3.32 slope 
corresponds to a 100% E. The slope should always be <-3.32, otherwise E is >100%, meaning 
amplification of other non-specific amplicons. We calculated the mean E per primer set using 
3 different wounded stromal cDNA templates. Only primers with a mean efficiency of 0.85-
1.00 were used for further qPCR analysis. 
The amplification specificity is controlled by a melting curve at the end of each PCR 
cycle; double-stranded DNA is denatured very slowly until the set primer annealing 
temperature is attained. This results in release of fluorescent label into the reaction mixture. 
The only fluorescent signal remaining corresponds to primer set amplicons, which is 
transformed into a peak. A single melting point curve peak corresponds to one single 
amplicon amplification. More than one peak corresponds to more than one amplicon product, 
in other words non-specific primers.  
 
3.2.3  Experimentation 
Primers for Nestin, as well as for two housekeeping control genes Beta-2 
microglobulin (B2m) and Tyrosine 3-monooxygenase (Th) were designed using Primer 
Express 3.0 (Applied Bioystems) and purchased from Eurogentec S.A (Belgium). All primers 
were tested first on cDNA from embryonic mouse tissue, and optimal cDNA and primer 
concentrations were determined. For all assays complete 2X SYBR® Green ER® qPCR 
SuperMix Universal buffer (Cat. No. 11762-100, Invitrogen, USA) was mixed with 1µl 
cDNA, and 1µl forward and reverse primer mix. Total reaction volume was 10µl. Nestin 
mRNA expression was analysed in seventeen control, thirteen D7, thirteen D14, fourteen D21 
and eleven D28 wounded stromal cDNA samples. Triplicate samples were used for all assays. 
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Reactions were performed in LightCycler 480 96-multiwell plates with sealing foils (Roche, 
UK) in the LightCycler 480 machine (Roche). PCR conditions were as follows: 50°C for 2 
minutes, denaturation at 95°C for 10 minutes, and amplification for 40 cylces of 95°C for 15 
seconds and 60°C for 1 minute.  
 
3.2.4 Statistical Analysis 
   Housekeeping control gene expression should be the same in all control and wounded 
stromal cDNA samples analysed. This is important for taking into account fluctuations in data 
resulting from cDNA quality. We chose Th and B2m genes that showed a constant expression 
across numerous control and wounded stromal cDNA samples [603]. We initially tested these 
genes based on the published demonstration of the corresponding Th and B2m human genes 
as good housekeeping genes across many different human tissues [604]. Relative stromal 
cDNA sample expression data for each gene of interest was calculated by REST 2009 [605] 
software (Qiagen, Munich, Germany) that takes into account normalisation of primer set Ct 
standard deviation to: 
 
• The Nestin primer set E calculation. 
• The E calculations of both housekeeping control gene Th and B2m primer sets (known 
as the 2-ΔΔCT method [606]).  
• The standard deviation of expression of both housekeeping control gene Th and B2m 
primer sets in control and wounded stromal cDNA samples.  
 
Non-parametric Mann Whitney tests were used for group-to-group comparisons. A value 
of p≤0.05 was considered statistically significant, determining if gene expression changes 
were statistically significant between different stromal cDNA samples.  
 
4 Sox2 RT-PCR 
A Quanti®Tect Primer Assay set for Sox2 was purchased from Qiagen (Cat. No. 
QT01539055, Qiagen, France). Sox2 mRNA expression was initially analysed by RT-qPCR, 
but a very high optimal concentration of cDNA template (600 pg/µl) was required for 
sufficient E calculations. Working with this cDNA sample concentration would have 
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exhausted the stock of stromal cDNA samples. We initially tried to overcome this problem by 
trying total RNA amplification using a combined RNA amplification and cDNA synthesis kit 
(Cat. No. L1016-01, SuperScript® RNA Amplification System). RNA amplification and/or 
cDNA synthesis was unsuccessful. Consequently, Sox2 mRNA expression was analysed by 
agarose gel electrophoresis quantification of qPCR gene products in control and D14 
wounded stromal cDNA samples. 5 µl of cDNA template (undiluted) was mixed with 
complete 2X LightCycler® 480 Green I master mix (Roche, UK) and 1.25 µl of forward and 
reverse primer mix at an optimised 10-fold dilution. Total reaction volume was 12.5 µl. PCR 
conditions were as follows: denaturation at 95°C for 15 minutes and amplification for 40 
cycles of 94°C for 15 seconds, 72°C for 30 seconds and 72°C for 30 seconds. Th 
housekeeping gene was used as a control. Ct data was not calculated for Sox2 primer assays, 
but melting curves were checked for Sox2 primer specific amplification before gene product 
analysis by 2% agarose gel electrophoresis. 50 bp DNA ladder was used for molecular weight 
determination (Fermentas, France. Cat. No. SM1211). 
Sox2 primer specificity was further confirmed by purifying Sox2 qPCR products using 
the QIAquick Spin PCR Purification Kit (PCR products 100 bp to 10 kb, Quiagen). 5 µl of 
purified products were added to 25 µl urea–LB (0.5 mg/ml bromephenol blue (Sigma, 
France), 8 M urea (Sigma, France), 1% (v/v) NP-40 (Tergitol®, Sigma), 1mM Tris (pH 8)). 
The products were then denatured at 80°C for 5 minutes and ran on a 1M urea-2% agarose 
denaturing gel in TAE1X buffer (40 mM Tris base (Sigma, France), 20 mM acetate, 2 mM 
EDTA (pH 8)) at 75V for 1.5 hours at 4°C. The gel underwent numerous washes with TAE 
1X buffer, followed by numerous washes with 100mM NaCl. The gel was incubated with 
SYBR® Gold Nucleic Acid Gel Stain (Molecular probes, Invitrogen, USA) for 30 minutes 
before visualisation under UV light of a band corresponding to the Sox2 primer amplicon. The 
band was excised and purified according to manufacturer’s instructions (QIAquick Gel 
Extraction Kit 50, Qiagen). Sequencing with a 3730xl sequencer (Applied Biosytems, 
MilleGen, Labège, France) using BigDye® Terminator v3.1 was carried out. The sequences 
obtained were compared to Mus musculus Sox2 sequence from Ensembl (Ensembl release 59-
Aug 2010© WTSI/EBI).  
 
5 Quantitative Telomerase Activity Analysis 
5.1 Principle 
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Quantitative determination of telomerase activity was performed using the 
Quantitative Telomerase Detection Kit (MT3011 Biomax, US) that detects real-time PCR 
telomerase activity in lysed tissues and cells. Telomerase activity is quantified upon the 
sample extract ability to synthesise artificial telomeric repeats onto an artificial 
oligonucleotide substrate. The products are then amplified by PCR and direct detection of 
SYBR Green dye binding to the double-stranded DNA product monitors direct detection of 
the PCR product.  
 
5.2 Experimentation 
    All reagents were supplied in the kit. All lysate preparation was carried out at +4°C. Six 
D14 wounded and six control stromal tissues were pooled separately and lysed. Human KG1 
myeloblastic cell line was used as a positive Tert activity and internal control (a gift from V. 
Mansat-De Mas, INSERM U563, Toulouse, France [607]). Cells were cultured at 37°C in 
IMDM medium (Invitrogen, Gibco, France) supplemented with 20% heat-inactivated fetal 
bovin serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified 
atmosphere containing 5% CO2. Cells were maintained for 2 weeks at 3x105 cells/ml by 
diluting with fresh medium every 2-3 days, and cell viability was assessed by trypan blue 
exclusion. A total of 1x105 cells were lysed and centrifuged. A two-fold serial dilution of 
KG1 cells was made in lysate buffer. 12.5 µl of D14 wounded stromal or KG1 cell lysate was 
added to 12.5 µl of QTD premix in Thermo-Fast® 96 PCR detection plates (AB-1100, 
Abgene, Thermo Fisher Scientific, UK). PCR conditions were carried out in the ABI PRISM® 
7000 Sequence Detection System (Applied BiosystemsTM, France) as follows: 
 
• Telomerase “warm-up” reaction 25°C for 20 minutes. 
• Initial activation: 95°C for 10 minutes. 
• 40 cycles of: Denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds 
and extension at 72°C for 30 seconds.  
 
The Ct was used to detect the signal associated with an exponential growth of PCR 
products during the log-linear phase and compared between control and D14 wounded 
stromas. The same experiment was repeated 3 times using triplicate stromal and KG1 cell 
lysate samples, and a negative control (lysate buffer). Relative telomerase activity was 
136 
 
 
determined using REST 2009 software, and normalised to the negative control telomerase 
activity data. Non-parametric Mann Whitney tests were used for group-to-group comparisons. 
A value of p≤0.05 was considered statistically significant. 
 
 6 Immunohistochemistry 
 6.1 Sectioning and Fixation 
Immunohistochemistry allows the visual localisation of protein in cell culture and 
tissues sample slices by the use of protein epitope antibody detection. Cryo-embedded 
enucleated mouse eyes were slowly frozen using isopentane before transport in liquid 
nitrogen for storage at -80°C. The eyes were then transported on dry ice for cryosectioning. 
Cryosections of a minimum of 7µm were required to maintain corneal structural integrity. For 
most primary antibodies used, sections were immediately fixed for 20 minutes in freshly 
prepared 4% paraformaldehyde at 4°C, then air dried before storage at -20°C. The anti-Nestin 
primary antibody required that sections were directly stored at -20°C after sectioning. These 
sections were then fixed just prior to immunostaining experimentation for 20 minutes in 
acetone at -20°C. For each eye sectioned, HE staining was carried out on a sample of slides to 
verify the state of the cornea before proceeding to primary antibody experimentation.  
 
 6.2 Immunodetection Experimentation 
For immunostaining, a minimum of 3 different controls and 3 different D7, D14, and 
D28 wounded mouse eyes were tested with each antibody for consistency (except for Lyve-
1/CD31 colocalisation experiments, for which we tested 5). Sections fixed in 
paraformaldehyde were incubated for 30 minutes in 0.1% NaBH4 in PBS for antigen 
retrieval. All sections were permeabilised in 0.5% Triton X-100 in PBS. Non-specific binding 
was blocked by incubation in 10% FBS (Cat. No. 10106151, Invitrogen) for 30 minutes, 
followed by blocking for 30 minutes with Image-iT™ FX Signal Enhancer (Cat. No. I36933, 
Invitrogen, USA). Incubations of sections with primary antibodies against the proteins Abcg2, 
CD133, Tert, Sox2, Oct-3/4, Nanog, Pax6, Nestin, Lyve-1 and CD31, followed by a 1 hour 
incubation with 1/400 dilutions of secondary Alexa Fluor® antibodies (Molecular probes, 
Invitrogen, USA) were performed according to table 3 (page 139). All sections were washed 
for 5 x 5 minutes with 0.5% Triton X-100 in PBS after incubations with primary and 
secondary antibodies. 0.5% Triton X-100 in PBS was used for all serum, primary and 
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secondary antibody dilutions. Negative controls were carried out using 0.5% Triton X-100 in 
PBS, as well as rat isotype IgG antibody, rabbit and goat serums in replacement of the 
primary antibodies used on sections of control and wounded eyes (see table 3 page 139). 
Nuclei were counterstained and mounted using ProLong® Gold antifade reagent with DAPI 
(Cat. No. P36935, Invitrogen, USA). All experiments were carried out under the same 
conditions, and antibody controls and wounded cornea staining were performed concurrently. 
 
6.2.1 Colocalisation Experiments 
Colocalisation experiments are used to determine if ≥2 different proteins are localised 
to the same or different tissues, cells and even subcellular structures. Abcg2/Tert, Oct-
3/4/Tert, Pax6/Sox2 and Lyve-1/CD31 colocalisation experiments were carried out. Note that 
for Lyve-1/CD31 colocalisation experiments, eye tissues were cryosectionned at 20µm in 
order to preserve vessel integrity for visualisation with confocal imaging. Different species 
primary and secondary antibodies were used to reduce non-specific background. The same 
protocol as in section 6.2 page 136 was applied for colocalsiation experiments. Firstly, 
sections were incubated with one primary antibody, followed by incubation with its 
corresponding secondary antibody. This was then repeated for the second primary antibody 
with corresponding secondary antibody. Additional washes in 0.5% Triton X-100 in PBS 
were carried out before addition of the second primary and second antibodies, and before 
nuclei counterstaining with DAPI. 
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Table 3  Primary and secondary antibodies used for protein detection with species, commercial, dilution and incubation information
Primary antibody Supplier information Dilution used Incubation 
 
Secondary antibody  
Rabbit polyclonal anti-CD133 ab19898 Abcam, England 1µg/µl 2h/room 
temperature 
Alexa 546, Cat. No. A11035 
Rat monoclonal anti-Abcg2 
 
ab24115 Abcam, England 1µg/µl 2h/room 
temperature 
Alexa 555, Cat. No. A21434 
Goat polyclonal anti-Tert sc-68721 Santa Cruz Biotechnolgy Inc, Germany 4µg/µl overnight/+4°C Alexa 555, Cat. No. A21432 
Goat polyclonal anti-Sox2 sc-17320 Santa Cruz Biotechnolgy Inc, Germany 4µg/µl overnight/+4°C Alexa 555, Cat. No. A21434 
Rat monoclonal anti-Nestin sc-101541 Santa Cruz Biotechnolgy Inc, Germany 2µg/µl overnight/+4°C Alexa 555, Cat. No. A21434 
Rabbit polyclonal anti-Nanog ab80892 Abcam, England 2µg/µl 2h/room 
temperature 
Alexa 546, Cat. No. A11035 
Rabbit polyclonal anti-Oct4 AB3209, Chemicon International Inc, USA 2.5µg/µl 2h/room 
temperature 
Alexa 546, Cat. No. A11035 
Rabbit polyclonal anti-Pax6 PRB-278P, Covance, California, USA 3µg/µl overnight/+4°C Alexa 546, Cat. No. A11035 
Rat monoclonal anti-Lyve-1 (IgM)  sc-65647 Santa Cruz Biotechnolgy Inc, Germany 0.4µg/µl overnight/+4°C Alexa 647, Cat. No. A21248 (IgM) 
Rat monoclonal anti-CD31 ab7388, Abcam, England 0.2µg/µl 2h/room 
temperature 
Alexa 555, Cat No. A21434 
Rat IgG2  MAB0061, R&D Systems Europe Ltd, England 1µg/µl overnight/+4°C Alexa 555, Cat No. A21434 
Rabbit serum  R 9133, Sigma-Aldrich Inc, France 1µg/µl 2h/room 
temperature 
Alexa 546, Cat No. A11035 
Goat serum  G 9023, Sigma-Aldrich Inc, France 4µg/µl overnight/+4°C Alexa 555, Cat. No. A21432 
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6.3 Imagery 
Firstly, slides were observed using 10X and 20X objectives (Leica DMR microscope) 
to select sections to proceed to confocal 20X objective and 63X oil objective microscopy 
(confocal Zeiss 710). For confocal microscopy a series of z-section images were acquired 
using Zen 2008 Software (Carl Zeiss GmbH SP1.1 Version 5.0). Fields were averaged 4 times 
to increase signal to noise ratio, and amplifier gain and offsets of each photomultiplier were 
adjusted for a given antibody, but were set constant for the sake of comparison between 
control and wounded corneas. Individual channels were devoid of fluorescence from other 
emission sources, thus eliminating bleed-through.  
 For Tert/Dapi colocalisation analysis, the Zen 2008 Software profile option was used 
to analyse the different colour fluorescence intensities per pixel of the image. This was 
presented graphically as a colocalisation profile.  Fluorescence intensities were normalised to 
Zen software 2008 standard. 
 The free online ImageJ Plugin software (National Institutes of Health, USA) was used 
for quantification of colocalisaiton experiments using two different primary antobodies in 
different wounded corneal stromal regions (the direct stromal wound zones versus wounded 
stromal peripheries). ImageJ Plugin quantifies colour channel pixels by means of manual 
intensity threshold settings. The degree of colocalisation for the colour channels is positively 
related to the Mander’s coefficient (M1), commonly known as the ‘overlap coefficient’ (OC) 
and is expressed as a percentage [608]. M1 was calculated in 25,000 pixel D14 stromal wound 
zone and D14 peripheral wounded stromal tissue areas. In this study, M1 corresponded to 
total percentage of red pixels that colocalised with green pixels. M1 was calculated 10 
independent times for D14 stromal wound zone and for D14 wounded peripheral stromal 
tissue areas from 5 independent Oct-3/4 (red)/Tert (green) and 5 independent Pax6 (red)/Sox2 
(green) colocalisation experiments. Two sample t-tests were carried out to test for a 
significant difference (p≤0.05) in M1 in D14 stromal wound zones compared to D14 wounded 
peripheral stromal tissues for both colocalisation experiments.  
 
 7 Immunoblotting 
To begin with primary antibodies were tested on protein extracted from embryonic 
mouse heads (E11.5). This was to develop protein extraction methods and test antibody 
specificity. Accordingly, protein was extracted from control, D14 and D28 wounded stromal 
tissue samples using a 1ml micro tissue grinder (Wheaton, USA) in PBS with protease 
140 
  
inhibitor cocktail (Roche, France) at +4°C. The supernatant was collected following a 10 
minute 13,000 rpm centrifugation and protein concentration was determined using a Dc 
protein assay kit (BioRad, France). This is based on the Bradford Protein Assay method; a 
colour-based change in absorbance as Coomassie Blue binds to amino acids present in the 
protein lysate. 10 µg lysates were denatured in 5X sample loading buffer for 5 minutes at 
95°C. Lysates were then run on 7.5-10% SDS-PAGE gels, transferred to Hybond-C extra 
nitrocellulose membranes (GE Healthcare, Canada) and blocked by incubation for 2 hours in 
5% non-fat milk or BSA (Cat. No. 04-100-810-C, Euromedex, France). Proteins were then 
labeled using monoclonal rat anti-Abcg2 (Cat No. ab24115, Abcam, England), monoclonal 
rabbit anti-Pax6 (Cat. No. ARP32741_P050, Aviva Systems Biology, USA) or monoclonal 
rat anti-Nestin (Cat. No. MAB353, Chemicon, France) primary antibodies overnight at +4°C. 
Monoclonal rabbit anti-Th (Cat No. ab75875, Abcam, England) primary antibody was used as 
a housekeeping control. Primary antibody dilutions were 1/500, 1/4000, 1/400 and 1/500 in 
their respective orders above. Labeling was followed by a 2 hour incubation at room 
temperature with 1/5000 dilutions of anti-rat and anti-rabbit IgG conjugated with horseradish 
peroxidase secondary antibodies (Cat. No. A5795 and A9169 respectively, Sigma, USA). 
Primary and secondary antibodies were diluted in 1% non-fat milk or BSA in PBS/Tween 1%. 
3 x 10 minutes washes in PBS/Tween 1% were used between primary and secondary antibody 
incubations and before visualisation using an ECL-based detection system (Chemiluminescent 
Peroxidase Substrate-3 kit, Sigma, France). Prestained protein ladders were used for 
molecular weight determination (Cat. No. SM0671, SM1811, Fermentas, France).   
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Figure 1 
 
 
Figure.1. Increased Expression of Keratocyte Progenitor Cell Markers during in vivo Corneal 
Wound Repair: ABCG2 and CD133.  
(A-E) Abcg2 immunostaining (red). (F-H) CD133 immunostaining. (A, C, F) Control cornea. 
Arrowheads highlight Abcg2-positive (C) or CD133-positive (F) cells. (B) D14 wounded cornea. (D, G) 
D14 wounded zone. (E, H) D28 wounded zone. Nuclei are counterstained with DAPI. (A-B) X200; 
scale bars represent 50 µm. (C-H) X630; scale bars represent 20 µm. (I) Western blot analysis of 
Abcg2 protein (72 Kda) expression in  control (C), D14 and D28 wounded stromas. Th (59 Kda) was 
used as a housekeeping control in control (C), D14 and D28 wounded stromas.  
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IV Results and Discussion  
 
Previous studies have claimed the identification of a potential repair subpopulation of 
cells expressing stem cell markers in the corneal stroma of several different species [403-405, 
457, 458, 511, 513]. These studies were based on either in vitro cell studies or unwounded 
corneas. Here we report for the first time the identification of stromal stem cell markers 
in the in vivo murine wounded cornea. Firstly, we demonstrate upregulation of known adult 
tissue stem cell markers in the wounded stroma. Secondly, the wounded stroma demonstrates 
upregulation of transcription factors important both for the maintenance of embryonic stem 
cell properties as well as ocular differentiation. Moreover, we show for the first time that the 
in vivo wounded corneal stroma can activate telomerase to extend cell division potential.  
 
1 Increased Expression of Keratocyte Progenitor Cell Markers during in 
vivo Corneal Wound Repair 
1.1  Abcg2 and CD133 Protein Expression is Increased in Stromal Wound 
Zones 
Firstly, we wanted to know if the normal corneal stroma harboured Abcg2 and CD133 
expression. We checked for this by simple immunostaining experiments. The control cornea 
expressed Abcg2 and CD133 in the limbal basal epithelial cell layer [521], and by a small 
number of stromal cells (Fig.1.A, C, F). This confirmed results by Du et al., (2005) [403] and 
Thill et al., (2007) [513] claiming that a minority of normal human stromal cells express 
Abcg2 and CD133 respectively. We then checked if Abcg2 and CD133 protein expression 
changed in wounded stromal tissues. D7 (data not shown) and D14 post-wounding, Abcg2 
and CD133 expression appeared more intense in the epithelium, endothelium, and was 
particularly increased in the stromal wound zones (Fig.1.B, D, G). No Abcg2 (Fig.1.B) or 
CD133 (data not shown) protein expression was localised in the stroma beyond the wound 
zone. In D28 stromal wound zones, Abcg2 and CD133 expression still appeared higher than 
in the control cornea (Fig.1.E, H). Fig.1.I shows that immunoblot results for Abcg2 protein 
expression were consistent with the immunostaining data. Abcg2 protein expression was 
higher in D14 wounded stromas compared to control stromas.  
 
In summary, upon corneal incision Abcg2 and CD133 protein expression increased in  
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Figure 2 
 
 
 
 
Figure.2. Increased Expression of Keratocyte Progenitor Cell Markers during in vivo Corneal 
Wound Repair: Pax6.  
(A-C) Pax6 immunostaining (red). (A) Control cornea. (B) D14 wounded zone. (C) D28 wounded zone. 
Nuclei are counterstained with DAPI. X630; scale bars represent 20 µm. (D) Western blot analysis of 
Pax6 protein (48 Kda) expression in  control (C), D14 and D28 wounded stromas. Th (59 Kda) was 
used as a housekeeping control in control (C) and D14 and D28 wounded stromas.  
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stromal wound zone cells, and this expression remained upregulated for 1 month. This implies 
that the normal corneal stroma could harbour a locally-derived Abcg2- and CD133-positive 
cell subpopulation that expands and is sustained in the stroma throughout the stroma 
remodelling process. This also correlates with an observation of elevated numbers of CD133-
positive cells found in human diseased corneas by Thill et al., (2007) [513]. Both Abcg2 and 
CD133 protein expression was only localised within the stromal wound zone, and not within 
peripheral stromal tissue away from the wound, implying that these markers are specific to a 
cell population recruited to the direct wound zone for a specific repair function. 
 Given the wide adult tissue stem cell expression of the CD133 marker [515-518], the 
exact origin of the corneal stromal cells that express CD133 is unclear. At this stage both 
ideas of an in situ undifferentiated stromal progenitor cell marker [516-518], or an external 
bone marrow-derived progenitor cell marker [514, 515] are plausible. 
 
1.2 Pax6 Expression is Increased in Stromal Wound Zones 
We tested for an upregulation of Pax6 expression in wounded stromas. Again, we 
tested for differences in Pax6 protein expression between control and wounded corneas by 
immunostaining. Control corneal stroma showed low Pax6 protein expression by 
approximately half of stromal cells (Fig.2.A). In D7 (data not shown) and D14 stromal wound 
zones Pax6 protein expression was more intense, and still at least half of stromal wound zone 
cells were Pax6-positive (Fig.2.B). By D28 post-wounding, stromal Pax6 expression was still 
more intense than in the control stroma (Fig.2.C). Fig.2.D shows that immunoblotting results 
were consistent with immunostaining results for Pax6 protein expression. Pax6 protein 
expression was detected in control stroma, and expression was slightly increased in D14 and 
D28 wounded stromal tissue samples. Housekeeping control Th protein expression was 
constant across control, D14 and D28 wounded stromas.  
 
Similar to Funderburgh et al., (2005) [404], Du et al., (2005) [403] and Du et al. 
(2007) [458], we found that Pax6 was expressed in the normal corneal stroma. However, these 
previous in vitro and ex vivo reports showed that only a small fraction (approximately 4%) of 
total bovine and human stromal cells were Pax6-positive. These results are concordant with 
total percentages of different progenitor cells in different muscle and skin dermal tissues. In 
these tissues progenitor cells account for 2- 9% of the total cell population of their cell niches 
[609-613]. On the contrary, we detected low levels of Pax6 protein in at least half of normal 
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Figure 3.A 
 
 
Increased Expression of Keratocyte Progenitor Cell Markers during in vivo Corneal Wound 
Repair: Tert.  
Figure.3.A. Tert Protein Expression and Activity in Control and Wounded Stromas. (A-D) Tert 
immunostaining (red). (A) Control cornea. (B) D7 wounded zone. (C) D14 wounded zone. (D) D28 
wounded zone. Nuclei are counterstained with DAPI. X630; scale bars represent 20 µm. (E) 
Telomerase activity assay. D14 wounded stromas were compared to control stromas. The stromas of 
six control corneas and the stromas of six D14 wounded corneas were pooled. Data (mean±SEM) are 
from three independent experiments. Activity is normalised to the negative control (lysate buffer). 
Human KG1 myeloblastic cells were used as a positive Tert activity control. KG1 500/250= 500/250 
equivalent cells respectively. *p≤0.05. For arrowhead (C) see Fig.3.C.           
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corneal stromal cells. These different observations are likely to be down to inter-species 
differences. In our mouse model, Pax6 expression could correspond in majority to adult 
keratocyte cells, and in minority to a stromal progenitor cell subpopulation. This theory is 
supported by reports made on an axolotl tail regeneration model in which all embryonic, 
differentiated mature, and regenerating mature spinal cord (neural tube) tissues showed Pax6 
expression [614]. In wounded corneal stromas, Pax6 protein expression increased in the 
stromal wound zone, and again at least half of the stromal cells expressed Pax6 protein. 
Overall, considering that Pax6 is expressed throughout ocular development [589], and there 
has been reports that Pax6 is expressed in regenerating adult ocular tissues [446, 448, 585], 
we can conclude that the majority of cells in the stromal wound zone are progenitor and/or 
keratocyte cells of ocular origin.  
 
1.3 Identification of an Active Stromal Progenitor Cell Population: 
Increased Tert Protein Expression and Activity in Wounded Stromas  
We wanted to know if stromal cells harboured functional progenitor cell function 
during corneal wound healing. Thus, we investigated Tert expression and activity as it is 
considered to be a stem cell marker upregulated in regenerative progenitor cells compared to 
somatic cells [590, 591]. Firstly, we compared Tert protein expression between control and 
wounded stromal tissues. Control cornea staining with Tert showed no reaction in the stroma, 
or the epithelial or endothelial cell layers (Fig.3.A.A). We observed an increase in Tert 
expression in wounded corneal epithelial and endothelial cells compared to the control cornea 
(Fig.3.A.B-D). Tert expression was increased in the D7 stromal wound zone, but not all 
stromal cells were Tert-positive (Fig.3.A.B). D14 wounded stromal zone showed high Tert 
expression and all stromal cells were Tert-positive. (Fig.3.A.C). At D28, the wounded stroma 
still showed higher Tert expression than in D7 and control stromas (Fig.3.A.D). We 
concluded that Tert stromal protein expression reached its highest level at approximately D14 
of the stromal wound healing process, and then decreased by D28. Thus, D14 wounded 
stromas were used to compare Tert activity to control stromas. At D14 post-wounding 
telomerase activity was more than double (2.4-fold increase) in wounded stromas compared to 
unwounded stromas (Fig.3.A.E).  
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Increased Expression of Keratocyte Progenitor Cell Markers during in vivo Corneal Wound 
Repair: Tert.  
Figure.3.B. Tert (green)/Abcg2 (red) colocalisation in Wounded Stromas. (A) Control cornea. X630; 
scale bar represents 20 µm. (B-E) X2500 magnification of arrowhead in Fig.A. Scale bar represents 5 
µm. (F) D14 proximal wound zone stromal tissue. Proximal tissue corresponds to intact and more 
highly organised corneal tissue neighbouring the direct incision wound zone. X630; scale bar 
represents 20 µm. (G-J) X2500 magnification of inset in F. Scale bar represents 5 µm. Nuclei are 
counterstained with DAPI.  
Figure.3.C. Cytoplasmic Tert Protein Localisation in D14 Wound Zone Stromal Cells. (A) X2500 
magnification of cell arrowed in Fig.3.A.C. Scale bar represents 5µm. (B) Colocalisation profile of red 
(Tert) and blue (DAPI) fluorescence intensities per pixel along the line in A. Intensities are normalised 
to Zen software 2008 standard.  
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This is first time in vivo evidence that the wounded corneal stroma has been 
observed to upregulate telomerase activity in response to corneal injury. Moreover, Tert-
positive cells in D7 (data not shown) and D14 (Fig.3.B) wounded stromas colocalised with 
Abcg2 protein. This suggests that Abcg2- and CD133-positive stromal cells are likely to 
correspond to corneal stromal progenitor cells that are mitotically active in the wounded 
stroma.  
Tert preserves telomere length during cell division-dependent DNA replication and is 
considered a necessary enzyme to escape senescence, promote cell survival, and maintain the 
possibility of unlimited cell divisions [590, 591]. It would be expected that an increase in Tert 
activity would correlate with an increase in division of progenitor cells in the wounded 
stroma. Logically, for this Tert activity function, it was initially considered that Tert was only 
active once translocated into the nucleus and recruited to chromosome telomeres [615]. We 
would expect to observe this for cells undergoing mitosis. Note that Tert protein expression 
was found to be in majority cytoplasmic in D14 wounded stromal cells (Fig.3.C).  
Interestingly, now, both cytoplasmic and nuclear Tert protein expression and activity 
has been demonstrated by mesenchymal stem cells from human amyotrophic lateral sclerosis 
subjects and glioblastomas  [616], mesenchymal progenitor cells from human endometria 
[617] and embryonic neural cells [618]. Moreover, cytoplasmic Tert protein-interacting 
proteins and signaling events have been found to play a role in anti-apoptotic effects, 
suggesting a survival promoting function of cytoplasmic Tert [619]. Thus, Tert in corneal 
stromal progenitor cells could function to elicit not only protection throughout cell division, 
but additionally promote a survival signal during the stromal wound response. Contrarily, we 
cannot exclude that cytoplasmic Tert protein expression could correspond to mitochondrial 
trafficking of Tert for degradation [615], or translocation of inactive Tert protein back into the 
cytoplasm [620]. 
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Figure 4 
 
Figure.4. Corneal Stromal Cells Reexpress Their Embryonic Stem Cell Markers. (A-C) Sox2 
immunostaining (red). (D-F) Oct-3/4 immunostaining (red). (G-I) Nanog immunostaining (red) (A, D, G) 
Control cornea. Arrowheads; Sox2-positive (A) and Oct-3/4 positive (D) cells. (B, E, H) D14 wounded 
zone. (C, F, I) D28 wounded zone. Nuclei are counterstained with DAPI. X630; scale bars represent 
20 µm. (J) Agarose gel electrophoresis quantification of Sox2 RT-qPCR products (75 bp amplicon) in 
control (C) and D14 wounded stromas. Controls: Th housekeeping gene control (110 bp amplicon) 
was used in control (C) and D14 wounded stromas. (-) Negative control. (M) DNA ladder, 50 bp.  
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2 Reexpression of Embryonic Cell Markers in the Wounded Stroma 
Corresponds to an Activated Adult Keratocyte Phenotype  
2.1    Increased Sox2, Oct-3/4 and Nanog Expression in Wounded Stromas 
Having demonstrated the existence of a potential stromal progenitor cell population, 
we investigated expression of embryonic stem cell markers expressed by neural crest-derived 
tissues to further investigate progenitor cell lineage. We tested for differences in Sox2, Oct-
3/4 and Nanog protein expression between control and wounded stromal tissues by 
immunostaining. We found that Sox2 protein was expressed in the normal corneal epithelium 
and endothelium, and a small number of stroma cells were also Sox2-positive (arrowhead) 
(Fig.4.A). Oct-3/4 protein was expressed by limbal basal epithelial cells [621], and was also 
expressed by a minority of stroma cells (arrowhead) in the normal cornea (Fig.4.D). Nanog 
protein was not expressed in the normal cornea (Fig.4.G). In the D7 (data not shown) and D14 
wounded stroma, Sox2 protein expression was more intense in the epithelium and in the 
stromal wound zone. The majority of the stromal cells showed Sox2 protein expression 
(Fig.4.B). In the D28 wounded stromal zone, Sox2 protein expression still appeared higher 
than in the control, and at least half of the stromal cells were Sox2-positive (Fig.4.C). The 
same increase in expression was observed for Oct-3/4 and Nanog proteins in D7 (data not 
shown), D14 (Fig.4.E, H) and D28 (Fig.4.F, I) wounded stromal zones. Sox2 gene expression 
(mRNA) was assayed by RT-PCR and agarose gel electrophoresis in control and D14 
wounded stromas (Fig.4.J). Control stroma showed low Sox2 mRNA expression. Sox2 mRNA 
expression was higher in the D14 wounded stroma compared to the control stroma, 
concordant with Sox2 immunostaining results. Housekeeping control gene Th mRNA 
expression was constant across control and D14 wounded stromas. 
Sox2 RT-qPCR product sequences corresponded to the published Mus musculus Sox2 
sequence, confirming amplification of the Sox2 gene by our primers (data not shown).  
In summary, we report an upregulation of the expression of embryonic stem cell 
markers Sox2, Oct-3/4 and Nanog throughout 1 month of the stromal wound repair process. 
Protein expression of the these stem cell markers in the stromal wound zone is likely to 
localise to the same stromal progenitor cells expressing adut tissue stem cell markers, as the 
majority of wound zone stromal cells were positive for adult and embryonic stem cell markers 
(Fig.1). As Sox2, Oct-3/4 and Nanog are expressed by late embryonic neural crest stem cells 
[359] implies that a high proportion of stromal wound zone cells could be progenitor cells of 
neural crest origin.  
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Figure 5 
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2.2 Upregulated Stem Cell Marker Exression throughout the Entire Wounded 
Stroma 
Unlike Abcg2 and CD133 protein expression that was expressed exclusively in the 
stromal wound zone (Fig.1.B), we found Sox2 (Fig.5), Oct-3/4, Nanog, Pax6 and Tert (data 
not shown) protein was expressed throughout the entire wounded stroma at D7 (data not 
shown), D14 (Fig.5) and D28 (Fig.5) post-wounding. As well as protein expression localised 
in the stromal-incised wound zone as previously described, protein expression of these 
markers was also localised in proximal wound zone stromal tissue and in stromal tissue away 
from the wound zone (Fig.5). Proximal and peripheral wounded stromal tissue protein 
expression followed the same expression pattern as observed in the stromal wound zones; 
more stromal cells were positive for each protein marker in D14 wounded proximal and 
peripheral stromal tissues than in D28 wounded proximal and peripheral stromal tissues. By 
D28 post-wounding only a few cells in proximal and peripheral wounded stromal tissues 
showed protein expression, but expression still appeared higher than in equivalent control 
stromas.  
Among reports demonstrating that Sox2, Oct-3/4 and Nanog expression in somatic 
multipotent progenitor cells functions in a manner that mirrors its roles in embryonic stem 
cells [566-568, 587], an ex vivo rat tracheal epithelial wound model showed that surviving G0 
blocked epithelial repair stem cells expressed Sox2, Oct-3/4 and Nanog proteins. However, 
these stem cells were a small population of cells among many other non-stem cell types 
(somatic cells), not expressing stem cell markers in the regenerating epithelial tissue [588]. 
How can we explain this drastic upregulation of stem cell markers by adult stromal cells 
in the wounded cornea? 
 
2.3   A High Proportion of Sox2, Oct-3/4 and Nanog Expression in the Wounded 
Corneal Stroma does Not Correspond to Progenitor Cells  
 Based on the observation of global wounded corneal stromal tissue expression of stem 
cell markers, we thought that the expression of stem cell markers may not be specific to 
stromal progenitor cells as it seemed unrealistic to think that the wounded stroma could be 
populated by such a high quantity of progenitor cells. Taking into account that Tert is 
considered to be upregulated in progenitor cells compared to somatic adult cells [591], we 
carried out colocalisation experiments to determine if cells that expressed embryonic stem  
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Figure.6. Colocalisation of Stem Cell Markers in Wounded Stromas.  
Figure.6.A. D14 Wounded Zone: Oct-3/4 (red) and Tert (green) coimmunostaining. (A) Control 
cornea. (B) D14 wounded zone. X630; scale bar represents 20 µm.  
Figure.6.B. D14 Wounded Peripheral Tissue: (A-E) Oct-3/4 (red) and Tert (green) 
coimmunostaining (E) Magnification (X2500) of cell (arrowhead) in (D). Scale bar represents 5 µm.  
(F-J) Pax6 (red) and Sox2 (green) coimmunostaining. X630; scale bar represents 20 µm. (J) 
Magnification (X2500) of cell (arrowhead) in (I). Arrows indicate Pax6-/Sox- cells. Scale bar represents 
5 µm. Nuclei are counterstained with DAPI.  
(K) % Colocalisations in wounded stromas. Calculations of M1 (total percentage of red pixels that 
colocalise with green pixels) in D14 wounded stromal zones and D14 wounded peripheral stromal 
tissues. (i) Stromal Oct-3/4 protein (red) expression colocalisation with Tert protein (green) expression. 
(ii) Stromal Pax6 protein expression (red) colocalisation with Sox2 protein (green) expression. The 
mean and SEM are calculated from 10 independent confocal images from 5 independent D14 
wounded corneas. * represents a statistical significant difference in M1 in D14 wounded stromal zones 
compared to D14 wounded peripheral stromal tissues. ** represents no statistical significant difference 
in M1 in D14 wounded stromal zones compared to D14 wounded peripheral stromal tissues.  
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cells markers colocalised with Tert protein expression (likely to be progenitor cells) in 
wounded stromal tissues, or not. 
 Fig.6.A shows high colocalisation of Oct-3/4 and Tert expression in the D14 stromal 
wound zone (B) compared to in the control cornea (A). In the D14 wounded stromal 
periphery, only a small proportion of Oct-3/4-positive cells (red) were also Tert-positive 
(green) (Fig.6.B.(A-D)). Fig.6.B.(E) shows colocalisation of Oct-3/4 and Tert to the same 
stromal cell. Calculation of the Mander’s coefficient (M1) demonstrated that total Oct-3/4 
protein that colocalised with Tert protein in the D14 stromal wound zone (mean 95%) was 
significantly higher than within the D14 wounded stromal periphery (mean 26%) 
(Fig.6.B.(K.i)). Thus, we rejected the null hypothesis of equal means (t= 19.6498, df = 18, p-
value = 1.306x10-13).  
 We also carried out Pax6 and Sox2 colocalisation experiments to test for the 
possible indication of non-ocular-derived progenitor cells in the wounded stromal peripheries 
that could express embryonic stem cell markers. Similar to Fig.6.A.(B), Pax6 and Sox2 
protein colocalisation experiments showed high colocalisation of Pax6 and Sox2 protein 
expression within the D14 stromal wound zone (data not shown). The majority of Pax6-
positive cells were also Sox2-positive in the D14 wounded stromal periphery (Fig.6.B.(F-I)). 
A small number of cells in the D14 wounded stromal periphery were negative for both Pax6 
and Sox2 protein expression (Fig.6.B.I). Fig 6.B.(J) highlights colocalisation of Pax6 and 
Sox2 protein to the same stromal cells within the D14 wounded stromal periphery. We found 
no significant difference between the total percentage of Pax6 protein that colocalised with 
Sox2 protein in the D14 wound zone (mean 96%) compared to the D14 wounded stromal 
periphery (mean 93%) (Fig.6.B.(K.ii)). Thus, we accepted the null hypothesis of equal means 
(t = 1.7545, df = 18, p-value = 0.09635) 
 
 These results demonstrate that Oct-3/4 and Tert colocalisation was very high within 
cells in the stromal wound zones, whereas the majority of Oct-3/4-positive cells in the 
wounded stromal peripheries were Tert-negative, (even though a small number of Tert-
positive cells were localised in the stromal peripheries). Together these findings indicate that: 
 
1. The majority of wounded peripheral stromal cell expression of undifferentiated 
embryonic stem cell markers may not correspond to progenitor cells, but to non-
progenitor stromal cells.  
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2. The minority of Tert-positive progenitor cells localised throughout the 
wounded peripheral stromal tissues (Abcg2/CD133-negative) could be a 
different progenitor population to those within the stromal wound zone, 
(Abcg2/CD133-positive).  
 
These theories suggest that a high proportion of undifferentiated stem cell marker 
expression in the wounded stroma could actually correspond to non-progenitor adult 
keratocyte cells. We could deduce that adult keratocyte cells generally revert to an 
activated wound response state in the wonded stroma, even in stromal tissue away from 
the wound zone.  
Secondly, given that the majority of peripheral wounded stromal cells were Pax6-
positive, we can conclude that the wounded stromal peripheries are populated in majority by 
ocular-derived cells. Moreover, almost all Pax6-positive cells colocalsied with Sox2 protein, 
suggesting that the cells we observe in the peripheral wounded stromal tissues are highly 
likely to be activated adult keratocyte cells and progenitor cells. A minority of Pax6- and 
Sox2-negative cells were however localised in the D14 wounded peripheral stromal tissues. It 
is likely that these could cells correspond to either inflammatory cells or non-ocular cells that 
migrate into the stroma as previously decribed by Nakamura et al., (2005) [510], Sosnova et 
al., (2005) [511] and Barbosa et al., (2010) [369].  
 
2.4 The “Half Way State” 
Going back to the ex vivo rat tracheal epithelial cell wound model, once G0 blocked 
epithelial repair stem cells differentiated into downstream ciliate, mucous or basal cells, 
expression of Sox2, Oct-3/4 and Nanog was lost [588]. Moreover, it has recently been shown 
that introducing transient Oct-3/4 expression to adult human keratinocyte cells was enough to 
change their differentiation pathway [622]. These studies show that transcription factors 
involved in early stem cell self-renewal can be contextually activated in more mature tissues 
to foster proliferation and susceptibility to environmental differentiation signals. These 
findings, along with our observations, allow us to hypothesise that the adult keratocyte cell 
could retain a relative plasticity, being able after an injury to reactivate embryonic pathways 
in order to heal the stromal wound. Together with the observations made that late embryonic 
keratocyte cells could retain a larger undifferentiated phenotype of their neural crest origins  
than initially considered [284, 359] implies that at least some wounded stromal cells identified 
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could in fact be activated keratocyte cells that exhibit an “embryonic-like” phenotype. 
Similarly, it has recently been demonstrated that other regenerative blastema-type tissues, 
notably the tip of the zebrafish fin, are regulated by a range of factors (notably Oct-3/4 and 
Sox2) do not fully depend on regulation by pluripotent factors, but may retain more 
embryonic features from their tissues of origin than previously considered [623, 624]. This 
has been termed the “half way state” [623]. In this project we cannot distinguish between 
marker profiles of the“activated keratocyte half way state” cell phenotype from the stromal 
progenitor cell phenotype as expression profiles overlap for the moment. Thus, our results 
additionally suggest that the minority of normal corneal stroma residing cells expressing 
embryonic stem cell markers could either correspond to a progenitor cell population and/or to 
a minority of adult keratocyte cells going through the turnover programme. Finally, a role for 
active half way state keratocyte cells in the stromal wound response remains undertermined, 
but we cannot exclude a migration of this cell type into the stromal wound zone for a repair 
function. 
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Figure 7 
 
Figure.7. A Neural Crest-Derived Repair Pathway Replenishes Lost Keratocyte Cells. (A) Nestin 
mRNA was assayed in control and D7-D28 wounded stromas by RT-qPCR. Expression in wounded 
stromas is normalised to the expression in control stromas. *p≤0.05. Bars represent SEM for 
independent wounded stromal samples. (B) Western blot analysis of Nestin protein (220 Kda) 
expression in control (C), D14 and D28 wounded stromas. Th (59 Kda) was used as a housekeeping 
control in control (C), D14 and D28 wounded stromas. (C-F) Nestin immunostaining (red). (C) Control 
cornea. (D) D14 wounded zone. (E) D28 wounded zone. X630; scale bars represent 20 µm. (F) D28 
wounded cornea. X200; scale bars represents 70µm. * corresponds to incision wound zone. Nuclei 
are counterstained with DAPI. 
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3 A Neural Crest-Derived Repair Pathway Replenishes Lost Keratocyte 
Cells 
3.1 Increased Nestin Expression in Later Stroma Remodelling Stages 
Nestin marker analysis demonstrated a different expression pattern to all other adult 
and embryonic stem cell markers analysed in this project. Nestin mRNA was found to be 
upregulated at D14 post-wounding (approximately 1.5-fold), but was upregulated to a greater 
extent at D21 and D28 post-wounding (approximately 3.7-fold) (Fig.7.A). Nestin protein 
expression analysed by both immunoblotting (Fig.7.B) and immunostaining (Fig.7.C-E) 
followed the same trend. Immunoblotting results showed low Nestin protein expression in 
control stromas. Nestin protein expression increased in D14 wounded stromas, but was most 
highly expressed in D28 wounded stromas. Housekeeping control Th protein expression was 
constant across control, D14 and D28 wounded stromas. Nestin immunostaining in control 
stroma showed no reaction (Fig.7.C). D7 (data not shown) and D14 wounded corneas show 
Nestin expression by a few stromal cells in the wound zone (Fig.7.D). Nestin protein 
expression was significantly increased in the stroma at D28 post-wounding (Fig.7.E). In the 
stromal wound zone Nestin-positive cells were arranged in a linear, grouped organisation and 
showed an elongated morphology, indicating also that Nestin protein expression of 
neighbouring cells overlapped. This implied a stromal cell-cell network, characteristic of 
normal stromal keratocyte cells embedded in the normal stromal ECM [269].  
 
 3.2 The “Half Way State” versus Dedifferentiation 
Similar to Sox2, Oct-3/4 and Nanog, Nestin is known to be expressed by neural crest 
precursor cells during early embryogenesis [460-462], but also in several mitotically active 
adult stem cells [465, 466]. The Nestin promoter contains a POU-domain enhancer element 
[460], implying that the Oct-3/4 transcription factor may regulate Nestin expression. This 
theory has already been demonstrated where an Oct-3/4 molecular programme was thought to 
regulate the differentiation pathway of different adult mesoderm stem cell lineages into a 
Nestin-positive neural cell lineage [583]. An interesting point is that Nestin-positive cells 
were not found in peripheral corneal stromal tissues, but only in the direct stromal wound 
zone and proximal wounded stromal tissue. Expression was observed in the central stroma, 
not in epithelial- and endothelial-proximal stromal tissues (Fig.7.F). The Nestin-positive cells 
showed a highly similar cell morphology to adult keratocyte cells, but we know that Nestin is 
not expressed by adult keratocyte cells [467]. Nestin positive protein intermediate filaments 
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could be incompatible with specific cytoskeleton organisation required to maintain corneal 
stroma transparency. It could be that undifferentiated cell signals (notably Oct-3/4) regulate 
Nestin expression in some stromal wound zone cells, and that these cells then enter a 
keratocyte regeneration pathway to eventually replenish sites devoid of adult keratocytes. 
Thus, Nestin-positive cells could in fact be: 
 
• Neural crest-derived progenitor cells that could eventually differentiate 
into keratocyte cells once Nestin expression is lost.  
• Activated keratocytes that have exceeded their “half way state” and need 
to dedifferentiate into keratocyte cells once Nestin expression is lost via the 
reactivation of their embryological signaling pathways.  
 
If this is the case, the Sox2/Oct-3/4/Nanog-positive and Nestin-negative cells localised 
throughout the remainder of the wounded stroma could correspond to activated keratocyte 
cells that do not go beyond their “half-way state”, instead regaining their quiescent keratocyte 
state once they lose their expression of undifferentiated cell markers [572, 625].  
 
4 Different Interpretations of the Upregulation of Progenitor Cell and 
Undifferentiated Keratocyte Cell Markers in the Wounded Stroma 
Several alternative studies bringing forward interesting theories contest our ideas of 
the existence of an in situ corneal stromal progenitor subpopulation and of an undifferentiated 
adult keratocyte phenotype in the corneal stroma that are both activated following corneal 
injury.  
 
4.1 What Happened to the Famous Myofibroblast Cells? 
Literature clearly states that corneal stromal wounded areas must contain a lot of 
keratocyte cells that differentiate into myofibroblast cells [344], which are specifically 
identified by their expression of α-SMA [356, 357]. Our mouse corneal wound healing model 
also demonstrates increased expression of α-SMA in the wounded stromas [603]. Here in this 
project we demonstrate that the stromal wound zone harbours a high amount of cells that 
express both adult and embryonic stem cell markers. However, we know that late neural crest 
embryonic precursors also express α-SMA, in concert with Sox2, Oct-3/4 and Nanog 
expression [359]. It thus appears that it would be difficult to distinguish myofibroblast cells 
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from progenitor cells in the wounded stroma. Moreover, our results suggest that in fact 
myofibroblast cells may not be the major repair cell population in the stromal wound zone. 
Further work is however required to determine the stem cell expression profiles of 
myofibroblast cells before this theory can be developed further.  
 
4.2 External Corneal Recruitment 
4.2.1 Bone Marrow-derived Progenitor Cells 
Bone marrow-derived cells have been found to migrate into the wounded murine 
corneal stroma, and then undergo differentiation into myofibroblast cells [512]. Moreover, 
injection of both bone-marrow derived mesenchymal stem cell lineages isolated from human 
adult adipose [529] and from human umbilical cord [535] have shown integration into murine 
(not human) stromal structures, and differentiation into keratocyte-like cells. These 
observations raise the possibility of external corneal recruitment of progenitor cells into the 
wounded corneal stroma. However, taking into account we demonstrated Pax6 expression by 
many cells in the wounded stroma implies that a high proportion of cells in the in vivo 
wounded stroma could be of ocular origin, meaning external ocular progenitor cells may not 
be the major progenitor cell population in the wounded stroma.   
 
4.2.2 Lymphatic Vessel Formation 
Considering that some external progenitor cells are highly likely to home to the 
wounded corneal stroma, and given the known immune cell trafficking role of lymph vessels 
in wound repair [400], we could hypothesise that lymphangiogenesis could enable the 
recruitment of these cells into the wounded cornea [393]. We thus analysed the formation of 
lymph vessels in our mouse corneal wound healing model by means of Lyve-1 
immunostaining. Results demonstrated that the normal corneal stroma was not found to 
harbour either blood or lymph vessels as expected (data not shown). No D21 or D28 wounded 
corneal stromas showed formation of lymph vessels (data not shown). The majority of D7 
(Fig.8.A, C) and D14 wounded (data not shown) stromas did not demonstrate either blood 
vessel or lymph vessel formation (3/5 mice per time period (60%)). Lymph vessel formation 
was observed in some central corneal D7 (Fig.8.B) and D14 (data not shown) wounded 
stromas (1/5 mice per time period (20%)). Lymph vessel formation in these mice was 
observed in proximal wound zone stromal tissues. Lymphatic vessel outgrowth from stromal  
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Figure 8 
 
 
 
Figure.8. Lymph Vessel Formation in Wounded Stromas. Violet: Lyve-1. Red: 
CD31. Blue: Nuclear counterstaining with DAPI. (A-B) D7 proximal wound zone. (C-
D) D7 peripheral wounded stromal tissue (adjacent to the limbal region). X630; scale 
bar represents 20 µm.   
 
 
 
 
 
 
 
 
 
 
162 
  
peripheries was also observed into some D7 (Fig.8.D) and D14 (data not shown) wounded 
stromas. In these mice, lymph vessel formation was observed only in peripheral wounded 
stromal tissues (1/5 mice per time period (20%)). Lymph vessel formation was identified in 
wounded stromas manifesting (Fig.8.D) or not manifesting (data not shown) corneal blood 
vessel outgrowth from the corneal limbal region, indicating that lymphangiogenesis in our 
corneal wound model can occur in the absence of blood vessel formation, as previously 
demonstrated by the same mouse species [395, 626].  
Briefly, results showed a very high inter-mouse variance in the formation of lymph 
vessels in our mouse corneal wound healing model. However, all wounded mouse stromas 
showed an upregulation expression of progenitor cell markers, giving strong doubts that the 
formation of lymph vessels were responsible for the recruitment of progenitor cells into the 
wounded stroma of our wound model. Nevertheless, it is known that the mouse corneoscleral 
limbus vasculature harbors lymph vessels [627]. It could be that some repair cells are initially 
released in the limbal region, and then migrate into the wounded stroma. In this case, lymph 
vessel formation in proximity to the stromal wound zone may function to directly release 
supplementary repair cell into the stromal wound zone vicinity. The extent of lymph vessel 
formation could depend on inter-mouse variation in corneal wound responses, with more 
acute responses eliciting lymph vessel formation in proximity to the stromal wound zone. On 
the other hand, could lymph vessel formation function to supply repair cells from outside the 
cornea in proximity to the stromal wound zone? Further experimentation is required before 
such conclusions can be made. 
 
4.3 Existence of a Limbal Stromal Cell Niche 
First reports of the isolation of limbal stromal cells in a limbal niche were made in 
2005 by Dravida et al., 2005 [628]. This group separated the limbal stromal zone from the 
epithelial limbal zone of corneas from human patients undergoing cataract surgery. Limbal 
fibroblast-like cells were then isolated via cell surface Stage-Specific Embryonic Antigen-
4 (SSEA-4) expression. SSEA-4 is widely expressed by pluripotent human embryonic stem 
cells and adult bone marrow-derived mesenchymal stem cells [629]. Similar to wounded 
corneal stromal cells identified in this project, expression of embryonic stem cell markers was 
found by these isolated limbal stromal cells, notably expression of Sox2, Oct-4 and Nanog. 
Moreover, similar to stromal progenitor cells isolated from the adult cornea, these corneal 
limbal cells were also capable of growing clonally and had a multipotent differentiation 
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potential. They were capable of maturing into cells including neurons, chondrocytes, 
adipocytes, hepatocytes and corneal epithelial-like cells. Keratocyte cell generation was not 
reported or discussed.  
Polisetty et al., (2008) [630] found that limbal mesenchymal cell cultures could be 
established from epithelialised and depithelialised human corneal limbal tissue from limbal 
epithelial transplantation donors. Resulting limbal mesenchymal cells demonstrated elongated 
spindle morphology, similar to bone marrow-derived mesenchymal stromal stem cells. 
Contrary to an embryonic-like stem cell expression profile of limbal fibroblast-like cells 
isolated by Dravida et al., (2005) [628], this group discovered a mesenchymal stem cell-like 
surface marker phenotype (CD90+, CD166+), with negative expression of hematopoietic stem 
cell markers (CD14-, CD31-,CD45-).  
Finally, it was recently shown that the murine corneal limbus is a source of cells which 
have fibroblastic morphology, are of neural crest origin, and certainly in vivo are multipotent. 
These cells have been termed “neural crest-derived stem cell-like cells” (NCDSCs) [631]. 
These cells were isolated by culturing limbal tissue from mice between postnatal days 1 and 8 
(early eyelid opening stages). Interestingly, limbal tissue from mice older than this or from 
central corneal stromal tissue could not give rise to NCDSCs. NCDSCs were found to be Sca-
1 positive, an important marker for mesenchymal stem cells. They additionally expressed 
adult tissue restricted stem cell markers, such as Abcg2, as well as embryonic neural crest 
development markers Twist, Slug, Snail, and Sox9. To determine the origin of these cells, it 
was shown that they were positive for corneal stromal keratocyte markers CD34, Lumican 
and Aldh1, weakly positive for endothelial cell markers, and negative for epithelial cells 
markers. This data indicates that NCDSCs are likely to be of stromal origin. Interestingly, 
these cells showed limited in vitro proliferative potential, losing it during the first 10 passages 
of culture, in a similar way to mesenchymal stem cells. This study indicates that NCDSCs are 
of neural crest origin and behave like multipotent stem cells. Note that these cells did not 
express Pax6, implying that this cell population is likely not to correspond to the half way 
state keratocyte phenotype identified by us in this project, but could however correspond to 
some progenitor cells. On the other hand, care in the interpretation of these results is required 
as the primary cultures mentioned here could have been contaminated with some epithelial 
cells that could have undergone EMT, also potentially accounting for this stem cell marker 
expression profile and morphological phenotype.  
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We cannot exclude that the limbal region may harbour progenitor cell populations that 
contribute to the stromal wound response upon migration into the wounded stroma from their 
limbal niche. These cells may also constantly migrate into the normal corneal stroma to 
function as guardians, accelerating migratory pathways and/or proliferation in order to expand 
the progenitor pool following corneal stromal injury.  
   
 4.4 Epithelial/Endothelial-to-mesenchymal Transitions 
 Limbal basal epithelial stem cells are well documented to express a wide variety of 
known progenitor cell fate* and undifferentiated cell markers [297, 621]. We documented an 
upregulated expression of all the markers analysed in this project (except neural crest-derived 
Nestin) in the wounded mouse corneal epithelium. In 1995 first evidence demonstrated the 
possibility of corneal intra-stroma invasion by surface epithelia using rabbit epithelial cells in 
corneal explants [632]. More recently, in some corneal opacity forming diseases, such as 
ocular pterygium* and limbal stem cell deficiency, the underlying mechanism of intra-stromal 
invasion by limbal basal epithelial stem cells, followed by migration, proliferation and EMT 
into fibroblast-like cells was put forward [633, 634]. Likewise, an in vitro rabbit corneal 
wound model based on culturing limbal extracts at the air-fluid interface (tissue air-lifting) 
was used to show that limbal basal epithelial cells can invade the underlying limbal stroma. It 
was also found that the epithelial stem cells underwent EMT in the limbal stroma [634]. The 
same group claims to have identified p63-positive corneal stromal cells from the pannus* of 3 
human patients suffering from total limbal stem cell deficieny [635]. P63 being a putative 
limbal basal epithelial stem cell marker [295], puts forward a role of epithelial stem cell EMT 
in fibrotic eye diseases.   
 Can we predict an epithelial cell role in adult stroma regeneration? 
 We cannot at this stage determine to what extent epithelial stem cells could participate 
in the stromal wound response in our mouse corneal wound model. It would be hard to 
believe that epithelial stem cells could account for the global wounded stromal cell stem 
expression profiles. This would require invasion of the entire stroma. It would be more likely 
that epithelial stem cells invade the stromal wound zone early-on following injury, and then 
undergo EMT in order to elicit a stroma remodelling function to fill in just part of a proximal 
stromal gap.  
 Normal human corneal endothelial cells have shown expression of CD133 [636], and 
expression of Telomerase, Oct-3/4, Wnt-1, Pax6 and Sox2 has been shown by exposed 
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damaged endothelial cells in adult human corneal graft bed tissue [378]. Similarly, we 
document an upregulation of CD133, Abcg2, Tert, Sox2, Oct-3/4, Nanog, Pax6 protein 
expression in wounded endothelial tissues in our mouse wound model. Likewise, we cannot 
exclude migration, proliferation and endothelial-mesenchmyal transition (EnMT) of corneal 
endothelial progenitor cells into the stromal wound zone [637], and to what extent in 
keratocyte replenishment this could bear. However, again it would be hard to imagine that the 
single cell endothelial cell layer could account for this entire stromal cell wound response. In 
summary, we concluded that the observations made in this report were in majority due 
to stromal cell responses. 
 
5 Summary of Results 
In conclusion, we report identification of more restricted adult tissue stem cell, neural 
crest-derived stem cell and embryonic stem cell markers throughout the in vivo mouse corneal 
stromal wound response (summarised in table 4 page 166). Our results show for the first time 
the localisation of a stromal cell subpopulation that expands to provide a progenitor pool 
during in vivo stromal wound repair. Whether these cells are present in situ or migrate from 
the limbus or elsewhere is not clear. For the first time we also demonstrate that the in vivo 
adult keratocyte could actually be an embryonic-like precursor in the wounded stroma, with a 
more plastic phenotype than previously considered. Expression of an adult and embryonic 
neural stem cell marker in later stromal wound healing stages in stromal wound zones could 
correspond equally to both hypothesises of a keratocyte replenishment function via the 
activation of keratocyte dedifferentiation and stromal progenitor cell differentiation. 
 
5        Résumé des résultats 
En conclusion, nous montrons l’expression de marqueurs de cellules souches qui sont 
exprimés par des tissus adultes, des cellule souches issues de la crête neural et des cellules 
souches pluripotentes lors de la réponse in vivo de cicatrisation cornéenne stromale adulte 
(résumé dans le tableau 4 page 166). Nos résultats in vivo démontrent pour la première fois la 
localisation d’une sous population de cellules progénitrices dans le stroma qui se multiplient 
lors du remodelage du stroma. Il reste à déterminer si ces cellules sont in situ, ou migrent du 
limbe, ou encore sont recrutées d’autres tissus. Notre étude suggère pour la première fois que 
le kératocyte adulte peut acquérir le phénotype de son précurseur embryonnaire dans le 
stroma blessé, concluant que son phénotype semble être plus plastique qu’on le considère. 
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L’expression d’un marqueur de cellule souche embryonnaire et adulte exprimé par des tissus 
neuraux a été localisée dans des cellules stromales exclusivement dans la zone blessée lors 
des stades tardifs de la cicatrisation. Cette expression pourrait correspondre à une voie de 
dédifférenciation des kératocytes, ainsi qu’à une différenciation des progéniteurs du stroma 
afin de régénérer les kératocytes perdus dans les zones du stroma blessé.  
 
 
Table 4 Changes in protein expression, mRNA expression (when indicated) and activity (when 
indicated) of stem cell markers in wounded compared to control stromas. Note that for Pax6, mRNA 
and protein expression patterns do not concord.  
 
 
- : No expression/activity 
+ : Increased expression 
constant: No change in expression  
NA: Not applicable 
NI: Not investigated 
 
 
 
 
 
 
Stem cell 
marker 
Stromal expression 
Tissue 
Sample 
Control D7 D14 D28 Wound 
zone 
Periphery 
Abcg2 Protein Low ++ ++ + + - 
CD133 Protein Low  ++ ++ + + - 
Tert Protein 
Activity 
Low 
- 
+ 
NI 
++ 
+ 
+ 
NI 
+ 
NA 
+ 
NA 
Sox2 mRNA 
Protein 
Low 
Low 
NI 
++ 
++ 
++ 
NI 
+ 
NA 
+ 
NA 
+ 
Oct-3/4 Protein Low ++ ++ + + + 
Nanog Protein -  ++ ++ + + + 
Pax6 mRNA 
Protein 
detected 
≥50% stromal cells 
constant 
+ 
constant 
+ 
constant 
+ 
NA 
+ 
NA 
+ 
Nestin mRNA 
Protein 
detected 
- 
+ 
+ 
+ 
+ 
++ 
++ 
NA 
+ 
NA 
- 
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Figure 9 
 
                                   
Supplementary Figure.9. Negative Control Immunostaining (red staining) using rat isotype IgG 
antibody (A-B), rabbit (C-D) and goat (E-F) serums in replacement of the primary antibodies on control 
(A, C, E) and D7 or D14 wounded (B, D, F) corneas. X630; scale bars represent 20 µm. Nuclei 
counterstained with DAPI.  
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V General Discussion 
 
 To date only in vitro cell studies and therapeutic cell injection studies have put 
forward the suggestion of the existence of a corneal stromal progenitor subpopulation with a 
keratocyte cell replenishment function. This project has not only shown the potential presence 
of a stromal progenitor cell population that expands throughout the in vivo corneal wound 
response, but has also demonstrated that the adult keratocyte may revert to an embryonic-like 
cell phenotype in the in vivo wounded stroma. The identification of these two new in vivo cell 
populations indicates the presence of unknown repair events that still need to be determined in 
the in vivo wounded stroma, involving at least these two cell populations. Two major 
questions need to be answered, what are the functions of these cells in the stromal wound 
response, and where do they originate from?  
 
1. Different Adult Tissue Regeneration Models 
 In an attempt to answer these questions we can consider the underlying mechanisms of 
wound healing responses in other adult tissues following injury. 
  
 1.1 The Skin 
 The skin has been abundantly studied for its regenerative capacity considering its 
exposed and therefore easy access location for experimentation. Similar to the cornea, the skin 
is an epithelial-lined organ, where the epidermis corresponds to the outer complex stratified 
squamous epithelial cell layer. The dermis is the thick underlying structural component that is 
constituted in majority by collagen and ECM, as well as hair follicles, sebaceous 
glands, apocrine glands, adipocytes, lymphatic and blood vessels. Thus, the dermis is a more 
complex tissue than the corneal stroma, harbouring at least three different stem cell lineages 
[638]. It does however contain the adult fibroblast cell, being the morphological and 
functional equivalent of the corneal stromal keratocyte cell. Similar to the cornea, much more 
attention has been placed on the definition and behavior of outer epidermal layer stem cells 
that are responsible for the maintenance of the skin barrier. Knowledge is still incomplete on 
how the dermis is coordinated at the cellular level during skin wound repair, but results have 
strongly shown the presence of a multipotent resident bone marrow-derived fibroblast-like 
stem cell subpopulation [638]. It has been suggested that this stem cell population has more of 
an “enhancer” role throughout wound healing, having a significant effect on the signalling 
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events involved in wound healing [638]. These cells secrete a variety of growth factors, 
cytokines* and chemokines* known to enhance cell growth [639-641], as well as factors that 
down-modulate inflammatory cytokines [642, 643], and this release has been found to be up 
to seven-fold higher than the release by activated adult fibroblast cells [639]. This implies a 
paracrine* signalling function of these stem cells to enhance, or guide the wound response of 
other cells in the tissue [638, 644]. On the other hand, some reports indicate that resident 
dermal stem cells also provide committed daughter progenitor cells that differentiate and 
directly contribute to the structural repair of wounds [644]. This suggests that bone marrow-
derived resident stem cells could elicit at least two different roles in dermis wound repair; 
guide other cells along their repair pathway, and themselves regenerate new cells for 
wound repair.  
 
 1.2 Skeletal Muscles 
 Another interesting point is that in more complex tissues, not one, but multiple 
different progenitor cell populations have been identified. In skeletal muscle there has been at 
least four different stem/progenitor cell populations characterised. These cells are side-
population cells, muscle-derived stem cells, CD133-positive progenitor cells and the Satellite 
progenitor cells [645]. Extensive cell isolation studies have found that these cells exist as 
independent populations based on their differences in surface antigens and origins; some are 
externally recruited via blood vessels [645]. Satellite progenitors are dormant cells localised 
in a specific niche found at the periphery of skeletal fibres and are largely considered to date 
the myogenic muscle repair cell population. In response to muscle stress or trauma, Satellite 
cells are activated, migrate and proliferate and differentiate into myogenic cells for 
regeneration [646]. To date the roles of the other stem/progenitor cell populations remains 
elusive [645]. 
 
 1.3 Neural Tissues 
Adult neurogenesis is generally considered an active process encompassing the 
proliferation and cell fate* specification of endogenous adult neural progenitors, and their 
subsequent differentiation, maturation and functional integration into the existing neuronal 
circuitry [647]. In the adult CNS, active neurogenesis occurs in two discrete ‘neurogenic’ 
regions in the brain; essentially a specialised compartement in the forebrain for supporting 
high rates of cell proliferation, and a subcompartment in the hippocampus involved in 
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memory consolidation [648, 649]. Experimental animal models of adult CNS inflammatory 
disorders, such as multiple sclerosis and autoimmune encephalomyelitis (both multipfocal 
demyelinating disorders), demonstrate that progenitor cells can suvbvert to migration to the 
areas of demyelination [650, 651]. Here these cells release an array of molecules containing 
immunomodulatory substances, neutrophic growth factors and stem cell regulators that 
coordinate progenitor cell proliferation, followed by their differentiation into glial cells [652]. 
Again the same conclusion can be made concerning the intrinsic function of progenitor cells 
in adult neurogenesis; they not only guide other cells along their repair pathway, they 
themselves contribute directly to the wound response by replacing lost somatic cells. Again, 
adult neural tissues undergoing repair have been found to harbour a heterogenous cell 
population, containing not only neural crest-derived stem cells, but bone marrow-derived 
mesencymal and haematopoietic stem cells [653].  
 The regenerative theories raised here can be somewhat extrapolated to try and 
decipher the mechanisms underlying the corneal stromal wound response (leaving merge for 
tissue and species differences).  
 
2. Functions and Origins of the Corneal Stromal Progenitor Cell 
Subpopulation(s) 
  The stromal wound zone progenitor cells identified in our study could be the 
equivalent of the muscle Satellite cell; resident in the normal stroma as a “dormant” 
subpopulation, but activates and proliferates following corneal injury, following 
differentiation into adult keratocyte cells in later stromal repair phases. Additionally, we could 
also expect progenitor cells to elicit a paracrine* signalling role to enhance endogenous adult 
keratocyte cell activation and inflammatory cell responses. Finally, work by Du et al., (2007) 
[458] demonstrated that in vitro corneal stromal progenitor cells were more efficient in novel 
stromal ECM production and secretion compared to corneal stroma-derived repair fibroblast 
cells. Thus, could we even attribute a direct contribution of wound zone progenitor cells to 
new ECM deposition?  
 In our mouse corneal wound healing model, the progenitor cell population in the 
stromal wound zone (Tert+/Abcg2+/CD133+) did not harbour expression of the same adult 
stem cell markers to the minor progenitor cell population within peripheral wounded stromal 
tissue (Tert+/Abcg2-/CD133-). Are these cells from a different tissue cell lineage? Do these 
cells elicit different functions? Progenitor cells localised within wounded peripheral stromal 
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tissue could elicit paracrine* signaling roles that guide other cells, in particular activated 
keratocyte cells, along their repair pathway. Tert expression could be involved in cell survival 
signals, as previously reported in mesenchymal stem and progenitor cells from several 
different human cell lineages [616-618]. This signal may involve inhibition of keratocyte cell 
apoptosis [619], while at the same time activating their half way state in the case of a 
requirement to adopt a repair fibroblast or myofibroblast phenotype for repair fucntion.  
 To my knowledge the localisation of just one progenitor cell lineage in an adult tissue 
has not been reported. Likewise, given the heterogeneity of the stem cell marker profiles 
identified in the in vitro studies that have tried to characterise corneal stromal progenitor cells 
[404, 457, 458, 513], we can expect some external corneal tissue progenitor cells to home to 
the wounded stroma. These are most likely to be progenitor cells of bone marrow-derived cell 
lineages [510-512]. On the other hand, skin, muscle and CNS neural tissues are more complex 
tissues than the cornea, involving many more cell types, so we could expect there to be less 
different progenitor subpopulations in the stroma than those that come into play in these 
tissues. Further in vivo cell isolation studies need to be carried out to determine progenitor 
surface antigens to identify the different progenitor lineages present in the normal and 
wounded stroma.  
 
3. Roles of the New Half Way State Keratocyte Phenotype 
Animal models based on determining the extent of dermal wound healing from adult 
mesenchymal stem cell function has been carried out upon application of mesenchymal stem 
cells to a wound bed within an isolated wound chamber (all surrounding skin tissue is 
removed). It was discovered that wounds only healed when a mixture of both mesenchymal 
stem cells with embryonic skin cells were applied to the wound chamber [654]. These results 
suggest that the resident dermal mesenchymal stem cells required the coexistence of other 
dermal cells for tissue regeneration. This finding, along with the theory made that similar 
signal upregulation is found in the developing CNS as in regenerative adult CNS, implies 
similarities between somatic cell responses in both embryonic development and adult tissue 
regeneration [614, 653]. In other words, it appears that pre-existing cells are required not only 
for a mechanical structure for tissue regeneration [638], but also for dedifferentiation to 
replenish lost cells [655] and for the release of signaling molecules to guide endogenous cell 
responses [638]. Accordingly, we could apply these same functions to the embryonic-like 
activated keratocyte cell in the wounded stroma. Their upregulation of undifferentiated 
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markers Sox2, Oct-3/4 and Nanog throughout the wounded stroma could play a role in self-
renewal and differentiation signaling events, as previously demonstrated in other adult tissues 
[553, 555, 566-569, 587, 588]. Initial upregulation followed by an expected loss of these 
signals would be important for keratocyte signals to respectively: 
 
1. Activate other keratocyte cells within the wound zone to proliferate. There 
could be additionally a role for these signals to activate stromal wound zone 
cells to adopt the repair fibroblast phenotype, or differentiate into 
myofibroblast cells, for wound repair.  
2. Activate the later stromal remodelling phase keratocyte regeneration pathway 
in order for myofibroblast cells in the wound zone to eventually differentiate 
into keratocyte cells to replace the cells lost from apoptosis.  
 
However, self-renewal and differentiation signals could equally be activated 
keratocyte-progenitor signals. We could expect a role of activated keratocyte cells in the 
regulation of progenitor cell expansion throughout the early stages of the in vivo corneal 
stromal wound response. Likewise differentiation signals could activate progenitor cell 
differentiation once stroma remodelling is complete.  
 
4. The Wounded Stromal Response; A Complex Network of Cell Repair Signals 
We can observe the stromal wound response as a controlled network of signaling 
events. Taking into account the different possible combinations of repair signals at play, we 
can start to assemble a complex network of stromal cell repair responses, with different signal 
pathways activated in different wound healing stages. Taking into account published 
observations and the results from this project; I put forward the following schematic 
representation of the cell responses in the in vivo corneal wound response: 
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4.1 The Normal Stroma 
 
 
 
The most abundant corneal stroma cell type is the quiescent adult keratocyte that does 
not express adult stem cell markers (SCMs), but is likely to express Pax6. The normal stroma 
is thought to harbour a progenitor cell subpopulation. Morphologically these cells are not 
distinguishable from adult keratocyte cells in order to retain the transparent corneal quality, 
but surface marker expression of adult stem cell markers allows us to distinguish them. There 
is also thought to be a minor subpopulation of cells that express embryonic stem cell markers, 
but we cannot yet determine if these cells are keratocyte cells turning over and/or progenitor 
cells. We do not know at present if the progenitor cell subpopulation is an in situ stromal cell 
population, or if progenitor cells migrate and reside in the stroma from a limbal niche of from 
external corneal tissues via the limbal region. Progentior cells in the normal stroma could act 
as guardians, ready to proliferate and elicit their stromal repair functions in the respone to 
corneal injury.  
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4.2 The Wounded Stroma 
4.2.1 D7-D14: The Stromal Wound Stabilisation Phase 
 
 
 
The earlier wound response stages could be considered as a coordinated network of 
signals and responses to promote repair cell synthesis and deposition of a new ECM to fill in 
lost stromal tissue [644]. We could expect the following cellular events (with many occurring 
simultaneously): 
 
• A decrease in adult keratocytes cells in the stromal wound vicinity due to apoptosis.  
• Keratocyte apoptosis and epithelium-stroma cell interactions activate the progenitor 
cell subpopulation, resulting in progenitor cell expansion in the wound zone. 
Progenitor cells within the wound zone could contribute to new ECM production. 
These cells express adult and embryonic stem cell markers. We could expect these 
cells to have a repair myofibroblast cell phenotype, and they could also express α-
SMA. 
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•  Progenitor cell signals (and perhaps half way state keratocyte cell signals) and 
epithelium-stroma cell interactions stimulate the differentiation of wound zone 
keratocyte cells into myofibroblast cells to synthesise and deposit new ECM. I would 
expect these cells to show an upregulation of α-SMA expression, and perhaps express 
both adult and embryonic stem cell markers. These cells could be considered as 
keratocytes that go beyond their half way state.  
• Progenitor cells away from the wound zone could be involved in paracrine* signaling 
events that enhance the activation of keratocyte cells throughout the entire wounded 
stroma, while proximal activated wound zone keratocyte cells could initiate the 
activation of other keratocyte cells via their ECM network. The keratocyte half way 
state phenotype would be adopted by adult keratocytes throughout the stroma. 
• We expect EMT/EnMT of some epithelial and endothelial cells respectively. Thse 
cells would migrate into proximal wounded stromal tissue to contribute to ECM 
synthesis. 
• We expect some influx migration of external stromal progenitor cells into the 
wounded stroma from the the limbal region and/or the blood circulation. 
• The formation of lymph vessels could also be observed, either directly in proximal 
wound zone stromal tissue or from limbal outgrowths into peripheral stromal tissue. 
These vessels could participate in influx of inflammatory and external stromal 
progenitor cells.  
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4.2.2 D21-D28: The Stromal Repair Phase 
 
 
The later wound healing phase corresponds to the eventual replacement of lost keratocyte 
cells by cells with similar functional characteristics in the new ECM [644]. We could expect 
the following signals and cellular events to activate this response: 
 
• Progenitor and half way state keratocyte undifferentiated cell signals (essentially Oct-
3/4) could induce Nestin expression in wound zone repair cells. Nestin expression 
could be regarded as a marker for cells going through, or at the beginning of a 
keratocyte regeneration pathway. We could expect Nestin-positive cells to be both 
neural crest-derived progenitor cells and/or keratocyte-derived myofibroblast cells that 
need to differentiate and dedifferenitate respectively to regenerate normal keratocyte 
cells required for restoring normal stromal transparency.  
• Half way state keratocyte cells away from the wound zone would begin to revert back 
to their quiescent adult keratocyte state.  
• We cannot exclude that epithelial- and endothelial-derived myofibroblast cells in 
stromal wound zones could regenerate keratocyte cells via the same Nestin-positive 
pathway.  
• We would expect migration of external progenitor cells to have stopped at this stage, 
unless of course some or all of the Nestin-positive cells in the stromal wound zone 
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correspond to a specific progenitor population recruited into the stromal wound zone 
at later stromal repair stages to regenerate adult kratocyte cells.  
 
 
4.2.3 > D28; Back to the Norm, or Not 
 
 
   
  A Normal Corneal Stromal Repair 
The majority of mouse corneas from our wound healing model lost their stromal 
opacity formation gradually after D14 post-wounding. We expect their new stromal ECM and 
cell types to eventually compare to that of a normal stroma. There would be a: 
 
• Decrease in undifferentiated cell signals (due to a decrease in progenitor and 
half way state keratocyte cells throughout the whole stroma) 
• Decrease in Nestin-positive cells 
• Increase in quiescent adult keratocyte-like cells.  
 
There still remains many unanswered questions regarding which cell types in the 
wounded stroma regenerate kertaocyte cells. It is unknown if there are specific cell types, or 
subsets of cells types that apoptose once stroma remodelling is complete, and if some cells 
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can revert back to a quiescent keratocyte-like cell phenotype in order to restore corneal 
transparency. For example, do some progenitor cells apoptose, or retain a more quiescent 
keratocyte-like phenotype to restore a progenitor pool, or do all progenitor cells differentiate 
into fucntional keratocyte cells? In the wound zone we could expect a subset of myofibroblast 
cells to apoptose, and a different subset to dedifferentiate [311, 333, 355, 358, 368, 369, 656]. 
However, more work is required to determine which cell subsets do what i.e. Could it be that 
neural crest-derived progenitor wound zone myofibroblast cells apoptose once the keratocyte-
derived myofibroblast cells dedifferentiate into keratocyte cells, or vice versa.   
  
  B Persistant Corneal Stromal Opacities 
Some of our mice retained a corneal stromal opacity for many month post-wounding. 
Corneal stromal opacity is due to the persistence of myofibroblast cells in the stroma [272]. 
Based on our findings in this project, we can now hypothesise many new factors that could 
contribute to the maintenance of myofibroblast cell phenotypes in the wounded stroma. Here 
are some examples: 
 
• A defect in activated half way state keratocyte cells i.e. they remain blocked in their 
activated state, meaning a constant upregulation of undifferentiated cell signals could 
inhibit the differentiation pathway of some myofibroblast/progenitor cells in the 
stromal wound zone.  
• A defect in/loss of progenitor paracrine* signaling events could lead to a lack of 
differentiation signals to myofibroblast cells, or lack of signals to deactivate the 
keratocyte half way state. It could also be that a subset of myofibroblast cells that 
undergo apoptosis rely on correct functioning of progenitor signals (i.e. loss of Tert 
survival signals).  
• The loss of a complete progenitor cell population required for the regeneration of 
keratocyte cells in the stromal wound zone. This could be due to a defect in in situ 
stromal progenitor cells, or a defect in the migration of progenitor cells from different 
tissues into the wounded stroma.  
• A defect in/incapability of epithelial/endotheial cell-derived myofibroblast cells to 
differenitatiate into keratocyte-like cells.  
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On the whole, we suggest that the in vivo stromal wound response could be more 
complex than previously considered. There are now more cell types to consider in the 
wounded stroma; half way keratocyte cells and local progenitor cells, not to mention the 
probable recruitment of external progenitor cells from different tissues that could also be 
capable of differentiating into myofibroblast-like cells to contribute to ECM restoration and 
keratocyte cell regeneration. There are likely to be interconnected repair cell signals and 
functions between progenitor and undifferentiated keratocyte cells. A loss or defect in the 
wound repsonse of one of these cell populations could perhaps lead to inhibition of 
myofibroblast cell differentiation events, and in turn lead to corneal opacity formation. A 
summary of the possible network of signals at play among repair cells is summarised in the 
diagram below.  
 
    
Schematic representation of the model for progenitor and keratocyte cell fates* and signalling events in corneal 
stromal wound healing. Dotted green arrows indicate progenitor guiding paracrine signals. The blue arrow 
indicates the role of undifferentiated cell signals that activate the dedifferentiation of keratocyte cells having 
exceeded their half-way state and/or progenitor cells to regenerate keratocyte cells for normal corneal 
transparency. ? Represents possible cell fates* of stromal progenitor cells. Note the bidirectional cell state 
between the quiescent and half way state keratocyte cell. We expect the repair fibroblast phenotype to appear 
between the half way state and myofibroblast cell phenotypes.  
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VI Perspectives 
 
1 Short Term Experimentation Currently Underway  
1.1 Regeneration of Keratocyte-like Cells 
 In vitro cell studies and therapeutic cell injection studies suggest that stromal 
progenitor cells differentiate into functional keratocyte-like cells [403-405, 457, 458, 513, 
527]. The next step in this study is to determine if once stromal wound zone cells lose their 
Nestin expression; do they express keratocyte markers? We are collecting wounded stromas at 
2 and 3 months post-wounding to investigate changes in Nestin and keratocyte-specific 
marker expressions (Keratocan, Keratocan sulphate, ALDH3A1) compared to D28 wounded 
stromas. A donwregulation of Nestin expression followed by an upregulation of keratocyte-
specific marker expressions would suggest keratocyte regeneration by wound zone stromal 
cells via a Nestin-positive regeneration pathway.  
  
1.2 Investigation of Permament Corneal Opacities 
We have also prolonged the sacrification times of some mice in which we observed 
grade 3 corneal opacities still at D28 post-wounding. We will test out the theory that stromas 
with opacity could harbour global expression of activated half way state keratocyte cells. This 
could confirm the requirement, or not, of inactivation of these cells for myofibroblast cells 
and/or progenitor cells to differentiate into keratocyte cells. We are also investigating co-
staining of α-SMA and Nestin in these stromal tissues to give an indication if persistant 
Nestin-positive myofibroblast cells are present in the stroma. If so, it could be a defect in the 
keratocyte regeneration pathway that underlies myofibroblast persistence and opacity 
formation.  
 
1.3 Contribution of Epithelial EMT to Stromal Wound Repair 
Considering that I hypothesise a small contribution of epithelial EMT in the stromal 
wound zone to myofibroblast formation, we are in the process of investigating for the 
expression of p63 by fibroblast-like cells in D7 and D14 wounded stromal tissues by 
immunostaining. P63 has already been used as a putative marker to trace epithelial stem cells 
that invade underlying fibrotic stromal tissue and undergo EMT [635]. The results will 
hopefully give us an insight into the extent of the contribution from epithelial cells in the our 
observed stromal wound response.  
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1.4 Additional Stem Cell Markers 
There is an extensive list of other adult and embryonic stem cell markers that could be 
additionally investigated to continue the identification of progenitor cell lineages and 
undifferentiated cell functions at play in the wounded stroma. We are in the process of 
carrying out CD45 (bone marrow-derived hematopietic stem cell marker) RT-qPCR and 
immunohistochemical anlyses in order to test for the migration of external bone marrow-
derived progenitor cells [484] into the in vivo wounded stroma.  
It would also be interesting to study the expression of other known embryonic stem 
cell markers known to regulate stem cell proliferation and differentiation. Among neural 
crest-derived embryonic stem cell markers identified by the handful of in vitro corneal 
stromal cell studies [404, 457, 458], Notch was identified as a stromal progenitor stem cell 
marker. This is an attractive target considering Sox2 has been shown to be downstream of 
Notch signaling in the mouse [657]. Similar to Sox2 signaling, Notch signaling has shown 
both regulatory roles over progenitor cell proliferation and differentiation in mammalian 
embryogenesis and adult stem cells [658-662]. In all cases, Notch signaling upregulation is 
known to lead to progenitor cell maintenance, and loss of Notch signals results in progenitor 
cell differentiation [2, 663]. Notch signaling cascades involved in self-renewal and 
differentiation in the developing and adult nervous sytsem bring into play a complex network 
of extracellular signals involving Wnt, β-catenin and Hedgehog proteins [658]. The Wnt/β-
Catenin pathway regulates cell fate* decisions during development of vertebrates and 
invertebrates. There is currently an active neuroscience research area based on the Wnt/β-
catenin signal network shown to promote neural stem cell proliferation and migration, but 
inhibition of differentiation into new neurons throughout adult neurogenesis [664]. Similarly, 
the Sonic hedgehog (Shh) signalling molecule assumes various roles in the CNS during 
vertebrate development via regulation of neural progenitor cell proliferation and 
differentiation [665]. Also, new research areas are beginning to question the function of the 
expression of Shh identified in both mature and regenerating neural stem cells [614, 666, 
667]. In addition, very recently it was shown that Twist activation is upstream of Notch 
signaling in adult muscle progenitor cells, suggesting that these two factors co-regulate 
maintenance and differentiation of embryonic and adult progenitor cells [668]. The fact that 
Twist2 activity loss in the normal adult mouse corneal stroma leads to corneal thinning due to 
keratocyte cell loss [495], implies that Twist may also be involved in this network of 
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undifferentiated cells signals we observed in the in vivo wounded stroma. We could perhaps 
predict a mirrored upregulation of these markers mentioned above with Sox2, Oct-3/4 and 
Nanog expression by activated keratocyte cells. Results will give speculations on the entity of 
the network of embryonic stem cell signals at play and their functions in the wounded stroma.  
 
2 Long Term Experimentation to Develop 
2.1 Identification and Isolation of Wounded Stromal Cell Populations 
 The identification of the surface antigens of the repair cell populations involved in the 
in vivo wounded stroma is necessary to determine the number of different repair cell 
populations present, and their origins. This will be carried carried out using fluorescent-
activated cell sorting (FACS). This technique allows sorting of heterogenous mixtures of cells 
based on multiple fluorescence signals from specific secondary antibodies via cell surface 
antigens of interest, giving quantitative cell numbers as well as physical isolation of cells of 
interest. This technique is considered to be of high sensitivity, selecting cell surface markers 
with higher specificity than simple immunostaining and microscopy observations that can 
take into account background noise from cells that do not actually bind the primary antibody 
[669]. Briefly experimental procedure would entail; removal of the epithelial and endothelia 
cell layers from corneal stromas (control, D7, D14 and D28). The stromas would then be 
diced into small cubes and cultured. After a maximum of 4 passages the cells would be 
saturated with primary and secondary antibodies before fluorescence analysis by FACS. A 
selection of primary antibodies based on markers from this project, with additional kertocyte-
specific, adult bone marrow-derived stem cell and neural crest-derived stem cell, ocular 
development and neural crest-derived embryonic stem cell markers could be tested. This 
technique will allow us to determine the heterogeneity of progenitor cell lineages involved in 
the in vivo stromal wound response, giving not only insights to where cells originate from, but 
also indications into the proportions of each cell population in the wounded stroma. 
Determination of more specific marker profiles of the stromal cells will allow us to isolate 
these cells for in vitro analysis of their functions in the wounded stroma.  
 
2.2 Functional Analysis of Adult Keratocyte to Embryonic-like Cell 
Phenotype Switching 
We aim to functionally determine if keratocytes do veritably switch to an embryonic 
phenotype in the in vivo wounded stroma. We aim to construct an adenoassociated viral 
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vector carrying GFP-mouse Oct-3/4 cDNA to transfect normal cornea stromal cells, as 
experimentally carried out by Galiacy et al. (2010) [603]. Transfected corneas will then 
undergo full thickness incision wounding, resulting in an upregulation of GFP expression by 
activated Oct-3/4-transfected cells. GFP-positive cells will be isolated from the cornea for 
FACS determination of their cell surface antigen profiles, which will give us insights into the 
quantity of total wounded stromal Oct-3/4-positive cells that are generated from adult 
keratocytes and from progenitor cells. Also, a simple coimmunostaining of the GFP-positive 
cells with adult stem cell markers would also give us a rough estimate of the proportion of 
Oct-3/4 positive cells that correspond to progenitor, and thus activated keratocyte cells.  
 
3 Therapeutic Implications for Corneal Opacity Treatments: Autologous 
Grafts 
 Unfortunately human allogenic corneal transplants are not widely used to replace 
corneal stromas with opacity formation. This is due to not only a lack of donors, but also due 
to immune rejection and an increasing popularity of laser eye surgery, often making corneas 
unsuitable for transplantation [670]. In the case for patients suffering from unilateral corneal 
opacity, it can be too much of a risk to transfer a sample of corneal stromal cells from the 
healthy eye to the defect eye. Such a stromal incision could activate the same opacity-forming 
response in the healthy contralateral eye, leaving the patient completely blind.  
 The solution? Wounded rat corneal epithelium with limbal stem cell deficiency has 
shown complete restoration once transplanted with autologous mesenchymal stem cells [671].  
Autologous isolation and injection of neural crest-/bone marrow-derived mesenchymal stem 
cells directly into the corneal stroma could be tested using Lum-/- animal models. This 
technique would supply the opacity bearing corneal stroma with an active progenitor pool, of 
which we could analyse injected stem cell capacities to differentiate into functional 
keratocyte-like cells, potentially reducing corneal stromal opacities.  
 On the other hand, patients could benefit from recent developments in the new huge 
research area based on the generation of pluripotent embryonic-like stem cells from human 
adult tissues, notably neural stem cells, skin fibroblast and keratinocyte cells [573, 622, 672]. 
Recently, a mouse sickle cell anemia model has shown successful replacement of defected 
cells with adult hematopietic stem cells generated from autologous induced pluripotent stem 
cells [673]. This shows that adult cells from a different, but autologous tissue can be 
reprogrammed into cells with a pluripotent embryonic-like cell phenotype to replace defective 
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cells and restore a normal non-diseased phenotype. Could induced pluripotent stem cells be 
injected into corneal stromas harbouring opacities? Following injection, induced 
pluripotent stem cells may differeniate into functional keratocyte-like cells in the stroma 
(Fig.10). Could we go as far as thinking that injected pluripotent cells could even stimulate 
pre-existing stromal myofibroblast cells (being the defective cell phenotype) to differentiate 
into keratocyte cells or apoptose? Not only would this technique overcome the problem of 
corneal graft limitations and failures, but would restore normal corneal stromal transparency, 
restoring vision for corneal opacity sufferers.  
 
 
Schematic representation of adult cell types generated from induced pluripotent stem cells 
involving reprogramming of human skin fibroblasts with genetic factors, and their subsequent 
differentiation into ectodermal, mesodermal and endodermal cell types [674]. Right: Added adaptation 
representing the idea of using induced pluripotent stem cells to restore corneal stromal 
transparency. Do these cells have the ability to repopulate corneal stromas with keratocyte cells, and 
stimulte differentiation and/or apoptosis of pre-existing myofibroblast cells? 
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 4 Conclusion: Project 2  
  In vitro cell studies have suggested that the normal adult corneal stroma harbours a 
cell subpopulation that expresses stem cell markers. These cells express a range of adult and 
embryonic stem cell markers, are multipotent and capable of switching phenotype to that of 
functional keratocyte-like cells. The idea of these cells being stromal progenitor cells with a 
keratocyte replenishment function has been discussed, but never investigated in adult corneal 
stroma repair. 
 We have localised for the first in vivo two different repair cell populations expressing 
a range of stem cell markers in the adult mouse wounded corneal stroma. The first population 
is a stromal progenitor cell subpopulation expressing both adult tissue and embryonic stem 
cell markers. This cell population expands essentially in the stromal wound zone following 
corneal injury, suggesting a potential repair role of these cells. Wether this population is in 
situ or migrates from the limbus or elsewhere is unclear. Secondly, we unexpectedly found 
that the majority of in vivo adult keratocyte cells could be more plastic cells than were 
previously considered to date, being capable of reexpressing their embryonic developmental 
markers (Sox2, Oct-3/4 and Nanog) to play a role in the stromal wound response. Finally, the 
expression of an adult and embryonic neural stem cell marker exclusively by wound zone 
stromal cells in later stroma remodelling stages could correspond equally to both hypothesises 
of activation of keratocyte dedifferentiation and neural crest-derived stromal progenitor cell 
differentiation to eventually regenerate adult keratocyte cells. 
 The precise stem cell marker expression profiles of these repair cell populations are 
required to allow us to distinguish between both cell types, and determine their roles in the 
stromal wound response. Further work is required to deduce the contributions of external 
stromal progenitors and their tissues of origin in order for us to construct a complete flow of 
stromal wound repair cellular events that lead to the regeneration of adult keratocyte cells and 
corneal transparency following injury.  
 
4 Conclusion: Projet 2 
 Des études cellulaires in vitro ont suggéré que le stroma cornéen adulte comporte une 
sous population cellulaire qui exprime des marqueurs de cellules souches adultes et 
embryonnaires. Ces cellules sont multipotentes et capable de se différencier en keratocytes 
phénotypiques et fonctionnels ; l’hypothèse émise est que ces cellules sont des progéniteurs 
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du stroma avec un rôle dans la régénération des kératocytes. Cette hypothèse n’a jamais été 
mise en évidence lors de la réparation stromale in vivo. 
 Pour la première fois, nous avons localisé in vivo deux populations de cellules 
différentes exprimant des marqueurs de cellules souches lors de la cicatrisation cornéenne 
stromale adulte. La première population est une population de progéniteurs du stroma 
exprimant des marqueurs de cellules souches adultes et embryonnaires. Suite à une blessure 
cornéenne, cette population progénitrice se multiplie principalement dans la zone du stroma 
blessé, suggérant un rôle réparateur potentiel de ces cellules. Ces progéniteurs sont peut être 
in situ, migrent d’une niche limbique ou d’un autre tissu. Nous suggérons également qu’in 
vivo la majorité des kératocytes adultes du stroma cornéen blessé acquièrent le phénotype de 
leurs précurseurs embryonnaires (expression du Sox2, Oct-3/4 et Nanog) pour jouer un rôle 
dans la réparation du stroma. Ces cellules sont vraisemblablement plus plastiques qu’on le 
considère. Finalement, nous montrons l’expression du marqueur Nestin par des cellules 
présentes exclusivement dans la zone stromale blessée lors des stades tardifs de la 
cicatrisation. Nestin n’est pas exprimé par des kératocytes adultes, mais exprimé par des 
cellules souches adultes et embryonnaires neurales, nous laissant penser que la régénération 
des kératocytes pourrait se faire via la différenciation de cellules progénitrices issues de la 
crête neurale et la dédifférenciation des kératocytes.  
 Les profils d’expression des marqueurs de cellules souches de chacune de ces 
populations cellulaires sont importants afin de pouvoir les distinguer entre elles et déterminer 
leurs rôles dans la réponse de la cicatrisation stromale. Plus de travaux sont nécessaires pour 
déterminer la contribution au remodelage du stroma par des cellules progénitrices à l’exterieur 
du stroma et leurs tissus d’origine.  
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Summary 
 
High myopia, known as severe shortsightedness, affects 4% of the western population 
and can in extreme cases lead to blindness. In the French Caucasian population high myopia 
is a heterogeneous complex disease, and previous attempts to localise the multiple underlying 
genes have failed. A new GWAS study has been designed based on limiting complex trait 
confounders by changing the previously used phenotype inclusion criterion from refractive 
error to axial length. A new cohort was recruited but not sufficiently completed, thus to 
overcome small cohort effects power calculations indicated the requirement to use a severe 
axial length cohort in a first genome scan, followed by a mutli-step replication analysis that is 
still underway today. The identification of genes involved in myopia development is the first 
step in the understanding of the physiopathology of the disease, but also in the development 
of alternative treatments that today depend on spectacles and contact lens wearing.  
Myopia can be treated by refractive error surgery. This requires damaging the cornea 
which can in an average of 1.75% of patients lead to the development of corneal stromal 
opacities. The mechanisms underlying both normal corneal stromal wound responses and 
stromal opacity formations are not fully elucidated. A handful of in vitro cell studies have 
tried to localise corneal stromal progenitor cells that differentiate into keratocyte-like cells. 
Thus, we investigated the phenotype of cells involved in in vivo stromal wound repair using a 
mouse model of full thickness corneal incision wounding. For the first time in vivo we suggest 
the localisaiton of a normal adult stromal progenitor cell pool that expands in response to 
corneal wounding. We also demonstrate that the majority of adult keratocyte cells in the in 
vivo wounded stroma could revert to a late neural crest embryonic-like cell phenotype 
(expression of Sox2, Oct-3/4, Nanog), indicating that adult keratocyte cells could be relatively 
plastic cells. Expression of a neural adult and embryonic stem cell marker exclusively by 
wound zone stromal cells in later stroma remodelling stages suggests keratocyte cells could 
regenerate via neural crest-derived progenitor cell differentiation and keratocyte 
dedifferentiation. Together our results give new insights into novel stromal progenitor and 
keratocyte cell stromal wound repair functions which could help develop new targets for the 
prevention and treatment of corneal opacity formations.  
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Resumé 
La myopie forte est un trouble sévère de la vision de loin, qui touche 4% de la population 
occidentale, et dans des cas extrêmes peut conduire à la cécité. Dans la population française 
caucasienne la myopie forte est une maladie complexe et les tentatives précédentes de localiser les 
multiples gènes de susceptibilité se sont soldées par des échecs. Une nouvelle étude d’association 
pangénomique a été développée afin de limiter l’hétérogénéité de la myopie forte en remplaçant le 
phénotype d’inclusion d’erreur de réfraction par la longueur axiale. Une nouvelle cohorte a été 
recrutée mais pas suffisamment étoffée. Pour contourner les effets d’une petite cohorte, les calculs 
de puissance ont mis en évidence le besoin d’effectuer un premier scan pangénomique d’une 
cohorte incluant des phénotypes de longueur axiale extrême, suivi par une analyse de réplication 
multi-étapes qui est toujours en cours. L’identification des gènes impliqués dans le 
développement de la myopie forte est le premier pas pour la compréhension de la 
physiopathologie de la maladie, mais également  pour le développement de traitements alternatifs 
qui se limitent actuellement à une correction de la réfraction par le port des lunettes et de lentilles.  
La myopie peut être traitée par la chirurgie réfractive. Cette chirurgie consiste à blesser la 
cornée, ce qui peut conduire à des opacités stromales chez une moyenne de 1,75% des patients 
opérés. Les mécanismes sous-jacents de la réponse réparatrice du stroma et la formation des 
opacités stromales sont élusifs. Des études menées in vitro ont essayé de caractériser une 
population de cellules progénitrices cornéennes stromales qui peuvent se différencier en cellules 
avec un phénotype et une fonction kératocytaire. Nous avons donc analysé les phénotypes des 
cellules impliquées dans la réparation du stroma in vivo à l’aide d’un modèle de cicatrisation 
cornéenne comprenant une blessure incisionnelle de la cornée complète chez la souris adulte. Pour 
la première fois in vivo nous avons identifié une population de cellules stromales progénitrices qui 
se multiplie à la suite d’une blessure cornéenne. Nos montrons également que in vivo, la majorité 
des kératocytes adultes du stroma cornéen après blessure semble acquérir un phénotype de leurs 
précurseurs embryonnaires (expression de Sox2, Oct-3/4, Nanog). Ceci suggère que ces cellules 
sont potentiellement plus plastiques qu'on le considère. L'expression d'un marqueur des cellules 
souches embryonnaires et adultes neuronales par des cellules exclusives de la zone stromale 
blessée lors des stades tardifs de la cicatrisation, laisserait penser que la régénération des 
kératocytes pourrait se faire via la différenciation de cellules progénitrices issues de la crête 
neurale et aussi la dédifférenciation des kératocytes. Nos résultats donnent de nouvelles 
perspectives sur les fonctions des cellules progénitrices stromales et cellules kératocytes adultes 
dans le stroma blessé, fournissant de nouvelles cibles potentielles pour la prévention et le 
traitement des opacités cornéennes. 
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Annex 1 
Project 1:  Published Review 1 entitled “Axial length: An underestimated 
endophenotype of myopia 
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Annex 2 
 
Project 1: Published Review 2 entitled “Axial length of Myopia: A Review of  Current 
Research  
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Annex 3 
Project 1 Recruitment protocol 
Protocole – Etude Génétique de la Myopie 
 
Contacts:  Jackie Butterworth (Doctorante) 
INSERM U563 
Dépt Génétique 
Equipe Malecaze/Calvas 
Bureau B513 (Couloir bleu) 
Tél  Bureau : 05 62 74 45 09 
Mon portable : 06 37 64 98 19 
                                      jacqueline.butterworth@toulouse.inserm.fr 
 
Bérengère Goderiaux (Orthoptiste) 
Portable : 06 59 86 29 22 
goderiauxberengere@yahoo.fr 
 
Description vulgarisée de l'étude (pour les patients): 
 
Une ancienne étude sur une population de familles françaises a localisé une région sur le 
chromosome 7 qui semble contenir un gène impliqué dans le déterminisme de la myopie forte. 
Pour la suite, il est nécessaire de recruter plus de volontaires pour poursuivre l’étude 
génétique (analyse d'association en utilisant le génotypage de 600 marqueurs d'ADN) dans 
cette région. Ceci devrait permettre d’identifier le gène causal (sur les 67 présents dans la 
région).  
 
Le patient s'intéresse parfois aux résultats, il faut donc expliquer que la durée de ce projet est estimée 
à 3 ans. Les patients peuvent nous contacter (numéro du bureau) pour en savoir plus.  
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Patients que vous pouvez recruter : 
 
1. Des myopes forts bilatéraux ≥ -6D (à l’œil le moins atteint) 
 
2. Des témoins sains  
 
SIGNATURE DU CONSENTEMENT INDISPENSABLE 
 
Il faut indiquer si le patient myope fort est un cas familial ou un cas sporadique: 
 
• Cas familial – quand il existe ≥1 myope fort bilatéral (≥ 6D) chez les 
frères/sœurs/parents/oncles et tantes/grands-parents/les enfants du patient. 
 
• Cas sporadique – quand le patient n’a pas d’autres myopes fortes dans sa famille 
(frères/sœurs/parents/oncles et tantes/grands-parents/leurs enfants). Myopes faibles 
bilatéraux (-1D > -6D) acceptés. 
 
Arbre généalogique obligé pour chaque patient myope fort et témoin qui montre les 
frères/sœurs, parents (avec oncles/tantes), grands-parents et leurs enfants sains et myopes 
faibles/myopes fortes. 
 
- Indiquez bien les membres de la familles qui sont myopes faibles ou myopes fortes. 
- Noms/prénoms dans la mesure du possible. 
- Notez les valeurs de réfraction connues des autres membres, sinon récupérez des numéros de 
téléphone des membres douteux si possible. 
- Si le patient ne sait pas s’il existe d’autres myopes dans la famille (membres de la famille   décédés 
ou injoignables): il est toujours possible de le recruter mais bien préciser qu'on n’a pas pu le classer 
comme un cas familial ou sporadique. 
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Utiliser ce système de symboles : 
           
• Témoins – des patients emmétropes sans des myopes fortes dans la famille 
(frères/sœurs/parents/oncles et tantes/grands-parents/leurs enfants). 
 
- Il faut toujours remplir les mêmes feuilles (avec l’examen ophtalmo complet) 
- Le plus simple est de prendre les conjoints, amis etc qui accompagnent le patient à la consultation. 
- On peut prendre des emmétropes qui n'appartiennent pas à la même famille du patient, mais pas 
les conjoints des mères/pères des patients myopes fortes !!! 
 
Les détails civils du patient et origines ethno-géographiques de sa famille 
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 Numéro de téléphone (domicile) le plus important!!!  
 Il faut préciser l'origine ethno-géographique (lieu de naissance) du patient, parents et 
grands-parents. 
-On peut être plus vague pour les grands-parents, comme le numéro du département, le pays ou 
dans le pire de cas le groupe ethnique (par exemple, Asiatique, Maghrébin) si le pays n’est pas 
connu.  
-Si le patient n'est pas sûr il faut le préciser (avec ?), il ne faut pas deviner ! 
 
L'examen ophtalmo complet (sur la feuille et dans la base de données) 
Obligatoire pour les patients myopes forts et les témoins 
• Besoin de savoir si le patient est né(e) prématuré(e) ou pas et une valeur à peu près pour le 
poids de naissance (si le patient ne sait pas entrer ? dans la BDD). 
• L'âge du début de la myopie – important mais une estimation me suffit (par exemple une 
tranche d'âge 10-12 ans). 
• Topographie pour les témoins. 
Je ne peux accepter aucun patient : 
• Atteint d'autres maladies oculaires (la rétinite pigmentaire, la rétinopathie du prématuré, 
dystrophie cornéenne, keratocône, Maladie de Wagner) 
• Patients opérés de cataracte ou laser (sauf si on peut récupérer l’examen ophtalmo qui 
précède la chirurgie). 
• Myopie avec un fort astigmatisme (≤-2) 
• Myopie syndromique (Syndrome de Marfan/Syndrome de Stickler type 1 et 2/Syndrome 
d’Ehlers-Danlos/Juvenile glaucoma/Maladie de Bornholm).  
 
Prélèvements – par les infirmières, on a fourni des tubes 10 ml (EDTA) et les aiguilles dans un 
placard d’une salle de consultation (voir avec Martine Castillon). 
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Annex 4 
Project 1 Patient recruitment file 
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Annex 5 
Project 1 Volonteer recruitment press articles 
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TITLE: Visual Disorders: From Genetics to Cell Biology 
 
SUMMARY 
 
High myopia is a severe ametropia. A new genome-wide study was designed to 
identify the genes underlying the high myopia phenotype in the French Caucasian 
population. A new cohort was recruited but not sufficiently completed, thus requiring a mutli-
step replication analysis that is still underway today. The identification of genes involved in 
myopia development is important for the understanding of the physiopathology of the 
disease.  
Myopia can be treated by refractive error surgery that remodels the cornea. An 
average of 1.75% of patients operated develop corneal stromal opacities. The mechanisms 
underlying the normal corneal stromal wound response are still elusive. We investigated the 
phenotype of cells involved in stromal wound repair using a mouse model of full thickness 
corneal incision wounding. For the first time in vivo we suggest the localisation of a stromal 
progenitor pool that expands in response to corneal wounding. We also demonstrate that 
adult keratocyte cells in the in vivo wounded stroma could revert back to their embryonic cell 
phenotype, indicating that these cells could be relatively plastic. These results give insights 
into novel cell phenotypes in the wounded stroma with potential roles in stromal repair and 
opacity formation that require further investigation.  
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RESUME en français  
 
La myopie forte est une amétropie sévère. Une nouvelle étude de génotypage pangénomique 
visant à identifier de gènes de susceptibilité à la myopie forte dans la population française 
caucasienne a été développée. Une nouvelle cohorte a été constituée. Sa taille modeste, nécessite 
une analyse de réplication en plusieurs étapes qui est en cours. L’identification des gènes impliqués 
est importante pour la compréhension de la physiopathologie de la maladie. 
Un des traitements courant de la myopie est la chirurgie réfractive. En moyenne, 1,75% de 
patients opérés développent des opacités stromales. Les mécanismes de la réponse cicatricielle 
normale du stroma restent méconnus. A la suite d’une blessure transfixiante de la cornée, nous avons 
analysé les phénotypes des cellules dans le stroma cornéen blessé chez un modèle murin. Pour la 
première fois in vivo, nous avons identifié des progéniteurs du stroma qui se multiplient à la suite 
d’une blessure. Nous montrons ainsi que les cellules stromales adultes semblent acquérir un 
phénotype identique à celui de leurs précurseurs embryonnaires dans le stroma blessé. Ceci suggère 
la plasticité de ces cellules. Nos résultats mettent en évidence de nouveaux phénotypes cellulaires 
dont les rôles potentiels dans la réparation du stroma et dans la formation des opacités doivent être 
évalués. 
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